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CHAPTER 1: REVIEW OF LITERATURE 
 
1.1. INTRODUCTION OF HERBAL MEDICINE  
 
Nature has been a source of medicinal agents for thousands of years and an 
impressive number of modern drugs have been derived from natural sources, 
many of these isolations were based on the uses of the agents in traditional 
medicine (Cragg and Newman 2001).  
 
Herbal Medicine is defined as a branch of science in which plant based 
formulations are used to alleviate diseases. It is also known as botanical 
medicine or phytomedicine. Lately phytotherapy has been introduced as more 
accurate synonym of herbal or botanical medicine. In the early twentieth 
century herbal medicine was prime healthcare system as antibiotics or 
analgesics were not as yet discovered. With the advent of allopathic system of 
medicine, herbal medicine gradually lost its popularity among people, which is 
based on the fast therapeutic actions of synthetic drugs (Singh 2007).  
 
Recently there has been a shift in universal trend from synthetic to herbal 
medicine, which can be said „Return to Nature‟. Medicinal plants have been 
known for millennia and are highly esteemed all over the world as a rich 
source of therapeutic agents for the prevention of diseases and ailments 
(Sharma et al. 2008). The search for eternal health and longevity and for 
remedies to relieve pain and discomfort drove early man to explore his 
immediate natural surroundings and led to the use of many plants, animal 
products, minerals etc. and the development of a variety of therapeutic agents 
(Nair and Chanda 2007).  
 
Plants have been used as medicines throughout history. Indeed, studies of 
wild animals show that they also instinctively eat certain plants to treat 
themselves for certain illnesses. In Asia, the practice of herbal medicine is 
extremely well established and documented; as a result, most of the medicinal 
plants that have international recognition come from China and India. In 
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Europe and North America, the use of herbal medicine is increasing fast, 
especially for correcting imbalances caused by modern diets and lifestyles. 
Many people now take medicinal plant products on a daily basis, to maintain 
good health as much as to treat illness. 
 
The importance of medicinal plants and traditional health systems in solving 
the health care problems of the world is gaining increasing attention. Because 
of this resurgence of interest, the research on plants of medicinal importance 
is growing phenomenally at the international level, often to the detriment of 
natural habitats and mother populations in the countries of origin. Most of the 
developing countries have adopted traditional medical practice as an integral 
part of their culture. Historically, all medicinal preparations are derived from 
plants, whether in the simple form of raw plant materials or in the refined form 
of crude extracts, mixtures, etc (Krishnaraju et al. 2005).  
 
In the early development of modern medicine, biologically active compounds 
from higher plants have played a vital role in providing medicines to combat 
pain and diseases. For example, in The British Pharmacopoeia (1932), over 
70% of organic monographs are on plant-derived products. However, with the 
advent of synthetic medicines, and subsequently of antibiotics, the role of 
plant derived therapeutic agents significantly declined (mostly) in the 
economically developed nations. Thus, in The British Pharmacopoeia (1980), 
the share of plant-based monographs fell to approximately 20%. In terms of 
new chemical entities introduced as medicinal agents over the past several 
decades, the share of plant-based drugs has been no more than 2% (Dev 
1997). 
 
This recent resurgence of interest in plant remedies has been spurred on by 
several factors (WHO 2002; WHO 2005; Calixto 2000; Kong et al. 2003): 
 
 The effectiveness of plant medicines 
 Source of direct therapeutic agents 
 Affordable by the people 
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 Raw material base for the elaboration of more complex semi-synthetic 
chemical compounds 
 Models for new synthetic compounds 
 Taxonomic markers for the discovery of new compounds 
 The production, consumption and international trade in medicinal 
plants and phytomedicines are growing and expected to grow in future 
quite significantly 
 Renewable source 
 The preference of consumers for natural therapies, a greater interest in 
alternative medicines and a commonly held belief that herbal products 
are superior to manufactured products 
 A dissatisfaction with the results from synthetic drugs and the belief 
that herbal medicines may be effective in the treatment of certain 
diseases where conventional therapies and medicines have proven to 
be inadequate 
 The high cost and side effects of most modern drugs 
 Improvements in the quality, efficacy, and safety of herbal medicines 
with the development of science and technology 
 Patients‟ belief that their physicians have not properly identified the 
problem; hence they feel that herbal remedies are another option 
 A movement towards self-medication 
 
Investigation of the chemical and biological activities of plants during the past 
two centuries have yielded compounds for the development of modern 
synthetic organic chemistry as a major route for discovery of novel and more 
effective therapeutic agents (Nair et al. 2007). 
 
1.2. INDIAN SYSTEM OF MEDICINE 
 
Ayurveda, meaning the “science of life,” is said to be the oldest and most 
complete medical system in the world and dates back to 5000 B. C.  There is 
no denying the benefits of Ayurvedic treatments that several Indians and 
others across the globe have experienced. The diagnostic and treatment 
procedures used are unique and are still valid today as are its foundational 
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principles of panchamahabhutha (five basic elements of nature), tridosha 
(three humours) and prakrithi (individual constitution) (Venkatasubramanian 
2007).  
 
Ayurveda has vast literature in Sanskrit and various Indian languages, 
covering various aspects of diseases, therapeutics, and pharmacy (Dev 
1999). The original source of Ayurveda is the Vedas and the texts known as 
the Samhitas, which are treatises on health care and describe medical 
procedures, including surgery and a form of massage of vital energy points 
(Ebadi 2007). The earliest references to such plants are found in the Rig Veda 
and the Atharva Veda, dating back to the second millennium B.C. The 
Charaka Samhita (900 B.C.) is the first recorded treatise fully devoted to the 
concepts and practice of Ayurveda; its primary focus was therapeutics 
(Charaka Samhita 1949; Sharma 1981). This text sets out all the fundamental 
principles of Ayurveda but concentrates most of its attention on digestion 
(described as internal fire, or agni). Another early classic, the Susruta 
Samhita, focuses on surgical techniques (Majumdar 1971; Krishnamurthy 
1991). The Astanga Hridayam, written in about 500 A.D., sets out most of the 
detailed principles of Ayurveda, including the dosha and subdosha (Grade 
1954; Sharma 1979). The Madhava Nidana (800-900 A.D.) was the next 
important milestone; it is the most famous Ayurvedic work on the diagnosis of 
diseases. As per Ayurveda, every material (dravya) is a manifestation of five 
elements (earth, water, fire, air and space) in different proportions. The 
material could be living as well as non-living things. Depending on the 
predominant combination of the elements, nature can be categorized into 
three doshas, namely vata, pitta and kapha:  
 
 Vata, linked to the wind, the force that controls movement and the 
functioning of the nervous system in the body  
 Pitta, the force of heat and energy, linked with the sun, that controls 
digestion and all biochemical processes in the body  
 Kapha, the force of water and tides, influenced by the moon, the 
stabilizing influence that controls fluid metabolism in the body  
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When balanced these three forces ensure that the body is healthy, but when 
they are “abnormal” or unbalanced, disease follows (Thomas 1997). 
 
India has a rich cultural heritage of traditional medicines which chiefly 
comprised the two widely flourishing systems of treatments i.e. Ayurvedic and 
Unani systems since ancient times (Surana et al. 2008). Ayurveda is 
considered not just as an ethnomedicine but also as a complete medical 
system that takes in to consideration physical, psychological, philosophical, 
ethical and spiritual well being of mankind. It lays great importance on living in 
harmony with the Universe and harmony of nature and science. This universal 
and holistic approach makes it a unique and distinct medical system. This 
system emphasizes the importance of maintenance of proper life style for 
maintaining positive health (Ravishankar and Shukla 2007).  
 
Nature has bestowed upon us a very rich botanical wealth and a large number 
of diverse types of plants grow wild in different parts of our country. In India, 
the use of different parts of several medicinal plants to cure specific ailments 
has been in vogue from ancient times (Bhattacharjee 1998). India is one of 
the 12-mega biodiversity centers having about 10% of the world‟s biodiversity 
wealth, which is distributed across 16 agro-climatic zones (Shiva 1996). In 
India around 20,000 medicinal plant species have been recorded recently 
(Dev 1997), but more than 500 traditional communities use only about 800 
plant species for curing different diseases (Kamboj 2000). With a view to 
strengthen the medicinal plants sector all over the country as well as to 
conserve the wild stock, the NMPB (National Medicinal Plants Board) was set 
up by the Government of India in 2000. The prime objective of setting up the 
board was to establish an agency which would be responsible for coordination 
of all matters with respect to the medicinal plants sector, including drawing up 
policies and strategies for in situ conservation, cultivation, harvesting, 
marketing, processing, drug development, etc. (Kala and Sajwan 2007). In 
India, several steps have been taken to improve the quality of Ayurvedic 
medicines. Good manufacturing practice (GMP) guidelines have been 
introduced so as to ensure quality control. Medicinal plant boards have been 
constituted at state and central level to inspire people particularly the farmers 
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for adopting cultivation of medicinal plants. Herbal gardens have been 
developed to make common man conversant with the rich heritage of Indian 
system of medicine. Various institutes like National Institute of Pharmaceutical 
Education and Research (NIPER), National Botanical Research Institute 
(NBRI), Central Institute of Medicinal and Aromatic Plants (CIMAP) and 
Central Research Drug Institute (CDRI) are playing pivotal role in laying down 
standards for Ayurvedic system of medicine (Singh 2007). 
 
1.3. THE RECENT DEVELOPMENT OF NATURAL DRUGS 
 
A total of 122 biologically active compounds have been identified, derived only 
from 94 species of plants. A conservative estimate of the number of flowering 
plants occurring on the planet is 2,50,000. Of these, only about 6% have been 
screened for biological activity and a reported 15% have been evaluated 
phytochemically. Consistent findings should be carried out to discover a 
probable abundance of medicinal extracts in these plants (Turker and Usta 
2008). 
 
The use of traditional medicine and medicinal plants in most developing 
countries, as a normative basis for the maintenance of good health, has been 
widely observed (UNESCO 1996). Furthermore, an increasing reliance on the 
use of medicinal plants in the industrialized societies has been traced to the 
extraction and development of several drugs and chemotherapeutics from 
these plants as well as from traditionally used rural herbal remedies 
(UNESCO 1998).  
 
The Pharmaceutical Research and Development Committee report of Ministry 
of Chemicals, Government of India also underscores the importance of 
traditional knowledge (Mashelkar 1999). The increasing use of traditional 
therapies demands more scientifically sound evidence for the principles 
behind such therapies and for effectiveness of medicines. Recent advance in 
the analytical and biological sciences, along with innovations in genomics and 
proteomics can play an important role in validation of these therapies. 
Western scientific community views traditional medicines cautiously and 
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stresses the concerns related to research, development and quality 
(Patwardhan et al. 2003; Fabricant and Farnsworth 2001). 
 
A large proportion of such medicinal compounds have been discovered with 
the aid of ethnobotanical knowledge of their traditional uses. The rich 
knowledge base of countries like India and China in medicinal plants and 
health care has led to the keen interest by pharmaceutical companies to use 
this knowledge as a resource for research and development programs in the 
pursuit of discovering novel drugs (Krishnaraju et al. 2005). 
 
The rapid pace of research and development in herbal medicine has made it 
an interdisciplinary science. If any scientific monograph of a medicinal plant is 
seen, it can be concluded that knowledge of Alternative and Complementary 
Systems of Medicines like Ayurveda, botany, pharmacognosy and 
phytochemistry, biochemistry, ethnopharmacology and toxicology is integral 
part of herbal medicine. There has been an explosive growth of herbal drug 
industry recently. Data analysis has shown that more and more people are 
consulting the herbal medicine practitioners. World Health Organization has 
also identified the importance of herbal medicines. According to a study from 
U.S., 60-70% patients living in rural areas are dependent on herbal medicine 
for their day to day diseases. Several authors have reported favorable results 
with herbal drugs (mostly in the form of extracts) either in animal or in human 
studies (Padma 2005). 
 
1.4. STANDARDIZATION OF PHYTOMEDICINE 
 
Herbs are natural products and their chemical composition varies depending 
on several factors, such ac botanical species, used chemotypes, the 
anatomical part of the plant used (seed, flower, root, leaf, fruit rind, etc.), also 
storage, sun, humidity, type of ground, time of harvest, geographic area etc. 
This variability can result in significant differences in pharmacological activity: 
involving both pharmacodynamics and phamacokinetics issues (Park 2008).  
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It is very important that a system of standardization is established for every 
plant medicine in the market because the scope for variation in different 
batches of medicine is enormous (Ekka et al. 2008). Herbal medicines are 
very different from well-defined synthetic drugs. For example, the availability 
and quality of the raw materials are frequently problematic; the active 
principles are frequently unknown; and standardization, stability and quality 
control are feasible but not easy. Strict guidelines have to be followed for the 
successful production of a quality herbal drug. The medicinal plants should be 
authentic and free from harmful materials like pesticides, heavy metals, 
microbial and radioactive contamination. The source and quality of raw 
materials, good agricultural practices and manufacturing processes are 
certainly essential steps for the quality control of herbal medicines and play a 
pivotal role in guaranteeing the quality and stability of herbal preparations. 
The herbal extract should be checked for biological activity in experimental 
animal models. The bioactive extract should be standardized on the basis of 
active compound. The bioactive extract should undergo limited safety studies 
(De Smet 1997; Blumenthal et al. 1998; EMEA 2002; WHO 2004; Ahmad et 
al. 2006; Samy and Gopalakrishnakone 2007).  
 
1.5. MODERN MEDICINE FROM HIGHER PLANTS 
 
Natural products play an important role in the field of new drugs research and 
development, but it was not until the 19th century that man began to isolate 
the active principles of medicinal plants and the landmark discovery of quinine 
from Cinchona bark was made by the French scientists Caventou and 
Pelletier. Prior to World War II, a series of natural products isolated from 
higher plants became clinical agents and a number of them are still in use 
today (Kong et al. 2003). 
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Table 1.1 Some examples of plant derived drugs and their clinical    
applications  
 
Name of the plants Drugs Clinical application 
Rauwolfia serpentina Serpentine Hypertension and lowering 
of blood pressure 
Catharanthus rosesus Vinblastine Hodgkins, choriocarcinoma, 
non-hodgkins lymphomas, 
leukemia in children, 
testicular and neck cancer 
Phodophyllum emodi Phophyllotoxin Testicular, small cell lung 
cancer and lymphomas 
Papaver somniferum Codeine, morphin Headaches, arthritis and 
inducing sleep. 
Ephedra sinica Ephedrine Respiratory ailments 
Cinchona spp. Quinine Fevers 
Cephaelis spp. Emetine To induce vomiting and cure 
dysentery. 
Digitalis leaves Digoxin Heart therapy 
 
Natural products have served as a major source of drugs for centuries, and 
about half of the pharmaceuticals in use today are derived from natural 
products. Quinine, theophylline, penicillin G, morphine, paclitaxel, digoxin, 
vincristine, doxorubicin, cyclosporin, and vitamin A all share two important 
characteristics: they are cornerstones of modern pharmaceutical care, and 
they are all natural products (Ebadi 2007). 
 
In fact, most of the major anticancer drugs are derived from plants or 
microorganisms. Important examples include bleomycin, doxorubicin, 
daunorubicin, vincristine, vinblastine, mitomycin, streptozocin, and most 
recently, paclitaxel, ironotecan (a camptothecin derivative), and etoposide and 
tenoposide (podophyllotoxin derivatives) (Ebadi 2007). 
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1.6. MARKET POTENTIAL OF PHYTOMEDICINE  
 
Herbal medicines are readily available in the market from health food stores 
without prescriptions and are widely used  all over the world. The utilization of 
herbal drugs is on the flow and the market is growing step by step. The 
annual turnover of the Indian herbal medicinal industry is about Rs. 2,300 
crore as against the pharmaceutical industry‟s turnover of Rs. 14,500 crores 
with a growth rate of 15 percent (Krishnan 1998). The major pharmaceuticals 
exported from India in the recent years are isabgol, opium alkaloids, senna 
derivatives, vinca extract, cinchona alkaloids, ipecac root alkaloids, 
solasodine, diosgenine/16DPA, menthol, gudmar herb, papian, rauwolfia guar 
gum, jasmine oil, agar wood oil, sandal wood oil,  etc (Kokate et al. 2005). 
The global market for herbal medicines currently stands at over $60 billion 
annually. The sale of herbal medicines is expected to get higher at 6.4% an 
average annual growth rate (Inamdar et al. 2008). 
 
Herbal drugs are marketed in various forms. They are available in both 
classical forms (tablets, powder, decoction, medicated oil, medicated ghee, 
fermented products) and modern drug presentation forms like capsules, 
lotions, syrups, ointments, creams, granules etc. There are more than 8500 
manufacturers of herbal drugs in the country (Jain 2001).  
 
Thus, plant-based therapeutic agents continue to have scientific, social, and 
commercial significance and appear to be gathering a momentum in health-
relevant areas. A study of the process by which the traditional or more recent 
plant-based molecular drugs or the new breed of herbal drugs came to be 
used in present-day medicine reveals that, in over 70% of the cases, the 
starting point has been some reference to the use of that plant as an 
indigenous cure in a folklore or traditional system of medicine of one culture or 
other.  
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1.7. ROLE OF WORLD HEALTH ORGANIZATION IN PHYTOMEDICINE  
 
The legal process of regulation of herbal medicines changes from country to 
country. The reason for this involves mainly cultural aspects and also the fact 
that herbal medicines are rarely studied scientifically. World Health 
Organization (WHO) has published guidelines in order to define basic criteria 
for evaluating the quality, safety and efficacy of herbal medicines aimed at 
assisting national regulatory authorities, scientific organizations and 
manufacturers in this particular area (Akerele 1993). The salient features of 
WHO guidelines were: 1). Quality assessment: Crude plant materials or plant 
extract preparation and finished product. 2). Stability: Shelf life. 3). Safety 
assessment: Documentation of safety based on experience and toxicological 
studies. 4). Assessment of efficacy: Documented evidence of traditional use 
and activity determination (Animals and human).  
 
Since ages, literature has revealed plants to be the most important source of 
medicines for human health (Balandrin et al. 1993). According to the findings 
of the World Health Organization, up to 80% of the world‟s population relies 
on plants for their primary health care (Farnsworth et al. 1985; WHO 2002; 
Dash et al. 2005).  
 
1.8. NEED OF THE HOUR 
 
Herbal medicines are an essential and growing part of the international 
pharmacopeia. Knowledge of their medicinal properties is growing as a result 
of research and testing, which will make them an increasingly safe alternative 
or a preferred option to allopathic medicine. Today, there is a renewed 
interest in traditional medicine and an increasing demand for more drugs from 
plant sources. This revival of interest in plant-derived drugs is mainly due to 
the current widespread belief that “green medicine” is safe and more 
dependable than the costly synthetic drugs, many of which have adverse side 
effects (Parekh and Chanda 2006). There is a growing interest in correlating 
phytochemical constituents of a plant with its pharmacological activity (Gupta 
1994; Vaidya 1994). Scientists have even started correlating the botanical 
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properties of plants with their pharmacological activity (Rawat et al. 1997). In 
future, more co-ordinated multidimensional research aimed at correlating 
botanical and phytochemical properties to specific pharmacological activities 
is expected (Dahanukar et al. 2000). 
 
Thus, determining the biological activities of plants used in traditional 
medicine is helpful to the rural communities and informal settlements. Several 
studies are currently being undertaken to isolate the active compound(s) by 
bioassay-guided fractionation from the species that show high biological 
activity during screening. With the availability of primary information, further 
studies can be carried out like standardization of the extracts, identification 
and isolation of active principles and pharmacological studies of isolated 
compound. Therefore, these scientific investigations may be utilized to 
develop drugs for diseases. Further research is desired to isolate the 
compounds responsible for the observed biological activity.  
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CHAPTER 2: SCREENING OF SOME MEDICINAL PLANTS FOR 
ANTIMICROBIAL PROPERTY 
 
2.1. INTRODUCTION 
 
The discovery and development of antibiotics are among the most powerful 
and successful achievements of modern science and technology for the 
control of infectious diseases. However, the rate of resistance of pathogenic 
microorganisms to conventionally used antimicrobial agents is increasing with 
an alarming frequency (Ge et al. 2002; Nair and Chanda 2005; Neogi et al. 
2008). Isolation of microbial agents less susceptible to regular antibiotics and 
recovery of resistant isolates during antibacterial therapy is increasing 
throughout the world (Cohen 2002; Hancock 2005). In addition to this problem 
antibiotics are sometimes associated with adverse side effects on the host, 
which include hypersensitivity, depletion of beneficial gut and mucosal 
microorganisms, immunosuppression and allergic reactions (Al-Jabri 2005). 
The number of multi-drug resistant microbial strains and the appearance of 
strains with reduced susceptibility to antibiotics are continuously increasing. 
This increase has been attributed to indiscriminate use of broad-spectrum 
antibiotics, immunosuppressive agent, intravenous catheters, organ 
transplantation and ongoing epidemics of HIV infection (Ng 1994; Dean and 
Burchard, 1996; Gonzalez et al, 1996). Examples include methicillin-resistant 
staphylococci, pneumococci resistant to penicillin and macrolides, 
vancomycin-resistant Enterococci as well as multi-drug resistant gram-
negative organisms (Norrby et al. 2005). There is an urgent need to control 
antimicrobial resistance by improved antibiotic usage and reduction of hospital 
cross-infection (Voravuthikunchai and Kitpipit 2005; Sung and Lee 2007), 
however, the development of new antibiotics should be continued as they are 
of primary importance to maintain the effectiveness of antimicrobial treatment 
(van der Waaij and Nord 2000; Marchese and Shito 2001). 
 
The potential for developing antimicrobials from higher plants appears 
rewarding as it will lead to the development of a phytomedicine to act against 
Chapter 2: Antimicrobial screening 
 20 
microbes; as a result, plants are one of the bedrocks for modern medicine to 
attain new principles (Evans et al. 2002). Plant based antimicrobials represent 
a vast untapped source of medicine. Plant based antimicrobials have 
enormous therapeutic potential as they can serve the purpose without any 
side effects that are often associated with synthetic antimicrobials. Further 
continued exploration of plant derived antimicrobials is needed today (Hussain 
and Gorsi 2004). 
 
Historically, plants have provided a source of inspiration for novel drug 
compounds, as plant derived medicines have made large contributions to 
human health and well-being (Iwu et al. 1999). Medicinal plants constitute an 
effective source of both traditional and modern medicines. Herbal medicine 
has been shown to have genuine utility and about 80% of rural population 
depends on it as primary health care (Farnsworth et al. 1985; Akinyemi et al. 
2005). Over the years, the World Health Organization advocated that 
countries should encourage traditional medicine with a view to identifying and 
exploiting aspects that provide safe and effective remedies for ailments of 
both microbial and non-microbial origins (WHO 1978). In recent years, 
pharmaceutical companies have spent a lot of time and money in developing 
natural products extracted from plants, to produce more cost effective 
remedies that are affordable to the population (Doughari 2006). 
 
Scientific experiments on the antimicrobial properties of plant components 
were first documented in the late 19
th 
century (Zaika 1975). It is estimated that 
today, plant materials are present in, or have provided the models for 50% 
Western drugs (Robbers et al. 1996). Many commercially proven drugs used 
in modern medicine were initially used in crude form in traditional or folk 
healing practices, or for other purposes that suggested potentially useful 
biological activity. The primary benefits of using plant derived medicines are 
that they are relatively safer than synthetic alternatives, offering profound 
therapeutic benefits and more affordable treatment. 
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The medicinal plants around the world contain many compounds with 
antibacterial activity (Marjorie 1999). Many efforts have been made to 
discover new antimicrobial compounds from various sources such as micro-
organisms, animals, and plants. Systematic screening of them may result in 
the discovery of novel effective antimicrobial compounds (Tomoko et al. 
2002). The use of botanical medicines is generally on the rise in many parts of 
the world (Bbosa et al. 2007).  The screening of plant extracts and plant 
products for antimicrobial activity has shown that plants represent a potential 
source of new anti-infective agents (Amani et al. 1998; Salvat et al. 2001; 
Costa et al. 2008). Numerous experiments have been carried out to screen 
natural products for antimicrobial property (Martinez et al. 1996; Ateb and 
Erdourul 2003; Nair and Chanda 2006; Nair et al. 2007a; Ndhlala et al. 2009).  
 
Considering the above, it can be stated that plants are valuable sources for 
new compounds and should receive special attention in research strategies to 
develop new antimicrobials urgently required in the near future (Shahidi 
Bonjar et al. 2004; Aslim and Yucel 2008).  
 
In the present study, methanol and acetone extracts of 53 medicinal plants 
were screened for antimicrobial activity against 15 different standard strains of 
microorganisms. Further, the most potent plant extracts (4) were screened for 
antimicrobial activity against 24 standard strains of microorganisms and 74 
clinically isolated microorganisms.  
 
2.2. MATERIALS AND METHODS 
 
2.2.1. Plant materials 
 
Fresh plant/plant parts were collected randomly from Gujarat region, India 
(Anand Agricultural University, Anand; Junagadh Agricultural University, 
Junagadh and Saurashtra University campus, Rajkot). The details of the 
plant/plant parts screened, their families, voucher number, vernacular names 
and their therapeutic uses are given in Table 2.1 (Anjaria et al. 2002; Sriram 
et al. 2004; Khare 2007). Plants were compared with voucher specimens 
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deposited by Dr. P. S. Nagar at Department of Biosciences, Saurashtra 
University, Rajkot, Gujarat, India. Fresh plant materials were washed in tap 
water, air dried and then homogenized to fine powder and stored in airtight 
bottles. 
 
2.2.2. Extraction   
 
10 g of air-dried powder was taken in 100 ml of petroleum ether in a conical 
flask, plugged with cotton wool and then kept on a rotary shaker at 190-220 
rpm for 24 h. After 24 h, the supernatant was discarded and petroleum ether 
was evaporated from the powder. This dry powder was then taken in 100 ml 
of solvent (methanol or acetone) in a conical flask, plugged with cotton wool 
and then kept on a rotary shaker at 190-220 rpm for 24 h. After 24 h, the 
extracts were centrifuged at 5000 g for 10 min, the supernatant was collected, 
solvents were evaporated, and the dry extract was stored at 4oC in airtight 
bottles. The extraction was done at least three times for each plant and the 
mean values of extractive yields are presented (Vaghasiya and Chanda 
2007). 
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Table 2.1 Ethnobotanical information of the plants screened for antimicrobial activity  
 
No. Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
1 Abutilon glaucum (Cav.) (Malvaceae, Balbij) Leaf + stem (PSN42) Pectoral, demulcent, diuretic 
2 Adenanthera pavonina L. 
 (Mimosaceae, Raktchandan/Ratanjali) 
Leaf Boils, inflammation, ophthalmia, chronic 
rheumatism, gout, haematuria 
3 Agave vera Cruz, Mill. (Agavaceae, Agave) Leaf - 
4 Alangium salvifolium (Linn. f.) Wang. 
(Alangiaceae, Ankola) 
Leaf 
(PSN 346) 
Rheumatism, leprosy, inflammation and for 
external and internal application in case of 
bites of rabid  dog  
5 Alpinia speciosa (Wendl.) K.Schum.  
(Zingiberaceae, Sthulgranthi) 
Leaf + stem Diuretic, hypertension, antiulcerative, 
spasmolytic. 
6 Argemone mexicana L.  
(Papaveraceae, Darudi) 
Leaf + stem 
(PSN 11)  
Infestation, skin disease, leprosy, pruritus, 
blennorrhagia, inflammations, all type of 
poisoning  
7 Argyreia speciosa Sweet 
(Convolvulaceae, Samudra Shokha/ Bidhaaraa) 
Leaf + stem 
(PSN492) 
Tonic, aphrodisiac, nervine, diuretic, 
antirheumatic, hypotensive, spasmolytic, skin 
diseases, rubefacient, topically stimulant 
Chapter 2: Antimicrobial screening 
 24 
 
 
No. 
 
Name of the plant 
(Family, Vernacular name) 
 
Parts used 
(Voucher no.) 
 
Ethnomedicinal use 
8 Aristolochia bracteolata Lam. 
(Aristolochiaceae, Kidamari) 
 
Whole plant 
(PSN662) 
 
Constipation, inflammation, foul ulcers, boils, 
syphilis, gonorrhoea, eczema and intermittent 
fevers 
9 Aristolochia indica L. 
(Aristolochiaceae, Nodvel/ Isarmuula) 
Leaf In venomous insect bites and internally in 
intermittent fevers, blood complains, 
Oxytocic, abortifacient, emmenagogue. 
10 Asphodelus tenuifolius Cav. (Liliaceae, Dungro) Leaf + stem (PSN726) Diuretic, inflamed part, antiulcer 
11 Baliospermum montanum  
(Euphorbiaceae, Danti) 
Leaf + stem Purgative,  antiasthmatic,  ache and pain of 
joints, cathartic, antidropsical. 
12 Boerhavia diffusa L.  
(Nyctaginaceae, Satodi/ Punarnavaa) 
Leaf + stem  
(PSN 631) 
Asthma, anemia,  inflammation, hepatic 
disorder, rheumatic and gouty complains, 
chronic peritoneal conditions, heart disease 
and kidney ailments  
13 Bombax ceiba L. 
(Bombacaceae, Simlo)  
Leaf 
(PSN 74) 
Dysentery, influenza, menorrhagia, blood 
impurities, healing  
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No. 
 
Name of the plant 
(Family, Vernacular name) 
 
Parts used 
(Voucher no.) 
 
Ethnomedicinal use 
 
14 
 
Carissa carandas L. var. 
(Apocynaceae, Karamda) 
 
Leaf + stem 
(PSN440) 
 
Antiscorbutic, stomachic, refrigerant, 
digestive, astringent, anthelmintic   
15 Cassia occidentalis L. 
(Caesalpiniaceae, Kasundro) 
Leaf + stem 
(PSN254) 
Inflammation, diabetes, elephantiasis, 
leprosy, ulcers, constipation, hicough and 
fever, purgative, diuretic, febrifugal, 
expectorant, stomachic, skin diseases 
16 Casuarina equisetifolia L. 
(Casuarinaceae, Sharu) 
Leaf + stem + fruit  
(PSN713) 
Astringent, antidiarrhoeal, antispasmodic, 
used in colic, hypoglycaemic. 
17 Celastrus paniculatus  Willd.  
(Celastraceae, Malkangni) 
Leaf 
(PSN117) 
Painful joints, hemiflegia ulcers, skin disease, 
piles, brain tonic, diaphoretic, febrifugal, 
mental depression, hysteria, scabies, 
eczema, wounds, rheumatic pains, paralysis. 
18 Citrus medica L.  
 (Rutaceae, Bijoru)  
Leaf 
(PSN 106) 
Bilious fever, dyspepsia, inflammation, 
antiscorbutic, astringent, carminative, 
stomachic, antibacterial,  dyspepsia, cold. 
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No. Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
19 Clerodendrum phlomidis 
(Verbenaceae, Arani, Bhaandira) 
Leaf + stem 
(PSN602) 
Convalescence of measles, neglected 
syphilitic complains, obesity, diarrhoea, 
worms. 
20 Datura innoxia Mill.  
(Solanaceae, Daturo) 
Leaf  
(PSN 530) 
Dysmenorrhoea, neuralgia, sciatic, breast 
inflammation. 
21 Desmodium gangeticum L. DC 
(Fabaceae, Saliparni) 
Leaf  
(PSN 182) 
Anorexia, dysentery, dyspepsia, hemorrhoids, 
fever, gout, cough, inflammation, asthma, 
bronchitis, cardiopathy, debility  
22 Drypetes roxburghii  (Wall.) Hurasawa 
(Euphorbiaceae, Putranjiva) 
Leaf Burning sensation, hyperdipsia, constipation, 
elephantiasis, inflammations, strangury,  
habitual abortion, sterility  
23 Ficus carica L.  
(Moraceae, Anjir) 
Leaf 
(PSN 704) 
 
Constipation, renal and vesicle calculi, 
visceral obstruction, piles, gout and externally 
ulcers, gum, boils, asthma. 
24 Gymnema sylvestre (Retz.) R. Br. 
(Asclepiadaceae, Madhunasini) 
Leaf + stem In snake bites, swallon glands and visceral 
enlargement, internally in cough, diabetes, 
fever. 
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No. Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
25 Hemidesmus indicus (L.) R.Br. 
(Asclepiadaceae, Anantmul) 
Leaf 
(PSN465) 
Chronic cough, syphilitic, cachexia, 
lecorrhoea, strangury dyspeptic, nutritional 
disorders 
26 Holoptelea integrifolia (Roxb.) Planch.  
 (Urticaceae, Chibil/Charel) 
Leaf 
(PSN 711) 
Internally and externally used in rheumatism, 
scabies, ringworm. 
27 Jasminum auriculatum Vahl. 
(Oleaceae, Juuhi) 
Leaf Astringent, cardiac tonic, ringworm, chronic 
fistulas 
28 Leptadenia reticulata (Retz.) Wight & Arn. 
(Asclepidaceae, Dodishaak) 
Leaf + stem 
(PSN454) 
Stimulant and restorative, habitual abortion, 
skin diseases. 
29 Leucas aspera (Willd.) Link.  
(Labiatae, Chotahalkusa/Kubo) 
Leaf + stem  
(PSN 617) 
Colic, dyspepsia, verminosis, chronic skin 
eruption, cough, intermittent fevers, ulcers  
30 Madhuca indica Gmelin. 
(Sapotaceae, Mahudo) 
Leaf 
(PSN 426) 
Verminosis, gastropathy, Dipsia, bronchitis, 
consumption, dermatopathy, rheumatism, 
cephalgia and hemorrhoids  
31 Mangifera indica L.  
(Anacardiaceae, Keri) 
 
Seed Inflammation, constipation, hyperpiesia, 
hemorrhages, wounds, ulcers, dysentery  
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No. Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
32 Maranta arundinacea L. 
(Marantaceae, Kookaineer) 
Leaf + stem Nutritive, demulcent, acute diarrhea, 
gastroenteritis  
33 Merremia turpethum (L.) Shah and Bhatt 
(Convolvulaceae, Nashottar) 
Leaf Leucoderma, itch, ulcers, constipation, 
abdominal troubles, inflammation, anaemia, 
fever, jaundice 
34 Murraya paniculata (L.) Jack 
(Rutaceae, Kamini) 
Leaf + stem 
(PSN110) 
regulate fertility 
35 Origanum marjoram L.  
(Lamiaceae, Dawanam) 
Leaf + stem 
 
Antiseptic, Antispasmodic, Cholagogue, 
Tonic, Emmenagogue, Stimulant  
36 Phyla nodiflora (L.) Greene 
(Verbenaceae, Ratvelio) 
Leaf + stem Burning sensation, fever, ulcers, asthma, 
bronchitis, gonorrhoea 
37 Phyllanthus reticulatus Poir 
(Euphorbiaceae, Kamboi) 
Leaf + stem Burning sensation, strangury, sores, diarrhea, 
skin eruption 
38 Pluchea arguta Boiss 
(Asteraceae, Rashna)  
Leaf + stem 
(PSN402) 
Arthritis, constipation, respiratory disease, 
inflammation  
39 Randia dumetorum Lam. 
(Rubiaceae, Gangeda) 
Leaf + stem 
(PSN364) 
Nervine, calmative, antispasmodic, emetic, 
anthelmintic, abortifacient 
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No. Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
40 Rauvolfia tetraphylla L. 
(Apocynaceae, Bada Chand) 
Leaf + stem Sedative, hypotensive, skin diseases, to 
destroy parasites. 
41 Scaevola koenigii Vahl. 
(Goodeniaceae, Bhadraaksha) 
Leaf  
(PSN421) 
Digestive, carminative, applied externally on 
tumours and swollen legs, dysentery. 
42 Scindapsus officinalis (Roxb.) Schott 
(Araceae, Gajapipal) 
Leaf Pruritus, adentitis, ripening boils, ostalgia, 
arthralgia, malaria, inflammations, ulcers, 
Anthelmintic, purgative and tonic. 
43 Strychnos nux-vomica L 
(Loganiaceae, Zerchochlu) 
Leaf + stem Cholera, chronic wounds, ulcers, paralytic 
complains, diabetes, asthma, malaria  
44 Tamarindus indica L.  
(Caesalpiniaceae, Amli) 
Leaf + stem 
(PSN 263) 
Acidity, dyspepsia, constipation, intoxication 
from  spirituous, liquors, scurvy, bleeding 
piles, dysentery 
45 Tecomella undulata (Sm.) Seem.  
 (Bignoniaceae, Ragatrohido) 
Leaf + stem 
(PSN 566)  
Remedy for syphilis, spleen diseases  
46 Tephrosia purpurea (L.) Pers. 
(Fabaceae, Sarpankho) 
Leaf  
(PSN223) 
Jaundice, skin disease, elephantiasis, 
dyspepsia, asthma, pimples, syphilis, 
gonorrhea 
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No. 
Name of the plant 
(Family, Vernacular name) 
Parts used 
(Voucher no.) 
Ethnomedicinal use 
47 Thespesia populnea (L.) Sol ex Correa  
(Malvaceae, Paraspipal)  
Leaf  
(PSN 71) 
Cough, psoriasis, skin disease, dysentery, 
diabetes, gonorrhea, indigestion, ulcers.  
48 Tinospora cordifolia (Willd.) Miers Hook. F & Th  
(Menispermaceae, Galo) 
Leaf + stem  
(PSN 8) 
Malaria, rheumatism, dyspepsia, antipyretic, 
antiperiodic, anti-inflammatory, antirheumatic, 
spasmolytic, hypoglycaemic, hepatoprotective 
49 Trienthema monogyna L.  
(Aizoaceae, Satodo) 
Leaf + stem  
(PSN 308) 
Alexiteric, analgesic, diuretic, bronchitis,  
inflammation, ulcers, itching, night blindness  
50 Trigonella foenum-graecum L.  
(Fabaceae, Methi) 
Leaf + stem 
(PSN 230)  
Antipemic, anticholestremic, demulcent, 
diuretic, carminative aphroedisiac  
51 Vitex negundo L.  
(Verbenaceae, Nagod) 
Leaf + stem 
(PSN611) 
Catarrhal dengue, puerperal fever, splenic 
enlargement, irritable bladder, rheumatism, 
dyspepsia, colic worms, liver disease,  
52 Woodfordia fruticosa Kurz. 
(Lythraceae, Dhavdi) 
Leaf 
(PSN303) 
Astringent, acrid, refrigerant, stimulant, 
depurative, styptic, uterine sedative, 
constipating, antibacterial, skin disease 53 Woodfordia fruticosa Kurz. 
(Lythraceae, Dhavdi) 
Stem 
(PSN303) 
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2.2.3. Microorganisms  
The standard microorganisms (American Type Culture Collection) were 
obtained from National Chemical Laboratory, Pune, India and clinically 
isolated microorganisms were obtained from Department of Microbiology, 
Smt.N.H.L. Municipal Medical College, Sheth V.S. General Hospital, 
Ahmedabad and Spandan Diagnostics, Rajkot. The bacterial strains were 
grown in the nutrient broth and maintained on nutrient agar slants at 4oC, 
while fugal strains were grown in sabourad broth and maintained on MGYP 
slants at 4oC. 
 
2.2.4. Preparation of the extract for antimicrobial assay 
 
Plant extracts were dissolved in 100% dimethylsulphoxide (DMSO) for 
antimicrobial study. Concentration of methanol and acetone extracts of 53 
plants was 600 µg/disc. Concentrations of methanol extracts of four selected 
plants were 600 µg/disc and 1200 µg/disc.   
 
2.2.5. Antibiotics 
 
Fifteen antibiotics were used for antibiotic susceptibility study against 
standard and clinically isolated microorganisms. All antibiotic discs were 
purchased from Hi-Media, Bombay, India. The names and concentration of 
the antibiotics and antifungal are as follows: Amikacin (10 mcg), Azithromycin 
(15 mcg), Carbenicillin (100 mcg), Cefaclor (30 mcg), Ceftazidime (30 mcg), 
Chloramphenicol (30 mcg), Ciprofloxacin (10 mcg), Imipenem (10 mcg), 
Methicillin (5 mcg), Piperacillin (100 mcg), Tetracycline (10 mcg), 
Amphotericin-B (100 units), Fluconazole (25 mcg), Ketoconazole (10 mcg), 
Nystatin (100 units). 
2.2.6. Antimicrobial assay 
The antimicrobial assay was performed by agar disc diffusion method (Bauer 
et al. 1966, NCCLS 2003, Parekh and Chanda 2007). The molten Mueller 
Hinton Agar (HiMedia) was inoculated with 200 µl of the inoculum (1 x 108 
Chapter 2: Antimicrobial screening 
 32 
Cfu) and poured into the sterile Petri plates (Hi-media). The disc (7 mm in 
diameter, Hi-Media) was saturated with 20 µl of the extract and discs were air 
dried. Thereafter the discs were introduced on the upper layer of the seeded 
agar plate. Paper discs loaded with 20 µl of DMSO served as negative 
control. 11 standard antibiotics and 4 standard antifungal were used as 
positive controls. The plates were incubated at 37oC for all the bacterial 
strains while that of fungal strains were incubated at 28oC for 48 h.  The 
experiment was carried out three times and the mean values are presented. 
The antimicrobial activity was evaluated by measuring the diameter of zone of 
inhibition in mm. 
 
2.3. RESULTS AND DISCUSSION 
 
The use of antimicrobial agents is critical to the successful treatment of 
infectious diseases. Although there are numerous classes of drugs that are 
routinely used to treat infections in humans, pathogenic microorganisms are 
constantly developing resistance to these drugs (Al-Bari et al. 2006) because 
of indiscriminate use of antibiotics (Gibbons 1992; Rahman et al. 2001).  
 
The use of higher plants and preparations made from them to treat infections 
is a longstanding practice in a large part of the population, especially in the 
developing countries, where there is dependence on traditional medicine for a 
variety of ailments (Ahmad and Mohammad 1998). Interest in plants with 
antimicrobial properties increased because of current problems associated 
with the antibiotics (Emori and Gaynes 1993; Pannuti and Grinbaum 1995). 
Recently, the antimicrobial effects of various plant extracts against certain 
pathogens have been reported by a number of researchers (Ahmed and Beg 
2001; Erasto et al. 2004; Nair et al. 2007b; Carneiro et al. 2008; Liasu and 
Ayandele 2008; Parekh and Chanda 2008; Chanda et al. 2009). 
 
Disc diffusion method is the most widely used procedure for testing 
antimicrobial susceptibility (Sambath Kumar et al. 2006). The disc diffusion 
procedure (Kirby-Bauer method) has been accepted by the Food and Drug 
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Administration (FDA) and as a standard by the National Committee for Clinical 
Laboratory Standards (Barry and Thornsberry 1985; NCCLS 2003). 
 
In the present study, methanol and acetone extracts of 53 plants were studied 
against 15 standard strains of microorganisms (Table 2.2). Methanol extracts 
of 4 selected plants were studied against 41 clinically isolated bacterial 
strains, 33 clinically isolated fungal strains, 20 standard bacterial strains and 4 
standard fungal strains. 11 antibiotics were used as positive controls against 
all bacterial strains and 4 antibiotics were used as positive controls against all 
fungal strains.  
 
 
2.3.1. Antimicrobial screening of methanol and acetone extracts of 53 
plants  
 
Methanol and acetone extracts of 53 plants were screened for its antimicrobial 
potency against 15 medically important pathogenic microorganisms. The 
results of the antimicrobial screening are shown in Table 2.2. Antibacterial 
activity of plant extracts were compared with standard antibiotics (Table 2.6). 
 
22.64% of methanol extracts were active against S. aureus while, only 8.49% 
of acetone extracts showed antibacterial activity against S. aureus. Maximum 
activity against S. aureus was shown by acetone extract of Aristolochia indica 
followed by methanol extract of Abutilon glaucum. The activity of acetone 
extract of Aristolochia indica was more than seven antibiotics studied. 
 
S. epidermidis was inhibited by 10.38% methanol extracts and 7.55% acetone 
extracts of plants screened. Methanol extract of Mangifera indica showed 
maximum activity followed by acetone extract of Woodfordia fruticosa (stem) 
against S. epidermidis, which was comparable to Piperacillin and 
Azithromycin.
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Table 2.2 Evaluation of antimicrobial activity of methanol and acetone extracts of some medicinal plants and its extractive yield  
No. Plants Ext. 
 
Yield 
(%) 
Microbial strains 
Gram positive bacteria Gram negative bacteria Fungus 
SA SE BC BS MF PA EC KP PM PV ST CF CA CT CL 
1 Abutilon glaucum 
ME 5.37 16 - - - - - - 12 8 - - - 8 10 11 
AE 1.49 - - 9 - - - - 12 - - - - - - 15 
2 Adenanthera pavonina 
ME 3.9 - - - - 10 - - 10 - - - - - - - 
AE 2.18 - - 11 - - - - 10 - - - - - - - 
3 Agave vera 
ME 9.41 - - 13 15 - - - - - - - - 14 14 17 
AE 2.07 - - - - - - - 12 - - - - - - - 
4 Alangium salviifolicum 
ME 8.42 - - - - 13 - - 18 - - - - - - - 
AE 1.55 - - - - 10 - - 11 - - - - - - - 
5 Alpinia speciosa 
ME 7.9 10 - 11 - 19 - - 12 - - - - - 11 - 
AE 2.01 - - 12 - 11 - - 13 9 - - - - - - 
6 Argemone mexicana 
ME 4.6 10 9 10 9 21 - 8 11 8 - - - - 11 17 
AE 0.72 - 11 10 9 25  8 - 8 - - - 10 19 15 
7 Argyreia speciosa 
ME 2.92 - - 10 - - - - 9 - - - - - - - 
AE 0.8 - - - - - - - - - - - - - - - 
8 Aristolochia bracteolata 
ME 9.63 - - - - - - - 16 11 - - - - 11 - 
AE 1.98 15 - 14 11 - - - 13 13 - - 11 - - - 
9 Aristolochia indica 
ME 11.46 10 11 15 11 - - - 13 11 - - - - 10 - 
AE 1.47 19 - 16 13 - - - 13 13 - - - - - 13 
10 Asphodelus tenuifolius 
ME 11.36 9 - 13 - - - - - - - - 10 - 11 - 
AE 3.63 - - - - - - - 17 - - - - - 11 20 
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No. Plants Ext. 
 
Yield 
(%) 
Microbial strains 
Gram positive bacteria Gram negative bacteria Fungus 
SA SE BC BS MF PA EC KP PM PV ST CF CA CT CL 
11 Baliospermum montanum 
ME 13.01 9 - 13 - 12 - - 12 - - - - - - - 
AE 5.13 - - 12 - 12 - - 14 10 - - - - - - 
12 Boerhavia diffusa 
ME 4.38 - 11 - - - - - - - - - - - - - 
AE 1.2 - - - - - - - 11 - - - - - - - 
13 Bombax ceiba 
ME 4.3 - - - - - - - 12 - - - - - - - 
AE 1.09 9 - 11 - - - - - - - - - - - - 
14 Calastrus paniculatus 
ME 3.25 - - - - - - - - - - - - - - - 
AE 1.71 - - 10 - - - - 12 - - - - - - - 
15 Carissa carandas 
ME 8.53 10 - 12 12 - - - 11 10 - - - - 13 15 
AE 4.08 - - 10 - - - - - - - - - 10 - 12 
16 Cassia occidentalis 
ME 8.8 11 - 12 - - - - - 9 - - - - 12 10 
AE 1.78 - - - - - - - 11 - - - - - 11 - 
17 Casuarina equissetifolia 
ME 12.1 10 - 14 - 14 - - 11 10 11 12 14 - - - 
AE 2.46 - - 12 - 11 - - 10 - 10 9 11 - - - 
18 Citrus medica 
ME 4.08 - - - - - - - - - - - - - - - 
AE 1.71 - - - - - - - - - - - - - - - 
19 Clerodendron phlomidis 
ME 2.2 - 13 - - - - - - - - - 11 - - - 
AE 0.78 - - - - - - - - - - - - - - - 
20 Datura innoxia 
ME 14.4 - - 10 9 - - - 11 10 - - - 8 - 12 
AE 2.26 10 - 15 11 11 - - 18 11 - - - - - - 
21 Desmodium gangeticum 
ME 4.37 - - - - - - - 13 - - - - - - - 
AE 1.17 - - - - - - - - - - - - - - - 
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No. Plants Ext. 
 
Yield 
(%) 
Microbial strains 
Gram positive bacteria Gram negative bacteria Fungus 
SA SE BC BS MF PA EC KP PM PV ST CF CA CT CL 
22 Drypetes roxburghii 
ME 10.5 11 11 - - 13 - - - - - - - - - - 
AE 2.6 - 9 10 - 11 - - 13 - - - - - - - 
23 Ficus carica 
ME 7.62 - - - - - - - 10 - - - - - - - 
AE 1.58 - - - - - - - - - - - - 8 9 11 
24 Gymnema sylvestre 
ME 9.87 - - 10 - - - - 11 - - - - 10 - - 
AE 2.24 - - - - - - - - - - - - - - - 
25 Hemidesmus indicus 
ME 11.29 10 - 12 - 14 - - 11 - - - - 8 - - 
AE 4.48 - - 11 - 11 - - - 8 - - - - - - 
26 Holoptelea integrifolia 
ME 3.6 - - - - - - - - - - - - - - - 
AE 0.91 - - - - - - - 11 - - - - - - - 
27 Jasminum auriculatum 
ME 1.38 - - 11 - - - - 13 - - - - - 13 - 
AE 1.7 - - - - - - - - - - - - - - - 
28 Leptadenia reticulate 
ME 9.9 9 11 - - - - - 13 12 - - - - 9 - 
AE 2.52 - - - - - - - 11 15 - - 11 - 10 - 
29 Leucas aspera 
ME 7.7 - - - - - - - - - - - - - - - 
AE 2.5 - - - - - - - 8 - - - - - - - 
30 Madhuca indica 
ME 6.98 9 - 10 - - - - - - - - - - - - 
AE 2.2 10 - 10 - 11 - - - - - - - - - - 
31 Mangifera indica 
ME 8.24 14 15 16 9 12 13 15 11 14 14 18 17 - - - 
AE 3 11 12 15 - 16 13 12 11 10 12 15 13 - - - 
32 Maranta arundinacea 
ME 1.94 12 - 13 - - - - - 9 - - - - 12 11 
AE 1.68 - - - - - - - 13 8 - - - - 10 - 
33 Merremia turpethum 
ME 9.12 10 - 11 - - - - - - - - - - 15 - 
AE 2.58 - - - - - - - 11 - - - - - - - 
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No. Plants Ext. 
 
Yield 
(%) 
Microbial strains 
Gram positive bacteria Gram negative bacteria Fungus 
SA SE BC BS MF PA EC KP PM PV ST CF CA CT CL 
34 Murraya paniculata 
ME 16.69 - - 10 - - - - 12 - - - - 9 9 12 
AE 4.72 - - 10 - - - - 13 - - - - - - - 
35 Origanum marjoram 
ME 11.75 - 9 - - - - - 10 - - - - - - - 
AE 4.8  12 10 9    10 - - - - - - - 
36 Phyla nodiflora 
ME 10.82 - - 15 - - - - - - - - 14 - - - 
AE 2.5 - - 12 - - - - - - - - - - - - 
37 Phyllanthus reticulatus 
ME 7.66 9 - 13 - 23 - - - - - - 15 - - 11 
AE 2.49 - - - - 15 - - 12 - - - - - - - 
38 Pluchea arguta 
ME 9.9 10 - 15 - 20 - - 14 - - - - - 9 10 
AE 2.08 - - 10 - - - - 9 - - - - - - 20 
39 Randia dumetorum 
ME 9.02 11 - 11 - 15 - - - 9 - - - - 9 - 
AE 1.64 - - - - 12 - - - 9 - - - - - - 
40 Rauvolifera tetraphylla 
ME 13.48 - - 12 - 10 - - 20 9 - - - - 8 - 
AE 4.35 - - - - - - - - - - - - - - - 
41 Scaevola koenigii 
ME 11.78 11 - 10 - - - - 12 - - - - - 9 - 
AE 1.69 - - - - - - - 15 - - - - - - - 
42 Scindapsus officinalis 
ME 7.7 - - 14 - - - - 16 - - - 11 - - 11 
AE 2.12 - - - - - - - 12 - - - - - 10 16 
43 Strychnos nux-vomica 
ME 8.7 14 14 13 - 14 - - 13 - - - - - - - 
AE 3.73 - 13 11 - - 8 10 - - - 15 - - - - 
44 Tamarindus indica 
ME 10.41 - - - - - - - - - - - - - - - 
AE 4 - - - - - - - 11 - - - - - - - 
45 Tecomella undulate 
ME 7.91 - - 10 - - - - 9 8 - - - - - - 
AE 2.3 - - - - - - - - - - - - - - - 
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No. Plants Ext. 
 
Yield 
(%) 
Microbial strains 
Gram positive bacteria Gram negative bacteria Fungus 
SA SE BC BS MF PA EC KP PM PV ST CF CA CT CL 
46 Tephrosia purpurea 
ME 8.25 12 - 13 - - - - 20 - - - - - 8 12 
AE 1.98 - - - - - - - - - - - - - - - 
47 Thespesia populnea 
ME 9.89 - - 9 10 - - - 11 - - - - 10 - - 
AE 2.59 12 14 12 12 10 - - 14 13 - - - - - - 
48 Tinospora cordifolia 
ME 5.5 - - - - - - - - - - - - - - - 
AE 1.59 - - - - 10 - - - - - - - - - - 
49 Trienthema monogyna 
ME 5.58 - - - - - - - - - - - - - - - 
AE 1.34 - - - - - - - - - - - - - - - 
50 Trigonella foenumgraecum 
ME 9.7 - - - - - - - 9 - - - - - - - 
AE 1.5 - - - - - - - 8 10 - - - - - - 
51 Vitex negundo. 
ME 9.3 - - 11 - - - - 12 8 - - - 10 10 - 
AE 3.14 - - 12 - - - - 10 9 - - - - - - 
52 Woodfordia fruticosa (Leaf) 
ME 16.41 12 12 13 9 12 12 12 13 15 13 14 16 - - - 
AE 8.39 11 13 14 10 15 12 11 11 13 12 14 13 - - - 
53 Woodfordia fruticosa (Stem) 
ME 12.24 10 13 15 - 10 11 12 - 11 13 15 14 - - - 
AE 5.03 12 14 16 - 15 12 12 - 12 12 14 13 - - - 
 
SA-Staphylococcus aureus ATCC25923; SE-Staphylococcus epidermidis ATCC12228; BC-Bacillus cereus ATCC11778; BS-Bacillus subtilis ATCC6633; MF-
Micrococcus flavus ATCC10240; PA-Pseudomonas aeruginosa ATCC27853; EC- E. coli ATCC25922; KP-Klebsiella pneumoniae NCIM2719; PM-Proteus mirabilis 
NCIM2241; PV-Proteus vulgaris NCTC8313; ST-Salmonella typhimurium ATCC23564; CF-Citrobacter freundii ATCC10787; CA-Candida albicans ATCC2091; CT-
Candida tropicalis ATCC4563; CL-Cryptococcus luteolus ATCC32044; ME- Methanol extract; AE- Acetone extract; - means no activity; Data showed diameter of zone of 
inhibition in mm 
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31.13% of methanol extracts and 23.58% of acetone extracts showed activity 
against B. cereus. Maximum activity against B. cereus was shown by acetone 
extracts of Aristolochia indica and Woodfordia fruticosa and methanol extract 
of Mangifera indica, which was also comparable to Piperacillin. Only 7.55% 
methanol extracts and 6.6% acetone extracts showed antibacterial activity 
against B. subtilis. Maximum activity was shown by methanol extract of Agave 
vera, which was also comparable to Piperacillin (Table 2.2).  
 
M. flavus was inhibited by 15.09% of both methanol and acetone extracts. 
The maximum activity was shown by acetone extract of Argemone mexicana 
which was also comparable with standard antibiotics. Only 2.83% methanol 
extracts and 3.77% acetone extracts showed antibacterial activty against P. 
aeruginosa.  Methanol and acetone extracts of Mangifera indica showed 
maximum activity compared with the other extracts. E. coli was inhibited by 
3.77% methanol extracts and 4.72% acetone extracts. Methanol extract of 
Mangifera indica showed maximum zone of inhibition against E. coli, which 
was comparable to standard antibiotics Piperacillin and Amikacin (Table 2.2).  
 
Methanol and acetone extracts of the plants screened showed 31.13% and 
30.19% inhibition against K. pneumoniae respectively. Both the extracts 
showed almost similar antibacterial activity against K. pneumoniae. Methanol 
extracts of Rauvolifera tetraphylla and Tephrosia purpurea showed maximum 
inhibition against K. pneumoniae. P. mirabilis was inhibited by 16.04% 
methanol extracts and 15.09% acetone extracts of the plants screened. 
Acetone extract of Leptadenia reticulata and methanol extract of Woodfordia 
fruticosa showed maximum inhibition zone compared with other plant 
extracts. 
 
Only 3.77% methanol and acetone extracts showed antibacterial activity 
against P. vulgaris. Methanol extract of Mangifera indica showed maximum 
inhibition against P. vulgaris which was similar to the standard antibiotic 
Amikacin.  
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Similar to P. vulgaris, S. typhimurium was also inhibited by 3.77% of methanol 
extracts and 4.72% of acetone extracts. Here also methanol extract of 
Mangifera indica showed maximum inhibition, comparable to standard 
antibiotics. C. freundii was inhibited by 8.49% methanol extracts and 5.66% 
acetone extracts. Methanol extracts of Mangifera indica and Woodfordia 
fruticosa (leaf) showed maximum inhibition against C. freundii, which was 
more than standard antibiotic Amikacin and comparable to Piperacillin (Table 
2.2).  
 
Antifungal activity was investigated against C. albicans, C. tropicalis and C. 
luteolus. Methanol extracts of the plants screened showed 7.55% antifungal 
activity against C. albicans, 19.81% against C. tropicalis and 11.32% against 
C. luteolus. Acetone extracts showed 2.83% antifungal activity against C. 
albicans, 5.66% against C. tropicalis and 7.55% against C. luteolus (Table 
2.2). 
 
From the above results, it can be stated that methanol extracts showed 
34.72% antibacterial activity against Gram positive bacteria, 19.95% against 
Gram negative bacteria and 25.79% against fungal strains studied. Acetone 
extracts showed 24.53% antibacterial activity against Gram positive bacteria, 
19.41% against Gram negative bacteria and 10.69% against fungal strains. 
Thus, methanol and acetone extracts showed 29.62% inhibition against Gram 
positive bacteria, 19.68% inhibition against Gram negative bacteria and 
against 18.24% inhibition against fungal strains. 
 
Methanol extracts of Mangifera indica and Woodfordia fruticosa (leaf) showed 
higher antibacterial activity and acetone extract of Argemone mexicana 
showed higher antifungal activity.  
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2.3.2. Antibacterial screening of 4 selected plants against 41 clinically 
isolated bacteria  
 
From results of the antimicrobial study of methanol and acetone extracts of 53 
plants screened, methanol extracts of Aristolochia indica (AIM), Argemone 
Mexicana (AMM), Mangifera indica (MIM) and Woodfordia fruticosa (WFM) 
were selected for antimicrobial activity against 41 clinically isolated bacterial 
strains (Table 2.3).  
 
AIM showed 94.12% antibacterial activity against 17 Gram positive bacteria at 
both the concentrations, while AIM-600 and AIM-1200 showed 54.12% and 
58.13% antibacterial activity against 24 Gram negative organisms 
respectively. Enterococci species were the most susceptible strains amongst 
all the bacterial strains studied, which was comparable to standard antibiotics.  
 
AMM-600 and AMM-1200 showed 41.18% and 47.06% antibacterial activity 
against Gram positive bacteria respectively. AMM did not show any activity 
against Gram negative bacteria. AMM showed poor antibacterial activity when 
compared with other 3 plants studied. 
 
MIM showed 100% antibacterial activity against all the bacterial strains 
studied. MIM was the most potent extract which was comparable to standard 
antibiotics. Enterococci species were the most susceptible strains which was 
also comparable to standard antibiotics. MIM showed potent antibacterial 
activity against one of the urine samples of E. coli (E. coli-16), which was 
higher than all the antibiotics studied.  
 
WFM-600 and WFM-1200 showed 82.35% and 88.24% antibacterial activity 
against 17 Gram positive bacteria respectively, while WFM did not show 
antibacterial activity against Gram negative bacteria. 
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Table 2.3 Antibacterial activity of methanol extracts of 4 selected plants 
against some clinical isolates 
Gram negative  
Strains 
(Samples) 
Extracts (µg/disc) 
A
IM
-6
0
0
 
A
IM
-1
2
0
0
 
A
M
M
-6
0
0
 
A
M
M
-1
2
0
0
 
M
IM
-6
0
0
 
M
IM
-1
2
0
0
 
W
F
M
-6
0
0
 
W
F
M
-1
2
0
0
 
E. coli-1(F)   - - 10 11 - - 
E. coli-2 (P) 9 8 - - 9 10 - - 
E. coli-3 (P) 9 10 - - 10 11 - - 
E. coli-4 (St) - - - - 9 10 - - 
E. coli-5 (St) - - -  10 11 - - 
E. coli-6 (St) - - - - 10 11 - - 
E. coli-7 (St) 9 9 - - 11 10 - - 
E. coli-8 (St) - - - - 9 9 - - 
E. coli-9 (St) - - - - 9 10 - - 
E. coli-10 (St) 10 12 - - 12 15 - - 
E. coli-11 (Sw) 9 - - - 9 10 - - 
E.  coli-12 (Sw) - - - - 9 10 - - 
E. coli-13 (U)  - - - 10 10 - - 
E. coli-14 (U) 9 8 - - 10 11 - - 
E. coli-15 (U) - - - - 8 10 - - 
E. coli-16 (U) 11 11 - - 15 17 - - 
Kleb-1 (B) 10 9 - - 9 10 - - 
Kleb-2 (B) - 8 - - 9 10 - - 
Kleb-3 (B) 8 9 - - 9 9 - - 
Kleb-4 (C) 9 10 - - 10 11 - - 
Kleb-5 (P) 8 10 - - 9 11 - - 
Kleb-6 (Sw) 9 10 - - 10 11 - - 
Kleb-7 (U) 9 10 - - 10 11 - - 
Prot-1 (Sw) - 9 - - 9 10 - - 
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Gram positive  
strains  
(Samples) 
Extracts (µg/disc) 
A
IM
-6
0
0
 
A
IM
-1
2
0
0
 
A
M
M
-6
0
0
 
A
M
M
-1
2
0
0
 
M
IM
-6
0
0
 
M
IM
-1
2
0
0
 
W
F
M
-6
0
0
 
W
F
M
-1
2
0
0
 
Ent-1 (B) 13 17 - - 19 21 12 14 
Ent-2 (Sw)                    13 18 10 11 16 16 12 12 
S. alb-1 (B) 11 - - 12 9 14 10 12 
S. alb-2 (B) 9 11 - - 11 13 8 11 
S. alb-3 (B) 10 11 - - 13 13 - - 
S. alb-4 (P) - 12 - - 10 14 8 11 
S. aur-1 (P) 9 11 8 12 11 13 9 10 
S. aur-2 (P) 10 11 9 12 11 13 8 11 
S. aur-3 (St) 10 12 10 12 12 14 9 12 
S. cit-1 (P) 8 12 - - 12 18 - 11 
S. cit-2 (P) 10 11 - - 11 14 9 10 
S. cit-3 (U) 8 10 - - 13 15 8 10 
S. cit-4 (U) 9 12 - - 11 15 8 11 
Staph-1 (B) 12 14 - - 14 14 - - 
Staph-2 (P) 10 10 10 11 12 13 10 10 
Staph-3 (St) 10 12 8 11 13 14 8 10 
Staph-4 (St) 9 11 9 10 12 14 8 9 
 
n=3; Values indicate diameter of zone of inhibition in mm; - means no activity; B- Blood; C- 
Catheter; P- Pus; St- Stool; Sw- Swab; U- Urine; Ent- Enterococci species; S. alb- 
Staphylococcus albus; S. aur- Staphylococcus aureus; S. cit- Staphylococcus citrous;  
Staph- Staphylococcus species; E. coli- Escherichia coli; Kleb- Klebsiella species;  Prot- 
Proteus species; AIM- Methanol extract of Aristolochia indica; AMM- Methanol extract of 
Argemone mexicana; MIM- Methanol extract of Mangifera indica; WFM- Methanol extract of 
Woodfordia fruticosa 
 
Overall MIM-600 and MIM-1200 showed 100% antibacterial activity against 41 
clinically isolated Gram positive and Gram negative bacterial strains followed 
by AIM-1200 (73.17%), AIM-600 (70.73%). WFM-1200 (36.59%), WFM-600 
(34.15%), AIM-1200 (19.51%) respectively and AIM-600 showed poor 
antibacterial activity (17.07%) against clinically isolated bacterial strains. 
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Thus, methanol extract of Mangifera indica showed higher antibacterial 
activity followed by Aristolochia indica. Woodfordia fruticosa and Argemone 
mexicana showed poor antibacterial activity against clinically isolated bacterial 
strains.  
 
2.3.3. Antibacterial screening of 4 selected plants against standard 
bacterial strains  
 
Screening of methanol extracts of Aristolochia indica (AIM), Argemone 
mexicana (AMM), Mangifera indica (MIM) and Woodfordia fruticosa (WFM) 
was carried out against 20 standard bacterial strains (Table 2.4).  
 
AIM-600, AIM-1200 and MIM-600 showed 100% antibacterial activity against 
8 standard Gram positive bacterial strains followed by AMM-1200 (87.5%), 
MIM-1200 (87.5%), WFM-600 (87.5%), WFM (87.5%) and AMM-600 (75%) 
respectively. 
 
MIM-600, MIM-1200 and WFM-1200 showed 81.82% antibacterial activity 
against 11 standard Gram negative strains followed by WFM-600 (72.73%), 
AIM-1200 (63.64%) and AIM-600 (45.45%). AMM-600 showed only 9.09% 
antibacterial activity, while AMM-1200 did not show antibacterial activity 
against 11 standard Gram positive strains.   
 
Overall results showed that MIM-600 showed 85% antibacterial activity 
against all the standard strains of Gram positive and Gram negative bacteria 
followed by MIM-1200 (80%), WFM-1200 (80%), AIM-1200 (75%), WFM-600 
(75%), AIM-600 (65%), AMM-600 (35%) and AMM-1200 (35%), respectively.  
 
Thus, methanol extract of Mangifera indica showed higher antibacterial 
activity followed by Woodfordia fruticosa and Aristolochia indica against 
standard bacterial strains. Argemone maxicana showed poor antibacterial 
activity against standard bacterial strains.  
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Table 2.4 Antibacterial activity of methanol extracts of 4 selected plants 
against 20 standard bacterial strains 
 
 
n=3; Values indicate diameter of zone of inhibition in mm; - means no activity; Bc- Bacillus 
cereus ATCC11778; Bm- Bacillus megaterium ATCC9885; Bs- Bacillus subtilis ATCC6633; 
Cr- Cornybacterium rubrum ATCC 14898; Mf- Micrococcus flavus ATCC10240; Sa-1- 
Staphylococcus aureus ATCC25923, Sa-2- Staphylococcus aureus ATCC29737; Se- 
Staphylococcus epidermidis ATCC12228; Ss- Staphylococcus subflava NCIM2178; Cf- 
Citrobacter freundii ATCC10787; Ea- Enterobacter aerogenes ATCC13048; Ka- Klebsiella 
aerogenes NCTC418; Pmira- Proteus mirabilis NCIM2241; Pmorg- Proteus morganii 
NCIM2040; Pv- Proteus vulgaris NCTC8313; Pp- Pseudomonas pictoruim NCIB9152; Pstut- 
Pseudomonas stutgeri ATCC17588; Psyr- Pseudomonas syringae NCIM5102; Pt- 
Pseudomonas testosteroni NCIM5098; St- Salmonella typhimurium ATCC23564; AIM- 
Methanol extract of Aristolochia indica; AMM- Methanol extract of Argemone mexicana; MIM- 
Methanol extract of Mangifera indica; WFM- Methanol extract of Woodfordia fruticosa 
 
 
 
 
Standard  
strains 
Extracts (µg/disc) 
AIM- 
600 
AIM- 
1200 
AMM- 
600 
AMM- 
1200 
MIM- 
600 
MIM- 
1200 
WFM- 
600 
WFM- 
1200 
Gram positive strains  
Bc 13 14 10 10 15 15 10 12 
Bm 9 8 11 13 8 - 9 9 
Bs 11 12 9 10 9 10 - - 
Cr 10 11 - - 14 15 9 10 
Mf 12 14 20 21 13 12 12 12 
Sa-1 10 12 10 10 13 14 9 9 
Sa-2 11 13 10 10 13 15 10 12 
Se 12 12 - 10 14 15 10 11 
Ss 10 10 - 8 10 10 8 10 
Gram negative strains 
Cf - - - - 15 16 14 15 
Ea - - - - - - - - 
Ka 11 14 - - 13 14 10 12 
Pmira 9 11 - - 13 13 8 10 
Pmorg 10 12 - - 11 14 10 11 
Pv - 10 -  14 15 12 12 
Pp 12 12 - - 12 11 14 15 
Pstut  11 - - 14 15  10 
Psyr 10 10 10 - 11 11 9 9 
Pt - - - - - - - - 
St - - - - 16 17 12 13 
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2.3.4. Antifungal activity of methanol extracts of 4 selected plants 
against 33 clinically isolated fungal strains and 4 standard fungal 
strains 
 
AIM, AMM, MIM and WFM did not show antifungal activity against clinical 
isolates of Candida species and standard fungal strains (Data not presented). 
AMM showed antifungal activity against three standard fungal strains, C. 
neoformans, C. tropicalis and T. beigelli (Table 2.7). 
 
2.3.5. Antibiotic susceptibility study of clinical isolates and standard 
microorganisms 
 
Clinically, in vitro antimicrobial susceptibility tests are useful as a guide for 
determining antimicrobial chemotherapy whenever the susceptibility of a 
pathogen is unpredictable or when an infection has not responded to therapy 
that otherwise appears appropriate. 
 
Eleven antibiotics were studied against clinically isolated and standard Gram 
positive and Gram negative microorganisms and the results are presented in 
Table 2.5 and Table 2.6 respectively. The results of antibiotic susceptibility 
study against Gram positive bacteria (clinical isolates) were as follows: 
Imipenem (100%) < Tetracycline and Amikacin (94.12%) < Chloramphenicol 
(82.35%) < Cefaclor (70.59%) < Carbenicillin and Ciprofloxacin (64.71%) < 
Ceftazidime (58.82%) < Azithromycin and Piperacillin (52.94%) < Methicillin 
(35.29%). The results of antibiotic susceptibility study against Gram positive 
bacteria (standard strains) were as follows: Amikacin, Azithromycin, 
Tetracycline, Imipenem, Chloramphenicol, Cefaclor and Ciprofloxacin (100%) 
< Carbenicillin, Ceftazidime, Piperacillin and Methicillin (87.5%). 
 
Antibiotic susceptibility study against Gram negative bacteria (clinical 
isolates) was as following manner: Imipenem (100%) < Amikacin (87.5%) < 
Tetracycline (70.83%) < Chloramphenicol (66.67%) < Ceftazidime (33.33%) 
< Carbenicillin and Cefaclor (16.67%) < Azithromycin and Ciprofloxacin 
(12.5%) < Piperacillin (8.33%) < Methicillin (0%). Antibiotic susceptibility 
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study against Gram negative bacteria (standard strains) was as following 
manner: Tetracycline, Imipenem and Chloramphenicol (100%) < Piperacillin 
(92.86%) < Amikacin and Ciprofloxacin (85.71%) < Ceftazidime and 
Carbenicillin (71.43%) < Azithromycin (64.29%) < Cefaclor (57.14%) < 
Methicillin (14.29%). 
 
Table 2.5 Antibiotic susceptibility study of 41 clinically isolated bacteria 
Gram positive strains 
(Samples) 
Antibiotics 
M At Pc Ak T I Cb Ca C Cj Cf 
Ent-1 (B)                 - - 13 25 31 30 17 - 30 16 35 
Ent-2 (Sw) - - 11 16 32 21 12 10 21 16 20 
S. alb-1 (B) - 16 - 16 11 18 - 10 20 12 - 
S. alb-2 (B) - - - 19 10 40 - - - - - 
S. alb-3 (B) - - - 10 8 15 - - 12 - - 
S. alb-4 (P) - - - 10 - 16 - - 20 - - 
S. aur-1 (P) 15 12 - 10 20 30 - - - - - 
S. aur-2 (P) 15 15 - 10 24 32 - - - - - 
S. aur-3 (St) 12 15 10 - 12 24 15 16 20 19 8 
S. cit-1 (P) - - 35 21 21 40 35 25 20 26 20 
S. cit-2 (P) - - 25 16 20 30 30 20 25 30 23 
S. cit-3 (U) - 15  14 20 30 30 18 25 22 20 
S. cit-4 (U) - 16 25 20 20 35 30 20 15 25 - 
Staph-1 (B) - - 20 13 28 15 19 - 16 10 15 
Staph-2 (P) 17 10 28 10 20 42 10 15 19 20 - 
Staph-3 (St) 12 11 10 11 20 30 8 16 16 13 9 
Staph-4 (St) 12 13 - 17 16 21 10 15 15 16 - 
Gram negative strains 
(Samples) 
Antibiotics 
M At Pc Ak T I Cb Ca C Cj Cf 
E. coli-1(F)             - - - - 18 11 -  15 - - 
E. coli-2 (P) - - - 13 - 20 - -  - - 
E. coli-3 (P) - - - 15 - 19 - - 15 - - 
E. coli-4 (St) - 24 - 15 17 30 21 16 28 9 26 
E. coli-5 (St) - - - 13 9 14 - - 21 - - 
E. coli-6 (St) - 25 11 14 15 15 17 13 25 - 21 
E. coli-7 (St) - - - 16 - 19 - 8 14 - - 
E. coli-8 (St) - - - 18 10 20 - 9 20 - - 
E. coli-9 (St) - - - 15 - 20 - -  - - 
E. coli-10 (St) - - - 15 - 20 - - 13 - - 
E. coli-11 (Sw) - - - 13 9 17 - - 17 - - 
E.  coli-12 (Sw) - - - 17 8 20 - - - - - 
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Gram negative strains 
(Samples) 
Antibiotics 
M At Pc Ak T I Cb Ca C Cj Cf 
E. coli-13 (U) - 30 30 25 11 20 28 26 30 13 12 
E. coli-14 (U) - - - 20 24 16 15 15 20 11 - 
E. coli-15 (U) - - - 18 9 25 - - 25 - - 
E. coli-16 (U) - - - 15 - 16 - 11 - - - 
Kleb-1 (B) - - -  10 19 - - 10 - - 
Kleb-2 (B) - - - 15 13 15 - - 15 - - 
Kleb-3 (B) - - - - 15 20 - - - - - 
Kleb-4 (C) - - - 20 9 21 - - - - - 
Kleb-5 (P) - - - 8 10 11 - - 8 - - 
Kleb-6 (Sw) - - - 13 12 16 - - - - - 
Kleb-7 (U) - - - 15 - 20 - 12 14 10 - 
Prot-1 (Sw) - - - 9 10 9 - - - - - 
n=3; Values indicate diameter of zone of inhibition in mm; - means no activity; B- Blood; C- 
Catheter; P- Pus; St- Stool; Sw- Swab; U- Urine; Ent- Enterococci species; S. alb- 
Staphylococcus albus; S. aur- Staphylococcus aureus; S. cit- Staphylococcus citrous;  Staph- 
Staphylococcus species; E. coli- Escherichia coli; Kleb- Klebsiella species;  Prot- Proteus 
species; Ak- Amikacin, At- Azithromycin, T- Tetracycline, I- Imipenem, C- Chloramphenicol, 
Cj- Cefaclor, Cf- Ciprofloxacin, Cb- Carbenicillin, Ca- Ceftazidime, Pc- Piperacillin, M- 
Methicillin 
 
Imipenem was the most active antibiotic against all the clinically isolated 
Gram positive and Gram negative microorganisms followed by Amikacin and 
Tetracycline, while Methicillin showed less activity against Gram positive 
organisms as compared with the other antibiotics. Methicillin did not show 
antibacterial activity against clinically isolated Gram negative organisms.   
 
The standard Gram positive strains were highly susceptible to all the 
antibiotics in the range of 87.5 to 100% while the susceptibility of standard 
Gram negative strains to antibiotics was only in the range of 14.29 to 100%. 
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Table 2.6 Antibiotic susceptibility study of 20 standard bacterial strains 
 
Bc- Bacillus cereus ATCC11778; Bm- Bacillus megaterium ATCC9885; Bs- Bacillus subtilis 
ATCC6633; Cr- Cornybacterium rubrum ATCC 14898; Mf- Micrococcus flavus ATCC10240; 
Sa-1- Staphylococcus aureus ATCC25923, Sa-2- Staphylococcus aureus ATCC29737; Se- 
Staphylococcus epidermidis ATCC12228; Ss- Staphylococcus subflava NCIM2178; Cf- 
Citrobacter freundii ATCC10787; Ea- Enterobacter aerogenes ATCC13048; Ka- Klebsiella 
aerogenes NCTC418; Pmira- Proteus mirabilis NCIM2241; Pmorg- Proteus morganii 
NCIM2040; Pv- Proteus vulgaris NCTC8313; Pp- Pseudomonas pictoruim NCIB9152; 
Pstut- Pseudomonas stutgeri ATCC17588; Psyr- Pseudomonas syringae NCIM5102; Pt- 
Pseudomonas testosteroni NCIM5098; St- Salmonella typhimurium ATCC23564; Ak- 
Amikacin, At- Azithromycin, T- Tetracycline, I- Imipenem, C- Chloramphenicol, Cj- Cefaclor, 
Cf- Ciprofloxacin, Cb- Carbenicillin, Ca- Ceftazidime, Pc- Piperacillin, M- Methicillin 
 
 
 
 
Standard 
strains  
Antibiotics 
M At Pc Ak T I Cb Ca C Cl Cf 
Gram positive strains 
Bc - 11 16 11 17 36 10 18 10 20 19 
Bm 14 12  23 19 41 - - 14 12 27 
Bs 16 14 17 15 21 37 20 25 16 35 30 
Cr 15 14 19 16 20 24 22 19 15 27 16 
Mf 10 27 27 20 26 37 32 23 26 30 21 
Sa-1 20 15 18 12 15 25 21 18 20 25 15 
Sa-2 16 15 21 13 19 25 22 19 15 20 14 
Se 18 14 11 16 25 38 17 24 23 22 24 
Gram negative strains 
Cf - - 18 8 15 25 20 15 15 8 13 
Ea - - 12 16 11 19 17 16 13 - 11 
Ec - 12 14 24 16 24 13 12 24 - 35 
Ka - - 11 - 10 30 - - 13 16 10 
Kp - - 30 20 12 27 - 17 34 17 28 
Pmira 10 20 16 18 24 31 23 - 10 12 - 
Pmorg - - 10 10 15 30 - - 15 21 11 
Pv - 13 15 11 15 15 11 14 18 - 18 
Pa - 12 - 22 15 27 12 17 34 - 28 
Pp 14 18 15 20 25 27 20 12 25 23 23 
Pstut - 32 22 28 25 38 28 30 22 - 30 
Psyr - 17 18 - 20 30 12 - 16 21 - 
Pt - 20 10 12 15 11 - 10 16 - 25 
St - 11 14 15 18 16 21 18 16 17 15 
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Table 2.7 Antifungal activity of methanol extract of Argemone mexicana and 
four standard antifungal against 33 clinical isolates and 4 standard 
fungal strains 
 
Fungal strains Samples 
Antifungal drugs 
Extracts 
 (µg/disc) 
Ap Fu Kt Ns 
AMM- 
600 
AMM- 
1200 
Standard strains 
C. albicans ATCC2091 13 - 20 18 - - 
C. neoformans NCIM3542 17 27 23 21 9 9 
C. tropicalis ATCC4563 14 - - 19 11 12 
T. beigelli NCIM3404 15 - - 17 9 10 
Clinical isolates 
Candida spp.  Blood - - - - - - 
Candida spp.  Vaginal swab 10 - - 17 - - 
Candida spp.  Vaginal swab 10 - - 17 - - 
Candida spp.  Vaginal swab 15 14 12 20 - - 
Candida spp.  Vaginal swab 14 - - 18 - - 
Candida spp.  Vaginal swab 12 - - 15 - - 
Candida spp.  Vaginal swab 13 - - 15 - - 
Candida spp.  Vaginal swab 17 - - 20 - - 
Candida spp. Vaginal swab 12 - - 15 - - 
Candida spp. Vaginal swab 12 - - 14 - - 
Candida spp. Vaginal swab 12 - - 15 - - 
Candida spp. Vaginal swab 13 - - 15 - - 
Candida spp. Vaginal swab 14 - - 17 - - 
Candida spp. Vaginal swab - - - - - - 
Candida spp. Vaginal swab 12 - - 17 - - 
Candida spp. Vaginal swab 12 - - 15 - - 
Candida spp. Vaginal swab 14 - - 20 - - 
Candida spp. Vaginal swab 15 - - 17 - - 
Candida spp. Vaginal swab 13 - - 15 - - 
Candida spp. Vaginal swab 13 - - 18 - - 
Candida spp. Vaginal swab 12 - - 17 - - 
Candida spp. Vaginal swab 16 - - 21 - - 
Candida spp. Vaginal swab 15 - - 18 - - 
Candida spp. Vaginal swab 11 - - 15 - - 
Candida spp. Vaginal swab 13 - - 15 - - 
Candida spp. Vaginal swab 13 - - 18 - - 
Candida spp. Vaginal swab 15 - - 20 - - 
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Fungal strains Samples 
Antifungal drugs 
Extracts 
 (µg/disc) 
Ap Fu Kt Ns 
AMM- 
600 
AMM- 
1200 
Candida spp. Vaginal swab 12 - - 20 - - 
Candida spp. Vaginal swab 14 - - 20 - - 
Candida spp. Vaginal swab 15 - - 20 - - 
Candida spp. Urine 13 - - 13 - - 
Candida spp. Urine 12 - - 12 - - 
Candida spp. Urine 12 - - 12 - - 
n=3; Values indicate diameter of zone of inhibition in mm; - means no activity; Ap- 
Amphotericin-B; Fu- Fluconazole; Kt- Ketoconazole; Ns- Nystatin 
 
Amphotericin-B, Fluconazole, Ketoconazole and Nystatin were studied 
against 33 clinically isolated Candida species and 4 standard fungal strains 
for antifungal activity (Table 2.7). Amphotericin-B and Nystatin showed 100% 
antifungal activity against standard strains, while Amphotericin-B and Nystatin 
showed 93.94% antifungal activity against clinically isolated Candida species. 
Fluconazole showed antifungal activity against C. neoformans and only one 
clinically isolated Candida species. Ketoconazole showed antifungal activity 
against C. albicans, C. neoformans and only one clinically isolated Candida 
species. Thus, Amphotericin-B and Nystatin were more potent antifungal 
agents than Fluconazole and Ketoconazole against fungal strains studied. 
 
2.4. CONCLUSION 
 
Antimicrobial activities of various herbs and spices in plant leaves, flowers, 
stems, roots or fruits have been reported by many workers in different solvent 
extracts (Mau et al. 2001; Uz-Zaman et al. 2006; Al-Bayati and Sulaiman 
2008; Nair et al. 2009).  
 
From the results it can be concluded that methanol extracts of the plants 
screened gave better yield than acetone extracts. It is evident that the Gram-
positive microorganisms were more sensitive to the plant extracts than the 
Gram-negative microorganisms. These findings are in agreement with other 
researchers (Oboh et al. 2007; Nair and Chanda 2007; Costa et al. 2008; 
Khan et al. 2008). The susceptibility of Gram-positive bacteria may be due to 
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their cell wall structure which is of a single layer while the Gram-negative cell 
wall is a multi-layered structure and quite complex (Essawi and Srour 2000). 
All the extracts showed varying degrees of antimicrobial activity on the 
microorganisms tested. Some of these plant extracts were more effective than 
antibiotics to combat the pathogenic microorganisms studied. The 
antimicrobial activity was more apparent in methanol than acetone extracts of 
the same plants. These plants may be a source of new antibiotic compounds. 
This in vitro study demonstrated that folk medicine can be as effective as 
modern medicine to combat pathogenic microorganisms. Argemone 
mexicana, Aristolochia indica, Mangifera indica and Woodfordia fruticosa 
were more potent plants than other plants screened for antimicrobial activity 
against standard strains of the microorganisms. Mangifera indica was the 
most potent plant than the other three plants screened against clinically 
isolated bacterial strains, while methanol extracts of 4 selected plants did not 
show antifungal activity against standard and clinically isolated fungal strains. 
This study gives an indication of the efficacy of the plants obtained from the 
traditional healers. The results from this study form a basis for further studies 
of the potent plants so as to isolate the compounds responsible for the 
antimicrobial activity. 
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CHAPTER 3: PHYTOCHEMICAL ANALYSIS OF SOME 
MEDICINAL PLANTS 
 
3.1. INTRODUCTION 
 
Various medicinal properties have been attributed to natural herbs. Medicinal 
plants constitute the main source of new pharmaceuticals and healthcare 
products (Ivanova et al. 2005). The history of plants being used for medicinal 
purpose is probably as old as the history of mankind. Extraction and 
characterization of several active phytocompounds from these green factories 
have given birth to some high activity profile drugs (Mandal et al. 2007). A 
growing body of evidence indicates that secondary plant metabolites play 
critical roles in human health and may be nutritionally important (Hertog et al. 
1993). Phytochemical screening of plants has revealed the presence of 
numerous chemicals including alkaloids, tannins, flavonoids, steroids, 
glycosides, saponins etc. Many plant extracts and phytochemicals show 
antioxidant/free radical scavenging properties (Larson 1988; Nair et al. 2007; 
Parekh and Chanda 2007a). Secondary metabolites of plants serve as 
defense mechanisms against predation by many microorganisms, insects and 
herbivores (Lutterodt et al. 1999; Marjorie 1999). 
 
Normally free radicals of different forms are generated at a low level in cells to 
help in the modulation of several physiological functions and are quenched by 
an integrated antioxidant system in the body. However, if free radicals are 
produced in excess amount they can be destructive leading to inflammation, 
ischemia, lung damage and other degenerative diseases (Halliwell et al. 1992; 
Hadi et al. 2000; Cavalcanti et al. 2006). Free radical reactions, especially 
with participation of oxidative radicals, have been shown to be involved in 
many biological processes that cause damage to lipids, proteins, membranes 
and nucleic acids, thus giving rise to a variety of diseases (Lee et al. 2005; 
Campos et al. 2006).  
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The phenolic compounds are one of the largest and most ubiquitous groups of 
plant metabolites that possess an aromatic ring bearing one or more hydroxyl 
constituents (Singh et al. 2007). Phenolic compounds are widely found in the 
secondary products of medicinal plants, as well as in many edible plants 
(Hagerman et al. 1998). A number of studies have focused on the biological 
activities of phenolic compounds, which are potential antioxidants and free 
radical-scavengers (Rice-Evans et al. 1995; Kahkonen et al. 1999; Sugihara 
et al. 1999; Cespedes et al. 2008; Reddy et al. 2008). Several studies have 
described the antioxidant properties of medicinal plants, foods, and beverages 
which are rich in phenolic compounds (Brown and Rice-Evans 1998; Krings 
and Berger 2001). 
 
Flavonoids are a broad class of plant phenolics that are known to possess a 
well established protective ability against membrane lipoperoxidative 
damages (Sen et al. 2005).  
 
Plant products have been part of phytomedicines since time immemorial.  
These can be derived from any part of the plant like bark, leaves, flowers, 
roots, fruits, seeds, etc (Gordon and David 2001) i.e. any part of the plant may 
contain active components.  Knowledge of the chemical constituents of plants 
is desirable because such information will be of value for the synthesis of 
complex chemical substances. Such phytochemical screening of various 
plants is reported by many workers (Mojab et al. 2003; Parekh and Chanda 
2007b; Parekh and Chanda 2008). 
 
In the present work, qualitative and quantitative phytochemical analysis was 
carried out in the 53 plants screened. 
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3.2. MATERIALS AND METHODS  
 
3.2.1. Plant collection and extraction  
 
Plant collection and extraction was done as described in Chapter 2.2.1 and 
Chapter 2.2.2. The preliminary qualitative phytochemical analysis was carried 
out in crude dry powder of 53 plants; while total phenol and flavonoid content 
was estimated in methanol and acetone extracts of 53 plants.    
 
3.2.2. Preliminary qualitative phytochemical screening (Harbone 1998; 
Parekh and Chanda 2007b) 
 
3.2.2.1. Alkaloids 
 
The methanolic extract of the crude dry powder of each plant was evaporated 
to dryness in a boiling water bath. The residue was dissolved in 2 N HCl. The 
mixture was filtered and the filtrate was divided into 3 equal portions. One 
portion was treated with a few drops of Mayer's reagent; one portion was 
treated with equal amount of Dragondroff’s reagent and the other portion was 
treated with equal amount of Wagner's reagent. The creamish precipitate, 
orange precipitate and brown precipitate, indicated the presence of respective 
alkaloids (Salehi-Surmaghi et al. 1992). 
 
3.2.2.2. Flavonoids 
 
The presence of flavonoids was estimated by Shinoda test. The alcoholic 
extract of the crude dry powder of each plant was treated with a few drops of 
concentrated HCl and magnesium ribbon. The appearance of pink or tomato 
red colour within a few minutes indicated the presence of flavonoids 
(Somolenski et al. 1972). 
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3.2.2.3. Tannins 
 
The water extract of the crude dry powder of each plant was treated with 
alcoholic FeCl3 reagent. Blue color indicated the presence of tannins 
(Segelman et al. 1969). 
 
3.2.2.4. Cardiac glycosides 
 
Keller-kiliani test was performed to assess the presence of cardiac glycosides. 
The  crude dry powder of each plant was treated with 1 ml of FeCl3 reagent 
(mixture of 1 volume of 5% FeCl3 solution and 99 volumes of glacial acetic 
acid). To this solution a few drops of concentrated H2SO4 was added. 
Appearance of greenish blue color within a few minutes indicated the 
presence of cardiac glycosides (Ajaiyeobu 2002). 
 
3.2.2.5. Steroids  
 
Liebermann-Burchard reaction was performed to assess the presence of 
steroids. A chloroform solution of the crude dry powder of each plant was 
treated with acetic anhydride and a few drops of concentrated H2SO4 were 
added down the sides of the test tube. A blue green ring indicated the 
presence of terpenoids. 
 
3.2.2.6. Saponins  
 
The presence of saponins was determined by Frothing test. The crude dry 
powder of each plant was vigorously shaken with distilled water and was 
allowed to stand for 10 minutes and classified for saponin content as follows: 
no froth indicate absence of saponins and stable froth more than 1.5 cm 
indicated the presence of saponins (Kapoor et al. 1969). 
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3.2.3. Quantitative phytochemical screening      
 
3.2.3.1. Total phenol determination: 
 
Total phenolic content of the extracts was determined by Folin Ciocalteu 
reagent method (Mc Donald et al. 2001) with some modifications. Plant 
extract (1 ml) was mixed with Ciocalteu reagent (0.1 ml, 1 N), and allowed to 
stand for 15 min. Then 5 ml of saturated Na2CO3 was added. The mixtures 
were allowed to stand for 30 min at room temperature and the total phenols 
were determined spectrophotometrically at 760 nm. Gallic acid was used as a 
standard. Total phenol values are expressed in terms of gallic acid equivalent 
(mg g-1 of extracted compound). 
 
3.2.3.2. Flavonoid determination: 
 
Aluminium chloride colorimetric method (Chang et al. 2002) with some 
modifications was used to determine flavonoid content. Plant extract (1ml) in 
methanol was mixed with 1ml of methanol, 0.5 ml aluminium chloride (1.2 %) 
and 0.5 ml potassium acetate (120 mM). The mixture was allowed to stand for 
30 min at room temperature; then the absorbance was measured at 415 nm. 
Quercetin was used as standard. Flavonoid content is expressed in terms of 
quercetin equivalent (mg g-1 of extracted compound). 
 
3.3. RESULTS AND DISCUSSION  
 
3.3.1. Preliminary qualitative phytochemical screening 
 
In recent years, secondary plant metabolites (phytochemicals) with 
antibacterial potency have been actively investigated as alternatives to and ⁄ 
or in combination with antibiotics in the therapy of bacterial infections (Sato et 
al. 1995; Liu et al. 2001).  
 
The preliminary qualitative phytochemical screening of the crude powder of 53 
plants was done to assess the presence of bioactive components. The 
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presence of alkaloids (Dragendroff, Mayer, Wagner), flavonoids, tannins, 
steroids, saponins and cardiac glycosides was determined (Table 3.1).  
 
Table 3.1 Preliminary qualitative phytochemical analysis of crude powder of 53 plants 
 
No. Name of the plants Alkaloids TN CG ST FL SP 
DR MR WR 
1 Abutilon glaucum  + - + - +++ + - - 
2 Adenanthera pavonina  + - - + +++ +++ - - 
3 Agave Vera  + - + ++ - - - +++ 
4 Alangium salvifolium  - - + + ++ ++ ++ + 
5 Alpinia speciosa  - - + +++ - - + - 
6 Argemone maxicana - - ++ +++ +++ ++ - + 
7 Argyreia speciosa  - - - - - - - + 
8 Aristolochia bracteolata  - - - +++ ++ ++ - + 
9 Aristolochia indica  - + + + + ++ - + 
10 Asphodelus tenuifolius  - - + - - - - - 
11 Baliospermum montanum  + + - +++ - - + ++ 
12 Boerhavia diffusa  - - - + ++ +++ - - 
13 Bombax ceiba + - - +++ + ++ - - 
14 Carissa carandas + - - +++ - +  + 
15 Cassia occidentalis + - - ++ + + + - 
16 Casuarina equissetifolia + - - +++ + + + - 
17 Celastrus paniculata   - - - - - ++ - - 
18 Citrus medica  + - - - + ++ - - 
19 Clerodendron phlomidis - - - - - - - - 
20 Datura innoxia  - - + - +++ +++ + - 
21 Desmodium gangeticum  - - - - +++ +++ - - 
22 Drypetes roxburghii   + - - +++ +++ ++ - + 
23 Ficus carica - - - ++ ++ + - - 
24 Gymnema sylvestre  + - - + +++ + - +++ 
25 Hemidesmus indicus  - - + +++ + - - + 
26 Holoptelea integrifolia  + - - + ++ +++ + + 
27 Jasminum auriculatum  - - + ++ ++ ++ - + 
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No. Name of the plants 
Alkaloids 
TN CG ST FL SP 
DR MR WR 
28 Leptadenia reticulata  - - - + +++ ++ - - 
29 Leucas aspera  - - - + ++ +++ - - 
30 Madhuca indica  +++ + - ++ - ++ - - 
31 Mangifera indica  - - - +++ - + - - 
32 Maranta arundinacea  - - - - - - - - 
33 Merremia turpethum  +  + + ++ ++ - - 
34 Murraya paniculata  - - + ++ ++ - - + 
35 Origanum marjoram  - - - ++ - - - - 
36 Phyla nodiflora  - - + +++ - - + - 
37 Phyllanthus reticulatus  + - - +++ + ++ - + 
38 Pluchea arguta  + ++ ++ +++ +++ - - + 
39 Randia dumetorum  ++ +  ++  + - + 
40 Rauvofia tetraphylla  - - + +++ ++ ++ - + 
41 Scaevola koenigii  - - + - - - + - 
42 Scindapsus officinalis  - - + + ++ ++ - - 
43 Strychnos nux-vomica  - - - +++ + +++ - - 
44 Tamarindus indica + + - - + - - - 
45 Tecomella undulata  + + + + + - - - 
46 Tephrosia purpurea  - -  +++ ++  - - 
47 Thespesia populnea  + - - - - - - - 
48 Tinospora cordifolia  - - - - + ++ - - 
49 Trienthema monogyna  - - - - - + - - 
50 Trigonella foenum-graecum  - - - - + +++ - - 
51 Vitex negundo  - - + +++ +++ - - + 
52 Woodfordia fruticosa (Leaf) +++ + + +++ - - - + 
53 Woodfordia fruticosa (Stem) ++ - - +++ + ++ - + 
 
DR- Dragondroff’s reagent; MR- Mayer’s reagent; WR- Wagner’s reagent; TN- Tannins; FL- Flavonoids; 
CG- Cardiac glycosides; ST- Steroids; SP- Saponins   
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Alkaloids were present in lower amount (+) in 32.08% of plants with 
Dragondroff test, in 13.21% with Mayer test and in 33.96% with Wagner test. 
Moderate amount (++) of alkaloids were present in 3.77% of the plants with 
Dragondroff test and Wagner test, 1.89% with Mayer test. Only 3.77% of 
plants contained higher amount (+++) of alkaloids with Dragondroff test. 
 
Tannins were present in 20.75% of plants in lower amount, 13.21% in 
moderate amount and 33.96% in higher amount. Cardiac glycosides were 
present in 22.64% of plants in lower amount, in 20.75% in moderate amount 
and in18.87% in higher amount. Steroids were present in 13.21% of plants in 
lower amount, 32.08% in moderate amount and 15.09% in higher amount. 
Flavonoids were present in 13.21% of plants in lower amount and 1.89% in 
moderate amount. Saponins were present in 33.96% of plants in lower 
amount, 1.89% in moderate amount and 3.77% in higher amount. 
 
3.3.2. Quantitative phytochemical screening  
 
Antioxidants and antimicrobial properties of various extracts from many plants 
have recently been of great interest in both research and the food industry, 
because their possible use as natural additives emerged from a growing 
tendency to replace synthetic antioxidants and antimicrobials with natural 
ones (Deba et al. 2008).  
 
The results of total phenolic content and flavonoid content of methanol and 
acetone extracts of 53 plants are presented in Table 3.2. 
 
Total phenolic content was higher in methanol extracts than acetone extracts. 
Only 11.32% acetone extracts showed higher total phenolic content than 
methanol extracts, while 88.68% methanol extracts showed higher total 
phenolic content than acetone extracts.  35.85% acetone extracts showed 
higher flavonoid content than methanol extracts, while 64.15% methanol 
extracts showed higher flavonoid content than acetone extracts. 
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Out of 53 acetone extracts of the plants studied, 9 plants contained higher 
total phenolic content (>70 mg/g), which were in the following order: 
Mangifera indica > Strychnos nux-vomica > Phyllanthus reticulates > 
Casuarina equissetifolia > Woodfordia fruticosa (Stem) > Drypetes roxburghii 
> Woodfordia fruticosa (Leaf) > Madhuca indica > Carissa carandas (Table 
3.2.).  
 
Table 3.2 Total phenolic and flavonoids content of acetone and methanol extracts of 
53 plants 
 
Plants Total phenol (mg/g) Flavonoids (mg/g) 
AE ME AE ME 
Abutilon glaucum 12.85 ± 0.11 17.89 ± 0.52 14.68 ± 0.38 18.25 ± 0.07 
Adenanthera pavonina 22.48 ± 0.35 57.43 ± 1.41 19.86 ± 0.46 32.50 ± 0.17 
Agave vera 27.51 ± 0.13 25.54 ± 0.46 4.16 ± 0.14 15.85 ± 7.89 
Alangium salviifolicum 15.48 ± 0.14 65.71 ± 1.93 0.83 ± 0.05 44.74 ± 0.11 
Alpinia speciosa 27.41 ± 0.19 120.54 ± 3.47 35.21 ± 0.73 64.65 ± 2.23 
Argemone mexicana 17.49 ± 0.26 29.75 ± 0.31 28.32 ± 0.30 79.54 ± 0.62 
Argyreia speciosa 58.43 ± 0.58 81.78 ± 0.19 33.87 ± 0.15 27.08 ± 3.97 
Aristolochia bracteolate 39.67 ± 0.92 59.22 ± 0.65 130.93 ± 2.58 36.06 ± 0.17 
Aristolochia indica 25.11 ± 0.18 56.66 ± 1.68 30.41 ± 0.19 27.22 ± 0.1 
Asphodelus tenuifolius 17.23 ± 0.53 23.88 ± 0.86 34.02 ± 1.20 8.79 ± 0.31 
Baliospermum montanum 16.87 ± 0.41 71.48 ± 1.98 52.55 ± 0.32 42.67 ± 8.17 
Boerhavia diffusa 28.07 ± 0.21 84.05 ± 0.11 1.23 ± 0.01 29.77 ± 0.20 
Bombax ceiba 31.11 ± 0.77 45.64 ± 0.24 25.74 ± 0.14 76.94 ± 0.60 
Calastrus paniculatus 7.68 ± 0.04 14.81 ± 0.11 29.62 ± 0.65 31.49 ± 0.19 
Carissa carandas 77.98 ± 0.60 84.70 ± 0.20 27.42 ± 5.20 28.65 ± 0.52 
Cassia occidentalis 65.82 ± 0.90 71.28 ± 0,84 21.90 ± 0.48 45.76 ± 0.51 
Casuarina equissetifolia 146.33 ± 0.73 248.15 ± 3.55 42.28 ± 0.74 33.38 ± 0.39 
Citrus medica 20.05 ± 0.41 40.77 ± 0.29 30.67 ± 0.53 22.62 ± 0.18 
Clerodendron phlomidis 9.05 ± 0.10 29.78 ± 0.32 35.88 ± 0.30 17.98 ± 0.55 
Datura innoxia 3.65 ± 0.05 29.53 ± 0.38 19.35 ± 0.20 33.00 ± 0.20 
Desmodium gangeticum 6.66 ± 0.16 49.19 ± 0.96 10.61 ± 0.47 37.02 ± 0.15 
Drypetes roxburghii 136.15 ± 2.18 83.04 ± 1.25 26.83 ± 0.31 42.32 ± 0.07 
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Plants 
Total phenol (mg/g) Flavonoids (mg/g) 
AE ME AE ME 
Ficus carica 4.02 ±0.08 46.45 ± 0.68 24.26 ± 0.24 65.44 ± 0.60 
Gymnema sylvestre 26.41 ± 0.32 40.22 ± 0.74 70.99 ± 0.89 17.98 ± 0.55 
Hemidesmus indicus 11.97 ± 0.14 85.45 ± 0.82 31.03 ± 0.42 26.29 ± 0.29 
Holoptelea integrifolia 10.65 ± 0.17 29.62 ± 0.30 43.59 ± 0.94 51.37 ± 0.37 
Jasminum auriculatum 68.74 ± 1.05 41.97 ± 0.68 26.14 ± 0.28 22.79 ± 0.12 
Leptadenia reticulate 24.45 ± 0.03 47.15 ± 0.21 24.9 ± 0.92 54.88 ± 9.42 
Leucas aspera 23.58 ± 0.46 50.90 ± 0.35 1.56 ± 0.02 48.19 ± 0.32 
Madhuca indica 83.02 ± 1.98 59.44 ± 0.26 15.15 ± 0.10 26.99 ± 0.15 
Mangifera indica 219.31 ± 3.69 427.28 ± 10.5 9.86 ± 0.7 6.36 ± 0.3 
Maranta arundinacea 5.96 ± 0.13 25.92 ± 0.86 13.69 ± 0.19 17.63 ± 0.38 
Merremia turpethum 12.34 ± 0.03 45.75 ± 0.14 15.81± 0.69 30.16 ± 0.09 
Murraya paniculata 14.83 ± 0.12 53.00 ± 0.90 25.3 ± 0.08 41.92 ± 13.92 
Origanum marjoram 33.75 ± 1.02 274.95 ± 2.63 27.65 ± 0.08 45.01 ± 0.92 
Phyla nodiflora 10.79 ± 0.26 64.84 ± 1.04 39.79 ± 0.26 31.64 ± 0.18 
Phyllanthus reticulatus 191.73 ± 6.62 172.27 ± 2.90 20.31 ± 0.30 49.84 ± 0.13 
Pluchea arguta 59.50 ± 0.79 78.82 ± 1.28 88.47 ± 0.91 53.67 ± 0.44 
Randia dumetorum 23.65 ± 0.08 66.72 ± 0.13 49.16 ± 0.86 22.98 ± 0.08 
Rauvolifera tetraphylla 25.54 ± 0.59 59.3 ± 0.80 20.21 ± 0.61 65.50 ± 0.60 
Scaevola koenigii 18.69 ± 0.14 36.31 ± 0.30 16.03 ± 0.15 14.36 ± 0.18 
Scindapsus officinalis 7.81 ± 0.13 54.35 ± 0.52 63.12 ± 0.19 33.11 ± 0.18 
Strychnos nux-vomica 208.18 ± 2.73 337.82 ± 2.80 19.15 ± 0.10 56.76 ± 0.29 
Tamarindus indica 17.84 ± 0.28 29.26 ± 0.17 3.84 ± 0.05 18.77 ± 0.02 
Tecomella undulate 31.46 ± 0.07 65.01 ± 1.24 14.77 ± 0.08 34.14 ± 0.16 
Tephrosia purpurea 16.52 ± 0.46 58.74 ± 0.06 15.89 ± 0.11 31.84 ± 0.03 
Thespesia populnea 6.78 ± 0.32 37.77 ± 0.45 28.64 ± 0.13 27.41 ± 0.07 
Tinospora cordifolia 15.9 ± 0.32 38.86 ± 0.32 17.76 ± 0.10 28.09 ± 0.08 
Trienthema monogyna 11.69 ± 0.01 26.85 ± 0.46 11.83 ± 0.09 14.82 ± 0.43 
Trigonella  
foenumgraecum  
15.79 ± 0.11 46.03 ± 0.51 14.49 ± 0.11 30.97 ± 0.24 
Vitex negundo 23.81 ± 0.47 62.38 ± 0.55 16.37 ± 0.51 21.8 ± 0.69 
Woodfordia fruticosa (Stem) 140.28 ± 5.73 130.43 ± 2.13 14.87 ± 0.85 9.10 ± 0.14 
Woodfordia fruticosa  
(Leaf) 
118.31 ± 6.19 387.84 ± 7.73 63.74 ± 0.71 38.42 ± 0.71 
n=3; Data is presented as Mean ± SEM; AE- Acetone extract; ME- Methanol extract 
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Of the methanol extracts of the 53 plants studied, 16 plants contained higher 
total phenolic content (>70 mg/g), which were in the following order: 
Mangifera indica > Woodfordia fruticosa (Leaf) > Strychnos nux-vomica > 
Origanum marjoram > Casuarina equissetifolia > Phyllanthus reticulatus > 
Woodfordia fruticosa (Stem) > Alpinia speciosa > Hemidesmus indicus > 
Carissa carandas > Boerhavia diffusa > Drypetes roxburghii > Argyreia 
speciosa > Pluchea arguta > Baliospermum montanum > Cassia occidentalis 
(Table 3.2.).   
 
Of the acetone extracts of the 53 plants studied, only 3 plants contained 
higher amount of flavonoids (>70 mg/g), which were in the  following order: 
Aristolochia bracteolate > Pluchea arguta > Gymnema sylvestre. Out of 53 
methanol extracts of the plants studied, only two plants contained higher 
amount of flavonoids, which were Argemone mexicana and Bombax ceiba. 
 
The antioxidant properties of plant extracts is attributed to their polyphenolic 
contents (Lu and Foo 2001; Murthy et al. 2002).  As such plants containing a 
high level of polyphenols have a greater importance as natural antimicrobics 
(Baravalia et al. 2009). 
 
From the results of antimicrobial screening, methanol extract of Mangifera 
indica showed potent antimicrobial activity, which might be due to the higher 
content of total phenolics. Similar results were reported by Salah et al. (2006). 
Acetone extract of Aristolochia bracteolate showed potent antimicrobial 
activity, which might be due to the higher content of flavonoids. Alpinia 
speciosa, Carissa carandas, Strychnos nux-vomica, Casuarina equissetifolia, 
Phyllanthus reticulatus, Pluchea arguta, Woodfordia fruticosa (Leaf) and 
Woodfordia fruticosa (Stem) showed good antimicrobial activity and higher 
total phenolic content. Argemone mexicana and Pluchea arguta showed good 
antimicrobial activity and higher amounts of flavonoids. 
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3.4. CONCLUSION 
 
The results of preliminary qualitative phytochemical study of the crude powder 
of 53 plants showed the presence of alkaloids (30.82%), tannins (67.92%), 
cardiac glycosides (62.26%), steroids (60.38%), flavonoids (15.09%) and 
saponins (39.62%). Tannins were present in more number of plants followed 
by cardiac glycosides and steroids. 
 
The results of total phenolic and flavonoid content showed that the methanol 
extract of Mangifera indica showed highest total phenolic content, while 
acetone extract of Aristolochia bracteolate showed highest flavonoid content 
than other plant extracts. Thus, the plants studied here can be seen as a 
potential source of new useful drugs. The phytochemical characterization of 
the extracts, the identification of responsible bioactive compounds and quality 
standards are necessary for future study. 
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CHAPTER 4: SCREENING OF SOME PLANTS FOR ANTI-
INFLAMMATORY ACTIVITY IN CARRAGEENAN 
INDUCED PAW EDEMA MODEL 
 
4.1. INTRODUCTION 
 
There are hundreds of medicinal plants that have a long history of curative 
properties against various diseases and ailments. Alternative medicine for 
treatment of various diseases is getting more and more popular. Many 
medicinal plants provide relief comparable to that obtained from allopathic 
medicines. The majority of clinically important medicines belong to steroidal 
and non-steroidal anti-inflammatory chemical therapeutics for treatment of 
various inflammatory diseases (Choi and Hwang 2003).  
 
The greatest disadvantage in presently available potent synthetic drugs is 
their toxicity and reappearance of symptoms after discontinuation. Therefore, 
screening and development of drugs for anti-inflammatory activity is still in 
progress and there is much hope for finding anti-inflammatory drugs from 
indigenous medicinal plants (Verpoorte 1999; Amresha et al. 2007; Juneja et 
al. 2007). 
 
A number of animal models of inflammation such as paw edema, air pouch 
granuloma, sponge implantation and pleurisy have been developed using a 
variety of agents such as carrageenan (Fukuhara and Tsurufuji 1969), 
Freund’s adjuvant (Ohuchi et al. 1982), turpentine (Spector and Willougby 
1957), zymosan (Konno and Tsurufuji 1983), formalin (Northover and 
Subramanian 1961), dextran (Winter and Porter 1957) and monosodium urate 
crystals (Gordon et al. 1985).  
 
The presence of edema is one of the prime signs of inflammation (Sur et al. 
2002). It has been documented that carrageenan induced rat paw edema is a 
suitable in vivo model to predict the value of anti-inflammatory agents, which 
act by inhibiting the mediators of acute inflammation (Morebise et al. 2002). 
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The method was chosen for this study since edema induced by carrageenan 
has been widely used to induce experimental acute footpad edema in 
laboratory animals to screen new anti-inflammatory drugs (Niemegeers et al. 
1964; El-Shenawy et al. 2002; Badilla et al. 2003; Ratheesh and Helen 2007). 
This method was first introduced by Winter et al. (1962) and remains an 
acceptable preliminary screening test for anti-inflammatory activity.  
 
In the present study, six plants were screened for acute anti-inflammatory 
study by carrageenan induced paw edema. The plants were selected on the 
basis of traditional use of the plant or pharmacological activity reported in the 
literature. 
 
4.2. MATERIALS AND METHOD 
 
4.2.1. Collection and extraction:  
 
Aristolochia indica, Argemone mexicana, Alpinia speciosa, Causarina 
equissetifolia, Gymnema sylvestre and Pluchea arguta were screened for 
acute anti-inflammatory study. Collection and extraction of the plants is 
described in the Chapter 2.2.1 and Chapter 2.2.2. Family, part used and 
traditional uses of the plants are given in Table 2.1.  
 
4.2.2. Animals 
 
Wistar albino rats of either sex (200-300 g) were used for the anti-
inflammatory studies. The animals were obtained from Sarabhai Research 
Center (SRC), Baroda. All the rats were housed in standard plastic rat cages 
with stainless steel coverlids and wheat straw was used as bedding material. 
The animals were kept at the animal house of Department of Biosciences, 
Saurashtra University, Rajkot. The animals were kept in a group of 6-8 
animals per cage and facilitated with standard environmental condition of 
photoperiod (12:12 h dark: light cycle) and temperature (25 ± 2ºC). They were 
provided with commercial rat and mice feed (Pranav Agro Industries Ltd., 
Amruth Brand rat & mice pellet feed) and water given ad libitum. The use of 
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these animals and the study protocols were approved by CPCSEA approved 
local ethical committee. 
 
4.2.3. Preparation of test drug and standard drug 
 
The test drug (Methanol extract of all the plants) and standard drug 
(Indomethacin) were prepared as a suspension in distilled water using mortal 
and pestle.  
 
4.2.4. Animal Grouping 
 
The animals were divided in to fourteen groups for acute anti-inflammatory 
study. Each group consisted of six animals of either sex. The groups were: 
 
Group I:   Vehicle treated control (Distilled water) 
Group II: Indomethacin (2.5 mg/kg) 
Group III: Methanol extract of Aristolochia indica (200 mg/kg) 
Group IV: Methanol extract of Aristolochia indica (400 mg/kg) 
Group V:  Methanol extract of Argemone mexicana (200 mg/kg) 
Group VI: Methanol extract of Argemone mexicana (400 mg/kg) 
Group VII: Methanol extract of Alpinia speciosa (200 mg/kg) 
Group VIII: Methanol extract of Alpinia speciosa (400 mg/kg) 
Group IX: Methanol extract of Causarina equissetifolia (200 mg/kg) 
Group X: Methanol extract of Causarina equissetifolia (400 mg/kg) 
Group XI: Methanol extract of Gymnema sylvestre (200 mg/kg) 
Group XII: Methanol extract of Gymnema sylvestre (400 mg/kg) 
Group XIII: Methanol extract of Pluchea arguta (200 mg/kg) 
Group XIV: Methanol extract of Pluchea arguta (400 mg/kg) 
 
4.2.5. Carrageenan induced rat paw edema (Winter et al. 1962) 
 
After grouping, the animals initial paw volume was measured using a 
plethysmograph (Bhatt et al. 1977). The plethysmograph employed, consisted 
of 10 ml glass vessel (25 mm x 65 mm) fixed 2 ml glass syringe through 
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pressure tubing. About 4 ml of mercury was filled in the syringe and the 
mercury level was adjusted to zero mark on the micropipette. The space 
between the zero mark and the fixed mark on the glass vessel was filled with 
the water. The initial level of the water was adjusted and set at zero. The paw 
was immersed in water exactly up to tibio tarsal articulation. The increased 
level of water in the glass vessel was adjusted to the prefixed mark by 
releasing the pressure of connected syringe. The level where water and 
mercury interface in the micropipette was recorded as paw volume.  
 
Thereafter, distilled water or indomethacin (2.5 mg/kg) or methanolic extract 
of the plants (200, 400 mg/kg; p.o.) were orally administered to the respective 
group of the animals. After drug administration hydration was given to all the 
animals (4 ml/100 g body weight). One hour after drug administration, 
oedema was induced by subplantar injection of freshly prepared 0.1 ml of 1% 
carrageenan (Hi-media) in normal saline. After injection of carrageenan, the 
paw volume was measured at 1 h, 2 h and 3 h. Increase in the paw volume 
(%) was calculated by following formula: 
 
 
Increase in paw volume (%) = 
Final paw volume – Initial paw volume  
X 100 
Initial paw volume 
 
 
4.3. RESULTS AND DISCUSSION  
 
Carrageenan injection into the rat paw provokes a local, acute inflammatory 
reaction that is a suitable criterion for evaluation of anti-inflammatory agents 
(Segura et al. 1998). The inflammation consists of two phases, early phase 
which is related to the production of histamine, 5- hydroxytryptamin, 
bradykinins and cyclooxygenase products and delayed phase which is linked 
to neutrophil infiltration, as well as production of arachidonic acid metabolites 
(Dawson et al. 1991; Salvemini et al. 1996; Boughton-Smith et al. 1999). The 
results of the present study showed that the extracts of all the plants showed 
decrease in paw volume in carrageenan induced inflammation in rats at the 
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dose level of 200 mg/kg and 400 mg/kg as compared to the control group 
(Table 4.1).  
 
A. indica showed significant decrease in paw volume at 1 h (51.9%, P≤ 0.05) 
and 2 h (47.57%, P≤ 0.01) at 400 mg/kg dose level. A. indica did not show 
significant decrease in paw volume at 200 mg/kg dose level.  
 
Like A. indica, A. mexicana also did not show any significant decrease in paw 
volume at 200 mg/kg dose level. However, A. mexicana showed significant 
decrease in paw volume at 1h (58.58%, P≤ 0.01), 2 h (42.43%, P≤ 0.05) and 
3 h (42.80, P≤ 0.05) at 400 mg/kg dose level. 
 
A. speciosa showed significant decrease in paw volume at 1 h (50.63%, P≤ 
0.01) and 2 h (48.15%, P≤ 0.05) at 200 mg/kg dose level and also showed 
decrease at 400 mg/kg (59.24%, P≤ 0.01 at 1 h and 54.46%, P≤ 0.001 at 2 h). 
It did not show any significant anti-inflammatory activity at 3 h. 
 
C. equissetifolia showed significant decrease in paw volume at 1 h (55.32%, 
P≤ 0.01), 2 h (48.63%, P≤ 0.01) and 3 h (39.78%, P≤ 0.05) at 200 mg/kg dose 
level. At 400 mg/kg dose level, it showed significant decrease in paw volume 
at 1 h (62%, P≤ 0.01) and 2 h (50.82%, P≤ 0.01) only.  
 
G. sylvestre did not show any significant anti-inflammatory activity at 200 
mg/kg dose level like A. indica and A. mexicana. While it showed significant 
decrease in paw volume at 2 h (27.22%, P≤ 0.05) at 400 mg/kg dose level 
only.  
 
P. arguta showed significant decrease in paw volume at both the dose levels. 
It showed significant decrease in paw volume at 1 h (58.54%, P≤ 0.01), 2 h 
(54.22%, P≤ 0.001) and 3 h (48.71%, P≤ 0.05) at 200 mg/kg dose level, and 
at 400 mg/kg dose level, the decrease in paw volume at 1 h was  (71.61%, P≤ 
0.001), 2 h (56.68%, P≤ 0.001) and 3 h (44.3%, P≤ 0.05) at. Anti-
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Table 4.1 Anti-inflammatory screening of six medicinal plants by carrageenan induced rat paw edema 
 
Group 
No. 
Groups Dose 
1h 2h 3h 
% Increase 
In paw 
Volume 
% 
Change 
 % Increase 
In paw 
volume 
% 
Change 
% Increase 
In paw 
volume 
% 
Change 
I Control D/W (5ml/kg) 28.45 ± 2.88 - 38.98 ± 2.45 - 38.94 ± 5.33 - 
II Indomethacin 2.5 mg/kg 9.26 ± 1.25***# 67.45↓ 13.05 ± 3.17***# 66.53↓ 10.67 ± 3.39**# 72.61↓ 
III 
A. indica 
200 mg/kg 17.39 ± 4.13# 38.89↓ 31.16 ± 5.49# 20.05↓ 28.02 ± 3.91# 28.04↓ 
IV 400 mg/kg 13.69 ± 3.69*# 51.90↓ 20.44 ± 4.2**# 47.57↓ 24.88 ± 3.98# 36.10↓ 
V 
A. mexicana 
200 mg/kg 21.16 ± 2.58# 25.64↓ 35.54 ± 4.10# 8.82↓ 27.80 ± 4.11# 28.61↓ 
VI 400 mg/kg 11.78 ± 1.44**# 58.58↓ 22.44 ± 4.60*# 42.43↓ 22.27 ± 2.65*# 42.80↓ 
VII 
A. speciosa 
200 mg/kg 14.05 ± 2.55**# 50.63↓ 20.21 ± 5.66*# 48.15↓ 25.67 ± 3.35# 34.09↓ 
VIII 400 mg/kg 11.60 ± 2.26**# 59.24↓ 17.75 ± 1.90***# 54.46↓ 27.74 ± 4.02# 28.76↓ 
IX 
C. equissetifolia 
200 mg/kg 12.71 ± 2.50**# 55.32↓ 20.02 ± 2.38**# 48.63↓ 23.45 ± 3.43*# 39.78↓ 
X 400 mg/kg 10.81 ± 3.05**# 62.00↓ 19.17 ± 3.88**# 50.82↓ 29.88 ± 4.55# 23.28↓ 
XI 
G. sylvestre 
200 mg/kg 21.80 ± 4.56# 23.38↓ 25.88 ± 5.62# 33.60↓ 24.12 ± 3.78# 38.06↓ 
XII 400 mg/kg 22.93 ± 2.86# 19.41↓ 28.37 ± 1.90*# 27.22↓ 23.80 ± 3.28# 38.87↓ 
XIII 
P. arguta 
200 mg/kg 11.80 ± 2.65**# 58.54↓ 17.85 ± 2.32***# 54.22↓ 19.97 ± 4.93*# 48.71↓ 
XIV 400 mg/kg 8.08 ± 1.59***# 71.61↓ 16.89 ± 2.77***# 56.68↓ 21.69 ± 3.95*# 44.30↓ 
       Data are expressed as mean ± SEM, P≤ (0.05*, 0.01**, 0.001***), F ≤ 0.05 
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inflammatory activity of P. arguta was comparable with the standard 
indomethacin at the 1 h at 400 mg/kg dose level. 
 
Anti-inflammatory activity of 6 plants studied was as following manner at 1h: P. 
arguta (400 mg/kg) > C. equissetifolia  (400 mg/kg) > A. speciosa (400 mg/kg) > 
A. mexicana (400 mg/kg) > P. arguta (200 mg/kg) > C. equissetifolia  (200 
mg/kg) > A. indica (400 mg/kg) > A. speciosa (200 mg/kg) > A. indica (200 
mg/kg) > A. mexicana (200 mg/kg) > G. sylvestre (200 mg/kg) > G. sylvestre 
(400 mg/kg) (Table 4.1). 
 
Anti-inflammatory activity of 6 plants studied was as following manner at 2 h: P. 
arguta (400 mg/kg) > A. speciosa (400 mg/kg) > P. arguta (200 mg/kg) > C. 
equissetifolia  (400 mg/kg) > C. equissetifolia  (200 mg/kg) > A. speciosa (200 
mg/kg) > A. indica (400 mg/kg) > A. mexicana (400 mg/kg) > G. sylvestre (200 
mg/kg) > G. sylvestre (400 mg/kg) > A. indica (200 mg/kg) > A. mexicana (200 
mg/kg) (Table 4.1). 
 
Anti-inflammatory activity of 6 plants studied was as following manner at 3 h: P. 
arguta (200 mg/kg) > P. arguta (400 mg/kg) > A. mexicana (400 mg/kg) > C. 
equissetifolia  (200 mg/kg) > G. sylvestre (400 mg/kg) > G. sylvestre (200 mg/kg) 
> A. indica (400 mg/kg) > A. speciosa (200 mg/kg) > A. speciosa (400 mg/kg) > 
A. mexicana (200 mg/kg) > A. indica (200 mg/kg) > C. equissetifolia  (400 mg/kg) 
(Table 4.1). 
 
4.4. CONCLUSION 
 
The results of the present study revealed that all the plants showed anti-
inflammatory activity as compared to the control group. A. indica and A. 
mexicana showed anti-inflammatory activity in dose dependent manner, while A. 
speciosa, C. equissetifolia and P. arguta showed higher activity in lower dose 
(200 mg/kg) than higher dose (400 mg/kg) at 3 h. G. sylvestre showed higher 
activity in lower dose (200 mg/kg) than at higher dose (400 mg/kg) at 1 h and 2 h. 
Methanol extracts of A. indica, A. speciosa, C. equissetifolia and P. arguta 
showed higher anti-inflammatory activity at 1 h than at 3 h at both the doses.  
Methanol extract of A. mexicana showed higher activity at 3 h than at 1 h in lower 
dose, while it showed higher activity at 1 h than at 3 h in higher dose. Methanol 
extract of G. sylvestre showed higher anti-inflammatory activity at 3 h than at 1 h.  
 
Thus, methanol extracts of A. indica (400 mg/kg), A. mexicana (400 mg/kg), A. 
speciosa (200 and 400 mg/kg), C. equissetifolia (200 and 400 mg/kg) and P. 
arguta (200 and 400 mg/kg) significantly inhibited early phase of the inflammation 
induced by carrageenan, while A. mexicana (400 mg/kg), C. equissetifolia (200 
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mg/kg) and P. arguta (200 and 400 mg/kg) significantly inhibited late phase of 
inflammation induced by carrageenan.  
 
Out of six plant extracts, the methanol extract of P. arguta posses a potent anti-
inflammatory activity followed by C. equissetifolia and A. speciosa, while G. 
sylvestre showed less anti-inflammatory activity. Thus, on the bases of 
availability of plant material and literature search, P. arguta (Leaf + stem) was 
selected for further pharmacognostic, toxicological and pharmacological studies. 
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CHAPTER 5: PHARMACOGNOSTIC STUDY OF PLUCHEA 
ARGUTA BOISS.  
 
5.1. INTRODUCTION 
 
Pharmacognosy is the scientific study of structural, physical, chemical and 
sensory characters of drugs. As late as the beginning of the 20th century, the 
subject had developed mainly on botanical side being concerned with history, 
identification, collection, preparation and storage of botanical drugs (Shinde 
and Dhalwal 2007). 
 
Evaluation of plant materials and their derived products has always been an 
important part of the professional expertise of a pharmacognosist (Brain and 
Turner 1975). However, over the years the nature and degree of this 
evaluation have changed. Initially it was considered sufficient to authenticate 
the plant material by comparison with a standard botanical description or 
monograph. Later it was realized that, for detection of adulterants, this 
practice must be supplemented with other important procedures like 
microscopy, chemical tests and advanced analytical techniques. Currently 
plant based drugs are researched, dispensed, formulated and manufactured 
in modern framework. Hence, it has becomes an important interface among 
various branches of pharmaceutical sciences. It is now emerging as 
interdisciplinary science that incorporates inputs from chemistry, biology and 
biotechnology directed towards natural products based drug discovery 
(Kinghorn 2002).  
 
Medicinal plant materials are characterized according sensory microscopic 
and macroscopic characteristics. Taking into consideration the variation in 
sources of crude drugs and their chemical nature, they are standardized by 
using different techniques including the method of estimation of chief active 
constituent (Soni et al. 2008). 
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Several problems not applicable to synthetic drugs influence the quality of 
herbal drugs (Ahmed et al. 2006): 
 
 Herbal drugs are usually mixtures of many constituents. 
 The active principle(s) is (are), in most cases unknown. 
 Selective analytical methods or reference compounds may not be 
available commercially. 
 Plant materials are chemically and naturally variable. 
 Chemo-varieties and chemo cultivars exist. 
 The source and quality of the raw material are variable. 
 The methods of harvesting, drying, storage, transportation and 
processing for example, mode of extraction and polarity of the 
extracting solvent, instability of constituents etc. have an effect. 
 
Strict guidelines have to be followed for the successful production of a quality 
herbal drug. Among them are proper botanical identification, phytochemical 
screening and standardization. Quality control and the standardization of 
herbal medicines involve several steps. The source and quality of raw 
materials, good agricultural practices and manufacturing processes are 
certainly essential steps for the quality control of herbal medicines and play a 
pivotal role in guaranteeing the quality and stability of herbal preparations (De 
Smet 1997; Roberts and Tyler 1997; Blumenthal et al. 1998; EMEA 2002; 
WHO 2003; WHO 2004). 
 
The objective of the present study was to evaluate various pharmacognostic 
standards like botanical description, microscopy, ash values, extractive 
values, microscopical characteristics of powder, heavy metals, pH, solubility 
and preliminary phytochemical analysis of Pluchea arguta Boiss. (Leaf + 
stem). 
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5.2. MATERIAL AND METHODS  
 
5.2.1. Collection and identification of the plant material  
 
Fresh Leaves and stem of Pluchea arguta Boiss. were collected in the month 
of December 2006, from Junagadh Agriculture University, Junagadh, Gujarat, 
India. It was identified by Dr. P. S. Nagar, Department of Botany, M.S. 
University, Baroda, Gujarat, India (Voucher specimen number PSN 402). 
Fresh plant material was washed with tap water, air dried and then 
homogenized to fine powder and stored in airtight bottles.  
 
5.2.2. Botanical description   
 
Pluchea arguta Boiss. is a member of family Asteraceae, it is a short 
branched shrub, shrubby and with thin leaves, the upper parts glandular 
pubescent. Leaves sessile, 1-3 inch long, varying much in breadth, obovate 
oblong or oblanceolate, sometimes inciso pinnetified, glandular pubescent 
acutely serrate or dentate, narrowed at the base. Heads peduncled, 
subsolitary 1/3 – 1/2 inch in diameter. Involucre bracts rigid, ∞ seriate, the 
outer very small, narrowly lanceolate subulate, pubescent and ciliate, those of 
intermediate rows similar but longer, the innermost elongate, linear, acute, 
pubescent and ciliate at the tip. Receptacle naked. Pappus hairs slander, 
shortly barbellate. Achenes with a few appressed hairs, cylindric, slightly 
ribbed (Figure 5.1).     
 
5.2.3. Microscopic characteristics  
 
Free hand sections of the fresh leaf and stem samples of Pluchea arguta 
were taken. Sections were cleared with chloral hydrate and then stained with 
phloroglucinol and hydrochloric acid and mounted with glycerin. Same 
procedure was followed for microscopic characteristics of powdered material 
of leaf and stem of Pluchea arguta.  
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 5.2.4. Determination of physicochemical parameters  
 
Following physicochemical parameters was carried out: (The Ayurvedic 
Pharmacopoeia of India 2008; Vaghasiya et al. 2008) 
 
 Total ash  
 Acid insoluble ash 
 Water soluble ash 
 Alcohol soluble extractive 
 Water soluble extractive 
 Methanol soluble extractive  
 Petroleum ether soluble extractive  
 Solubility test 
 pH  
 Heavy metal analysis  
 Determination of microorganisms  
 
5.2.4.1. Loss on drying 
 
2 g of crude powder of Pluchea arguta (Leaf + stem) was taken in an 
evaporating dish and then dried in an oven at 105ºC till constant weight was 
obtained. The weight after drying was noted and loss on drying was 
calculated. The percentage was calculated on the basis of sample taken 
initially.  
 
5.2.4.2. Total ash 
 
2 g powder of Pluchea arguta (leaf + stem) was taken in a silica crucible and 
ignited it by gradually increasing the heat to 500°C until it was white, 
indicating the absence of carbon. Ash was cooled in a desiccator and 
weighed without delay. Total ash value was calculated in mg per g of air-dried 
material. 
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5.2.4.2.1. Acid insoluble ash 
 
To the crucible containing total ash, 25 ml of hydrochloric acid (~70g/l) was 
added; it was covered with a watch-glass and boiled gently for 5 minutes. The 
watch-glass was rinsed with 5 ml of hot water and this liquid was added to the 
crucible. The insoluble matter was collected on an ashless filter paper and it 
was washed with hot water until the filtrate was neutral. The filter paper 
containing the insoluble matter was transferred to the original crucible; it was 
dried on a hot plate and ignited to constant weight. The residue was allowed 
to cool in a desiccator for 30 minutes and then weighed without delay. Acid 
insoluble ash was calculated in mg per g of air dried material. 
 
5.2.4.2.2 Water soluble ash 
 
To the crucible containing the total ash, 25 ml of water was added and boiled 
for 5 minutes. The insoluble matter was collected on an ashless filter paper. It 
was washed with hot water and ignited in a crucible for 15 minutes. Weight of 
insoluble matter was subtracted from the weight of total ash. The content of 
water soluble ash was calculated in mg per g of air dried material. 
 
5.2.4.3. Determination of alcohol soluble extractive 
 
Four grams of crude powder of Pluchea arguta was macerated with 100 ml of 
alcohol in a closed flask and was kept on a rotary shaker for 24 h. Thereafter, 
it was filtered and the filtrate was evaporated to dryness at 105ºC till constant 
weight was obtained. The percentage of extractable matter was calculated 
with reference to the sample taken initially. 
 
5.2.4.4. Determination of water soluble extractive 
 
Four grams of crude powder of Pluchea arguta was macerated with 100 ml of 
water in a closed flask and was kept on a rotary shaker for 24 h. Thereafter, it 
was filtered and the filtrate was evaporated to dryness at 105ºC till constant 
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weight was obtained. The percentage of extractable matter was calculated 
with reference to the sample taken initially. 
 
5.2.4.5. Determination of methanol soluble extractive 
 
Four grams of crude powder of Pluchea arguta was macerated with 100 ml of 
methanol in a closed flask and was kept on a rotary shaker for 24 h. 
Thereafter, it was filtered and the filtrate was evaporated to dryness at 105ºC 
till constant weight was obtained. The percentage of extractable matter was 
calculated with reference to the sample taken initially. 
 
5.2.4.6. Determination of petroleum ether soluble extractive 
 
Four grams of crude powder of Pluchea arguta was macerated with 100 ml of 
petroleum ether in a closed flask and was kept on a rotary shaker for 24 h. 
Thereafter, it was filtered and the filtrate was evaporated to dryness at 105ºC 
till constant weight was obtained. The percentage of extractable matter was 
calculated with reference to the sample taken initially. 
 
5.2.4.7. Solubility 
 
The quantitative solubility test of methanol extract of Pluchea arguta was 
determined in different solvents. 50 mg of extract was weighed for solubility 
test for different solvents. The extract was added in each solvent until 
saturated solution developed. Solubility was calculated in mg/ml.  
 
5.2.4.8. Determination of pH 
 
The methanol extract of Pluchea arguta was dissolved in distilled water and 
was kept in a water bath for 20 min. It was then filtered and the pH of the 
filtrate was noted with the help of a Systronic pH meter (pH system 361). 
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5.2.4.9. Determination of heavy metals 
 
The analysis for heavy metals like arsenic, chromium, cobalt, lead, mercury 
and nickel for crude powder and methanol extract of Pluchea arguta were 
done at Choksi Laboratries Limited, Vadodara. 
 
5.2.4.10. Determination of microorganisms  
 
Total bacterial and total fungal counts as well as specific count for Escherichia 
coli, Salmonella typhi and Pseudomonas aeruginosa for crude powder and 
methanol extract of Pluchea arguta (Leaf + stem) was carried out using 
reported methods (The Ayurvedic Pharmacopoeia of India 2008). 
 
5.2.5. Phytochemical study 
 
Preliminary qualitative phytochemical study for methanol extract of Pluchea 
arguta was carried out. Methods of alkaloids, flavonoids, tannins, cardiac 
glycosides, steroids and saponins were as described in Chapter 3.2.2.  
 
5.2.6. HPTLC fingerprinting  
 
The HPTLC fingerprinting of the methanol extract of Pluchea arguta was 
carried out at Anchrom Enterprises (I) Pvt. Ltd., Mulund, Mumbai. Analysis 
report was given by Anchrom Test Lab Pvt. Ltd.  
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Table 5.1 Information about HPTLC analysis given by Anchrom Test 
Lab Pvt. Ltd. 
 
Information 
Application position                                           8 mm 
Solvent front position 85 mm 
Instrument (CAMAG TLC Scanner 3) 
Executed by  Anchrom  
Number of tracks  12 
Position of first track X 20.7 mm 
Distance between tracks 14.5 mm 
Scan start position Y 5 mm 
Scan end position Y 85 mm 
Slit dimensions 6 X 0.45 mm, Micro 
Optimize optical system  Light 
Scanning speed  20 mm/s 
Data resolution 100 µm/step 
Measurement Table 
Wavelength 230/290/580 
Lamp  D2 
Measurement type Remission  
Measurement mode Absorption  
Optical filter  Second order 
Detector mode Automatic 
PM high voltage 342 V 
Detector properties  
Y-position for 0 adjust 5 mm 
Track # for 0 adjust 0 
Analog offset 10% 
Sensitivity Automatic 
Integration 
Properties 
Data filtering  Savitsky-Golay-7 
Baseline correction  Lowest slope 
Peak threshold min. slope  5 
Peak threshold min. height 10 AU 
Peak threshold min. area 50 
Peak threshold mix. height 990 AU 
Track start position 5 mm 
Track end position 75 mm 
Display scaling  1000 
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5.3. RESULTS AND DISCUSSION 
 
5.3.1. Microscopic characteristics  
 
5.3.1.1. Transverse section (T.S.) of Stem 
 
The T.S. of stem is shown in Figure 5.2. The epidermis is single layered and 
contains multi-cellular and glandular trichomes.   The cork cambium originated 
from the outer layer of collenchyma with tightly packed cells.  The cortex is 
made up of  collenchymatous cells and is multilayered; endodermis is present.  
A single layer pericycle is present.  The vascular bundles are of collateral 
type.  They are numerous, distinct and arranged in a ring. The medullary rays 
clearly separate the vascular bundles.  The pith is large and parenchymatous.   
 
5.3.1.2. Longitudinal section (L.S.) of Leaf 
 
The L.S. of leaf is as shown in the Figure 5.3. The upper epidermis is single 
layered, closely packed with a thick, waxy cuticle.  There are many 
multicellular trichomes present on upper epidermis.  The lower epidermis is 
also single layered but with a thin cuticle.  Multi-cellular trichomes are also 
present on the lower epidermis.  The mesophyll tissue is made up of palisade 
parenchyma and spongy parenchyma.  The palisade tissue contains 
numerous oil glands. The spongy parenchymatous  cells are irregular and 
more on lower side as compared to upper side.  The vascular bundles are of 
collateral type. The xylem is exarch..    
 
5.3.1.3. Powder characteristics        
 
The microscopic study of the powder of leaf and stem is presented in Figure 
5.4 and Figure 5.5. The powder study of stem showed starch grains, cork 
cells, annular/spiral vessel, sclerenchymatous cells and glandular trichomes. 
The powder study of leaf showed phloem fibers, multi-cellular trichome, 
spiral/annular xylem vessel,  and anisocytic stomata with wavy surface,  .   
 
Chapter 5: Pharmacognostic study 
98 
 
5.3.2. Determination of physicochemical parameters 
 
The results of physicochemical parameters are presented in Table 5.2 and 
Table 5.3.  
 
Table 5.2 Determination of proximate parameters of crude powder of 
Pluchea arguta 
Parameters  Value  
Loss on drying 6.21% (w/w) 
Total ash 14.94% (w/w) 
Acid insoluble ash 2.43% (w/w) 
Water soluble ash 10.7% (w/w) 
Water soluble extractive 12.57% (w/w) 
Alcohol soluble extractive  10.42% (w/w) 
Methanol soluble extractive 10.05% (w/w) 
Petroleum ether soluble extractive                              3.23% (w/w) 
pH  5.42 
 
The physical constant evaluation of the drugs is an important parameter in 
detecting adulteration or improper handling of drugs. The moisture content 
(6.21%) of the drug is not too high, thus it could discourage bacteria, fungi or 
yeast growth. Equally important in the evaluation of crude drugs, is the ash 
value and acid insoluble ash value determination. The total ash is particularly 
important in the evaluation of purity of drugs, i.e. the presence or absence of 
foreign inorganic matter such as metallic salts and/or silica (Musa et al. 2006). 
Total ash of crude powder of Pluchea arguta was 14.94%, acid insoluble ash 
was 2.43% and water soluble ash was 10.7%. Extractive yield of crude 
powder of Pluchea arguta was higher in water (12.57%) followed by alcohol 
(10.42%) and methanol (10.05%). Petroleum ether soluble extractive value 
(3.23%) was very less than other solvents studied.  pH value showed the 
crude powder of Pluchea arguta was acidic (5.42) in nature.  
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Table 5.3 Determination of solubility of methanol extract of 
Pluchea arguta 
 
Solvent Solubility (mg/ml) 
Acetone 8 
Chloroform 1 
Dimethylformamide                                           24 
Dimethylsulphoxide  31 
Dioxan 3 
Distilled water 20 
Ethyl acetate 3 
Hexane  - 
Methanol 29 
Petroleum ether - 
Toluene  - 
 
 
Methanol extract of Pluchea arguta was highly soluble in dimethylsulphoxide 
and methanol, while it was not soluble in hexane, petroleum ether and 
toluene.  
 
Contamination by toxic metals can either be accidental or intentional. 
Contamination by heavy metals such as mercury, lead, copper, cadmium, and 
arsenic in herbal remedies can be attributed to many causes, including 
environmental pollution, and can pose clinically relevant dangers for the 
health of the user and should therefore be limited (De Smet et al. 1992; 
Lazarowych and Pekos 1998). Arsenic, chromium, cobalt, lead, mercury and 
nickel were not present in crude powder and methanol extract of Pluchea 
arguta.  
 
Medicinal plant materials normally carry a great number of bacteria and 
moulds, often originating in soil. While a large range of bacteria and fungi form 
the naturally occurring micro flora of herbs, aerobic spore-forming bacteria 
frequently predominate. Current practices of harvesting, handling and 
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production may cause additional contamination and microbial growth. The 
determination of Escherichia coli and moulds may indicate the quality of 
production and harvesting practices (WHO 1998). In the present study cruder 
and methanol extract of Pluchea arguta were free from microbial 
contamination.  
 
5.3.3. Phytochemical study 
 
Qualitative phytochemical study of methanol extract of Pluchea arguta 
showed the presence of alkaloids, tannins and steroids in higher amount. 
Saponins were present in lower amount. Flavonoids were absent in methanol 
extract of Pluchea arguta.  
 
5.3.4. HPTLC fingerprinting  
 
High Performance Thin Layer Chromatography (HPTLC) technique is most 
simple and fastest separation technique available today which gives better 
precision and accuracy with extreme flexibility for various steps. The methanol 
extract of Pluchea arguta was subjected to HPTLC fingerprinting. The results 
showing number of peaks, start height, maximum Rf value, maximum height, 
maximum %, end Rf value, end height, total area and % area (Table 5.4 – 
Table 5.6). HPTLC spectral analysis was done in three different wavelengths 
230, 290 and 580 nm (Figure 5.6).  The results showed 10 peaks at 230 nm 
(Table 5.4), 11 peaks at 290 nm (Table 5.5) and 13 peaks at 580 nm 
wavelengths (Table 5.6). Peak number 7 covered maximum % of area at 230 
nm with 0.49 Rf value.  Peak number 7 covered maximum % of area at 290 
nm with 0.48 Rf value. Peak number 4 covered maximum % of area at 580 
nm with 0.34 Rf value. HPTLC plates showing different bands for methanol 
extract of Pluchea arguta at different wavelength (Figure 5.7). 
 
 
 
 
Chapter 5: Pharmacognostic study 
101 
 
Table 5.4 HPTLC spectral analysis of methanol extract of Pluchea arguta at 
230 nm wavelength 
 
Peak 
Start 
Rf 
Start 
Height 
Max 
Rf 
Max 
Height 
Max 
% 
End 
Rf 
End 
Height 
Area 
Area 
% 
1 -0.01 43.5 0.00 373.5 18.25 0.05 95.4 8034.4 9.66 
2 0.05 95.8 0.07 173.3 8.47 0.10 100.0 4837.7 5.82 
3 0.11 98.2 0.15 155.1 7.58 0.19 116.7 8370.6 10.06 
4 0.24 133.2 0.27 165.9 8.11 0.29 159.3 6028.8 7.25 
5 0.29 159.6 0.34 290.8 14.21 0.36 213.3 13624.3 16.38 
6 0.36 213.3 0.38 218.8 10.69 0.40 205.3 6421.9 7.72 
7 0.44 193.4 0.49 287.8 14.06 0.56 123.6 20329.5 24.44 
8 0.56 123.7 0.59 134.2 6.56 0.60 127.6 4158.5 5.00 
9 0.60 127.7 0.62 132.0 6.45 0.67 64.2 5728.9 6.89 
10 0.72 51.8 0.76 115.4 5.64 0.84 7.6 5657.2 6.80 
 
 
Table 5.5 HPTLC spectral analysis of methanol extract of Pluchea arguta at 
290 nm wavelength  
 
Peak 
Start 
Rf 
Start 
Height 
Max 
Rf 
Max 
Height 
Max 
% 
End 
Rf 
End 
Height 
Area 
Area 
% 
1 -0.02 1.1 0.01 469.1 15.41 0.05 148.4 10648.6 7.60 
2 0.05 148.4 0.07 253.1 8.31 0.10 155.3 7812.9 5.58 
3 0.10 155.5 0.15 252.5 8.29 0.20 199.9 16640.5 11.88 
4 0.22 206.0 0.27 271.0 8.90 0.28 264.9 12916.1 9.22 
5 0.29 265.1 0.34 419.0 13.76 0.36 346.7 21636.5 15.45 
6 0.37 346.8 0.38 351.6 11.55 0.42 338.4 14893.7 10.63 
7 0.44 337.1 0.48 402.0 13.20 0.56 186.0 30258.1 21.60 
8 0.56 186.4 0.59 217.0 7.13 0.61 207.3 7846.2 5.60 
9 0.61 207.3 0.62 208.2 6.84 0.67 98.4 7883.5 5.63 
10 0.67 98.5 0.70 111.3 3.66 0.73 80.1 4602.6 3.29 
11 0.74 80.0 0.76 90.2 2.96 0.87 0.9 4939.1 3.53 
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Table 5.6 HPTLC spectral analysis of methanol extract of P Pluchea arguta at 
580 nm wavelength 
 
Peak 
Start 
Rf 
Start 
Height 
Max 
Rf 
Max 
Height 
Max 
% 
End 
Rf 
End 
Height 
Area 
Area 
% 
1 -0.03 0.1 -0.01 122.2 8.53 0.03 29.9 2659.1 4.77 
2 0.04 29.6 0.06 56.3 3.93 0.09 23.2 1344.3 2.41 
3 0.09 23.3 0.17 61.2 4.27 0.19 59.4 3455.1 6.20 
4 0.19 59.2 0.34 203.9 14.24 0.37 100.1 17076.1 30.65 
5 0.38 100.1 0.38 101.4 7.08 0.42 90.4 3159.7 5.67 
6 0.44 89.7 0.48 130.0 9.08 0.48 127.0 4110.2 7.38 
7 0.48 127.9 0.49 138.5 9.67 0.52 102.4 3073.9 5.52 
8 0.52 102.8 0.53 109.3 7.63 0.55 87.8 2353.1 4.22 
9 0.55 89.2 0.55 114.9 8.02 0.58 89.6 2728.9 4.90 
10 0.58 89.5 0.63 133.2 9.30 0.70 61.2 8600.6 15.44 
11 0.70 62.1 0.71 96.4 6.73 0.74 43.4 2061.5 3.70 
12 0.74 43.8 0.77 94.6 6.60 0.81 47.9 3732.5 6.70 
13 0.81 48.2 0.82 70.2 4.90 0.87 0.4 1365.0 2.45 
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5.4. CONCLUSION 
 
The main goal of pharmacognosy is to assess the value of raw materials and 
to ensure that the final product is of the required standard. Strict 
standardization procedures and pharmacognostical studies of medicinal 
plants would reduce drastically much of the accidents in wrong prescriptions 
of traditional herbal medicines (Dinesh Kumar 2007). Standardization and 
quality control of plants, is of growing concern over ensuring purity of raw 
material before processing. Yet alternative medicines based on plant 
substances are extremely popular, even though their safety and efficacy have 
not been scientifically proven. Now a days routine pharmacognosy has 
changed demanding interdisciplinary research. From the present study it can 
be concluded that, contamination of heavy metals and microorganisms did not 
observed in dry powder of Pluchea arguta. Various pharmacognostic 
standards like botanical description, microscopy, ash values, extractive 
values, microscopic characteristics of powder, heavy metals, pH, solubility, 
HPTLC and preliminary phytochemical study of Pluchea arguta could be 
useful for the compilation of a suitable monograph for its proper identification.  
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CHAPTER 6:  ACUTE TOXICITY STUDY OF PLUCHEA 
ARGUTA BOISS. IN MICE 
 
6.1. INTRODUCTION 
 
Toxicology is an aspect of pharmacology that deals with the adverse effect of 
bioactive substance on living organisms. In order to establish the safety and 
efficiency of a new drug, toxicological studies are very essential experiments 
in animals like mice, rat etc. No drug substance is used clinically without its 
laboratory safety assessment at preclinical phase. Toxicological studies help 
to make a decision whether a new drug should be adopted for clinical use or 
not (Anisuzzaman et al. 2001; Alam et al. 2006). 
 
In order to support an application for a clinical trial or for the registration of a 
new drug, it is necessary to satisfy legislation that requires that certain data 
should be produced from a variety of toxicological investigations that show the 
safety profile of the compound to which humans may be exposed. Therefore, 
in the majority of cases of evaluation of the toxicity of most substances, 
rodents and non-human primates are first used in preclinical animal safety 
studies before further studies are done in humans. These animals are mainly 
used because of their biological similarity to humans that allows them to be 
regarded as the suitable metabolic models for humans in a broad range of 
investigations (Pascoe 1983; Loomis and Hayes 1996). 
 
Toxicity testing in animals is carried out on new drugs to identify potential 
hazards before administrating them to humans. It involves a wide range of 
tests in different species, with long term administration of the drug, regular 
monitoring for physiological or biochemical abnormalities, and a detailed 
postmortem examination at the end of the trial, to detect any gross or 
histological abnormalities (Rang et al. 2003).  
 
Plants have always been an important source of drugs. From ASPIRIN to 
TAXOL, modern pharmaceutical industries largely take profit of the diversity of 
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secondary metabolites from plants for new drug research. In developing 
countries, a substantial part of the population uses folk medicine for its daily 
health care. Some of the most common practices involve the use of crude 
plant extracts, which may contain a broad diversity of molecules with often 
unknown biological effects (Konan et al. 2007). 
 
The evaluation of the toxic action of plant extracts is indispensable in order to 
consider a treatment safe; it enables the definition of the intrinsic toxicity of 
the plant and the effects of acute overdose. Laboratory mice are sensitive to 
toxic substances occurring in plants. The administration of the extracts in 
increasing amounts enables the evaluation of the toxicity limits, and the test 
should be carried out in two ways, for three doses, and for both sexes, taking 
into account such factors as age, sex, weight, species, diet, and 
environmental conditions (Lagarto Parra et al. 2001). 
 
6.1.1. Toxicity aspects of use of herbal preparations 
 
The World Health Organization estimated that perhaps eighty percent of the 
inhabitants of the world rely chiefly on traditional medicines. It, therefore, 
approved the use of herbal products for national policies and drug regulatory 
measures in order to strengthen research and evaluation of the safety and 
efficacy of these products (Saxena 2001). Despite widespread use, few 
scientific studies have been undertaken to ascertain the safety and efficacy of 
traditional remedies (Veerappan et al. 2007). An increasing reliance on the 
use of medicinal plants in the industrialized societies has been traced to the 
extraction and development of several drugs and chemotherapeutics from 
these plants as well as from traditionally used herbal remedies (UNESCO 
1998). 
 
In the absence of an efficient primary health care system, traditional medicine 
occupies a central place in the provision of health care, especially among 
rural communities of developing countries. The strong historical bond between 
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plants and human health is well substantiated by plant species diversity and 
related knowledge of their use as herbal medicines (Tabuti et al. 2003) 
 
The use of plants for healing purpose is getting increasingly popular as they 
are believed as being beneficial and free of side effects (Leonardo et al. 
2000). Currently, there is an ongoing world-wide “green” revolution which is 
mainly premised on the belief that herbal remedies are safer and less 
damaging to the human body than synthetic drugs (Williamson et al. 1996; 
Parekh and Chanda 2006).  
 
Although many medicinal plant products are used as relief for many ailments 
in humans, very little is known about their toxicity. Safety should be the 
overriding criterion in the selection of medicinal plants for use in healthcare 
systems (Tomlinson and Akerele 1998). 
 
6.1.2. Route of administration  
 
To evaluate toxicity of a compound in animals various routes may be used, 
but two most commonly used modes of administration for animals studies are 
intraperitoneal injection or the oral route (Poole and Leslie 1989). 
 
The oral route is probably one of the most common means by which a 
chemical enters the body. In short, the oral administration is the form of 
administration involving the gastrointestinal tract, which may be viewed as a 
tube going through the body, starting at the mouth and ending at the anus. 
Although it is within the body, its contents are essentially exterior to the body 
fluids. Most orally administered chemicals can otherwise have a systemic 
effect on the organism only after absorption has occurred from the mouth or 
the gastrointestinal tract. Oral administration of chemicals that are rapidly 
absorbed from the gastrointestinal tract would theoretically expose the liver to 
concentrations of the agent that would not be obtained if other routes of 
administration were used (Loomis and Hayes 1996).  
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The acute toxicity defined by the Organization of Economic Cooperation and 
Development (OECD) Guidelines as the adverse effects occurring within a 
short time after oral administration of a single dose of a substance or multiple 
doses given within 24 h (Chan and Hayes 1994). 
 
Usually acute (single dose) toxicity study is carried out on laboratory animals 
by using high dose (sufficient to produce death or morbidity) of the substance 
in question and/or based on previous report on its toxicity or toxicity of 
structurally related compounds (Demma et al. 2007). There was no previous 
report on toxicity of Pluchea arguta.  
 
The present study was undertaken to contribute data on the safety of the 
methanol extract of Pluchea arguta, focusing on its acute toxicity study and its 
effect on gross behaviour changes, food and water intake, body weight 
changes, different organ weight changes and haematological parameters. 
 
6.2. MATERIAL AND METHODS  
 
6.2.1. Experimental animals 
 
Swiss albino mice of either sex (20-25g) were used for acute toxicity studies. 
The animals were obtained from Sarabhai Research Centre (SRC), Baroda. 
All the mice were housed in standard plastic cages with stainless steel 
coverlids and wheat straw as bedding material at the animal house of 
Department of Biosciences, Saurashtra University, Rajkot, Gujarat, India. The 
animals were kept in a group of 5-6 per cage and facilitated with standard 
environmental condition of photoperiod (12:12 h dark: light cycle) and 
temperature (25 ± 2oC). They were provided with commercial rat and mice 
feed (Pranav Agro Industries Ltd., Amrut brand rat and mice pellet feed) and 
water given ad libitum. The use of these animals and the study protocols were 
approved by CPCSEA local ethical committee. 
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6.2.2. Plant material 
 
Collection and identification of plant material is described in Chapter 5.2.1. 
 
6.2.3. Extraction 
 
The dried crude powder of Pluchea arguta Boiss was extracted by soxhlet 
extraction method (Vaghasiya et al. 2008). Plant material was defatted by 
petroleum ether. Defatted plant material was extracted in methanol. The 
methanol was evaporated from the extract, and the dried extract was 
collected, weighed and stored in air-tight bottles at 4OC for further 
experiments. 
 
6.2.4. Acute toxicity study 
 
6.2.4.1. Experimental groups and drug administration  
 
In order to study any possible toxic effect or changes in normal behaviour 4 
groups of 10 mice (five male and five female) were used in this experiment. 
Group I served as control group (D/W) and the other groups II, III and IV were 
treated with the extract of Pluchea arguta (1000, 3000 and 6000 mg/kg 
respectively). All the animals were fasted overnight prior to dosing. Before 
commencing the experiment, the body weight of mice was recorded. All the 
animals except group I were administered a single oral dose of methanol 
extract of Pluchea arguta at 1000, 3000, and 6000 mg/kg body weight. The 
control animals received only vehicle (D/W).  
 
6.2.4.2. Behavioural study 
 
The mice were placed one by one at the centre of three concentric circles 
drawn on a rubber sheet with diameter of 7 cm, 14 cm and 21 cm. After 
dosing all animals were observed for gross behaviour parameters like CNS 
depression (Hypoactivity, passivity, relaxation, narcosis and ataxia), CNS 
stimulation (Hyperactivity, irritability, stereotypy, tremors, convulsions, straub 
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tail and analgesia) and ANS stimulation (Ptosis and exophthalmia) at 1 h, 2 h, 
3 h, 24 h and 48 h (Morpugo 1971). The observed results were recorded as 
sign of toxicity/number of animals studied.  Signs of toxicity and mortality were 
observed daily for 7 days and were monitored daily for changes in body 
weight. 
 
6.2.4.3. Food and water consumption 
 
The amount of feed and water consumption was evaluated daily as known 
amount of food and water was given to each animal in each cage. After 24 h, 
the remaining food and water was taken from the cage and weighed. To find 
out the food and water consumption, remaining amount of food and water was 
deducted from the total amount. 
 
6.2.4.4. Absolute and relative organ weight 
 
The position, shape, size and color of internal organs such as liver, kidney, 
lung, heart, spleen, brain, adrenal, thymus, testis and uterus was visually 
observed for any sign of gross lesions. These organs were collected, 
weighted to determine the relative organ weight. The relative organ weight 
was calculated using the following formula:  
Relative organ weight (g) = [Organ weight (g) / body weight (g)] X 100 
Relative organ weight was compared with the control group.  
 
6.2.4.5. Haematological parameters 
 
On 8th day, the animals were made to fast overnight and sacrificed by 
decapitation and blood was collected. The haematological parameters like 
haemoglobin, total red blood cell (RBC), leukocyte (WBC), PCV, MCV, MCH, 
MCHC, neutrophils, lymphocytes, eosinophils and platelet counts were 
determined using an autoanalyzer (System H1, Bayer Diagnostics). 
 
 
 
Chapter 6: Acute toxicity study 
 112 
6.2.5. Statistical analysis 
 
All values are expressed as the mean ± SEM. The statistical comparisons 
were made by means of the student’s t test and one way ANOVA. Values are 
considered statistically significant at p<0.05 for t-test and F<0.05 for ANOVA. 
 
6.3. RESULTS AND DISCUSSION  
 
Phytotheraputic products are many times, mistakenly regarded as safe 
because they are natural (Gesler 1992). Nevertheless, these products contain 
bioactive principles with potential to cause adverse effect (Bent and Ko 2004). 
Therefore, all the natural products used in therapeutics must be submitted to 
efficacy and safety test by the same methods used for new drugs (Talalay and 
Talalay 2001).  Usually acute (single dose) toxicity study is carried out on 
laboratory animals by using high dose of the substance in question and/or 
based on previous report on its toxicity or toxicity of structurally related 
compounds. However, sometimes the acute toxicity test is criticized as a 
parameter for assessing toxicity but there are still occasions when some 
useful information could be obtained from such studies. Apart from giving a 
clue on the range of doses that could be used in subsequent toxicity testing, it 
could equally reveal the possible clinical signs elicited by the substance under 
investigation. It is also a useful parameter to investigate therapeutic index (i.e. 
LD50/ED50) of drugs and xenobiotics (Rang et al. 2001). 
 
6.3.1. Gross behaviour study 
 
No mortality was observed after the administration of methanol extract of 
Pluchea arguta at the doses of 1000, 3000 and 6000 mg/kg body weight. This 
is an indication that the extract has negligible level of toxicity when 
administered orally. According to Kennedy et al. (1986), substances with LD50 
higher than 5 g/kg by oral route are regarded as being safe or practically non-
toxic. The behavioral signs of toxicity such as CNS depression (Hypoactivity, 
passivity, relaxation, narcosis and ataxia), CNS stimulation (Hyperactivity, 
irritability, stereotypy, tremors, convulsions, straub tail and analgesia) and 
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ANS stimulation (Ptosis and exophthalmia) were also observed (Table 6.1 
and Table 6.2). No signs of toxicity were observed, in eighter sex, in the 
control or treated groups. In addition, gross necropsy findings did not show 
any adverse effects in male and female mice of any organs in treated groups 
as compared to control group. Diarrhoea was observed in male and female 
mice at the dose of 6000 mg/kg at 1 h, 2 h and 3 h. After 24 h all the animals 
were normal. Anti-analgesic effect was seen at the doses of 1000, 3000 and 
6000 mg/kg (Table 6.1 and Table 6.2). 
 
6.3.2. Food and water consumption 
 
Determination of food consumption is important in the study of safety of a 
product with therapeutic purpose, as proper intake of nutrients is essential to 
the physiological status of the animal and to the accomplishment of the proper 
response to the drug tested instead of a false response due to improper 
nutritional conditions (Stevens and Mylecraine 1994; Iversen and Nicolayen 
2003).   
 
In the present study, food and water consumption values were measured in 
male and female mice of both control and treated groups (Table 6.3 and Table 
6.4). Statistically no significant difference was observed in Pluchea arguta 
methanol extract treated groups when compared with control group.
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Table 6.1 Gross behavior study of methanol extract of Pluchea arguta at different doses in mice (Males)  
 
Data is presented as response / number of animals; HP- Hypoactivity; PS- Passivity; RL- Relaxation; NC- Narcosis; AT- Ataxia; HR- Hyperactivity; IR- Irritability; ST- 
Stereotypy; TR- Tremors; CN- Convulsions; SR- Straub tail; AN- Analgesia; PT- Ptosis; EX- Exophthalmia; DI- Diarrhea 
 
Groups 
 
Doses 
 
 
M
o
rt
a
li
ty
  Parameters of gross behaviour 
CNS 
Depression 
 CNS 
stimulation 
 ANS 
stimulation  
Others 
HP PS RL NC AT HR IR ST TR CN SR AN PT EX DI 
Group-I 
0 
(Vehicle) 
1h 0/5  0/5 0/5 0/5 0/5 0/5  0/5 0/5 0/5 0/5 0/5 0/5 0/5  0/5 0/5 
 
0/5 
2h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
3h 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
24h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
48h 0/5 3/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Group-
II 
1000 
mg/kg 
1h 0/5 1/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 0/5 0/5 0/5 
2h 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
3h 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
24h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
48h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Group-
III 
3000 
mg/kg 
1h 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
2h 0/5 2/5 2/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
3h 0/5 3/5 3/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 0/5 0/5 0/5 
24h 0/5 3/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
48h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Group-
IV 
6000 
mg/kg 
1h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 4/5 
2h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 2/5 0/5 0/5 4/5 
3h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 4/5 
24h 0/5 1/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 0/5 0/5 0/5 
48h 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 3/5 0/5 0/5 0/5 
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Table 6.2 Gross behavior study of methanol extract of Pluchea arguta at different doses in mice (Females) 
 
Data is presented as response / number of animals; HP- Hypoactivity; PS- Passivity; RL- Relaxation; NC- Narcosis; AT- Ataxia; HR- Hyperactivity; IR- Irritability; ST- 
Stereotypy; TR- Tremors; CN- Convulsions; SR- Straub tail; AN- Analgesia; PT- Ptosis; EX- Exophthalmia; DI- Diarrhea 
Groups 
 
Doses 
 
 
M
o
rt
a
li
ty
  
Parameters of gross behaviour 
CNS 
Depression 
 CNS 
stimulation 
 ANS 
stimulation  
Others 
HP PS RL NC AT HR IR ST TR CN SR AN PT EX DI 
Group-I 
0 
(Vehicle) 
1h 0/5  1/5 0/5 0/5 0/5 0/5  0/5 0/5 0/5 0/5 0/5 0/5 0/5  0/5 0/5 
 
0/5 
2h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
3h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 1/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
24h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
48h 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Group-
II 
1000 
mg/kg 
1h 0/5 1/5 0/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 3/5 0/5 0/5 0/5 
2h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
3h 0/5 2/5 0/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
24h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
48h 0/5 2/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Group-
III 
3000 
mg/kg 
1h 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
2h 0/5 1/5 0/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
3h 0/5 2/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
24h 0/5 1/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
48h 0/5 2/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
Group-
IV 
6000 
mg/kg 
1h 0/5 0/5 1/5 2/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 
2h 0/5 1/5 1/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 
3h 0/5 1/5 1/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 2/5 
24h 0/5 0/5 0/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
48h 0/5 0/5 0/5 1/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 0/5 1/5 0/5 0/5 0/5 
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Table 6.3 Food consumption values of acute toxicity study of 
methanol extract of Pluchea arguta extract in male and 
female mice   
Food consumption (g/animal/day) 
Groups Control PAM-1000 PAM-3000 PAM-6000 
Males 11.40 ± 0.46 10.45 ± 0.26 10.70 ± 0.67 9.75 ± 0.58 
Females  10.47 ± 0.45 10.03 ± 0.44 12.07 ± 0.52 8.67 ± 0.68 
Data is presented as mean ± SEM (Average value of seven days), PAM- 
methanol extract of P. arguta  
 
Table 6.4 Water consumption values of acute toxicity study of 
methanol extract of Pluchea arguta extract in male and 
female mice 
Water consumption (ml/animal/day) 
Groups Control PAM-1000 PAM-3000 PAM-6000 
Males 11.40 ± 0.46 10.12 ± 0.33  10.70 ± 0.67 9.75 ± 0.58 
Females  10.27 ± 0.44 10.03 ± 0.44 12.07 ± 0.52 8.67 ± 0.68 
Data is presented as mean ± SEM (Average value of seven days), PAM- 
methanol extract of Pluchea arguta  
 
 
Body weight changes are indication of adverse effects of drugs and chemicals 
and it will be significant if the body weight loss is more than 10% from the 
initial body weight occurred (Tofovic and Jackson 1999; Raza et al. 2002; Teo 
et al. 2002).  
 
Figure 6.1 and Figure 6.2 show the effects of P. arguta extract on body weight 
of male and female mice, respectively. Statistically no significant difference on 
body weights of the male and female mice receiving Pluchea arguta extract 
were noticed, as compared to the control group, throughout the experiment.  
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Fig. 6.1 Effect of methanol extract of Pluchea arguta (PAM) on 
body weight changes in male mice 
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Fig. 6.2 Effect of methanol extract of Pluchea arguta (PAM) on 
body weight changes in female mice 
 
 
6.3.3. Absolute and relative organ weight 
 
Organ weight also is an important index of physiological and pathological 
status in man and animals. Table 6.5 and Table 6.6 depict the effect of 
methanol extract of Pluchea arguta on the weight of some vital organs in male 
and female mice. Pluchea arguta extract administration did not cause 
statistical difference in organ weight of male and female mice as compared to 
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the control group. Moreover, gross examination of internal organs of all the 
mice revealed no detectable abnormalities.  Thus, it can be suggested that 
Pluchea arguta methanol extract of leaf is nontoxic at single dos level. 
 
 
6.3.4. Haematological parameters 
 
Blood parameters analysis is relevant to risk evaluation as the hematological 
system has a higher predictive value for toxicity in humans (91%) when assay 
involve rodents and non-rodents (Olson et al. 2000). 
 
 
Hematological analyses (haemoglobin, total red blood cell (RBC), leukocyte 
(WBC), PCV, MCV, MCH, MCHC, neutrophils, lymphocytes, eosinophils and 
platelet counts) all the parameters were statistically not significant when 
compared to the control group, discarding the possibility of anemia or 
disturbances in the erythrocytes or hemoglobin production. 
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Table 6.5 Absolute organ weight (g) and relative organ weight values (g/100g body weight) of acute toxicity study of 
methanol extract of Pluchea arguta in male mice 
   
Organs 
Control 
 
PAM-1000 
 
PAM-3000 
 
PAM-6000 
AOW ROW AOW ROW AOW ROW AOW ROW 
            
Heart 0.18 ± 0.02 0.50 ± 0.03 
 
0.18 ± 0.02 0.51 ± 0.04 
 
0.19 ± 0.01 0.51 ± 0.02 
 
0.18 ± 0.004 0.50 ± 0.02 
Liver 1.79 ± 0.09 5.16 ± 0.19 1.96 ± 0.09 5.43 ± 0.2 2.02 ± 0.07 5.39 ± 0.25 1.96 ± 0.18 5.41 ± 0.32 
Brain 0.5 ± 0.02 1.45 ± 0.09 0.54 ± 0.02 1.51 ± 0.04 0.53 ± 0.02 1.41 ± 0.05 0.51 ± 0.03 1.42 ± 0.09 
Lung 0.3 ± 0.03 0.90 ± 0.14 0.36 ± 0.02 0.99 ± 0.04 0.33 ± 0.03 0.87 ± 0.07 0.38 ± 0.03 1.07 ± 0.07 
Spleen 0.13 ± 0.02 0.37 ± 0.05 0.18 ± 0.03 0.49 ± 0.08 0.16 ± 0.02 0.43 ± 0.06 0.17 ± 0.04 0.47 ± 0.1 
Kidney 0.33 ± 0.3 0.94 ± 0.09 0.36 ± 0.02 1.01 ± 0.04 0.37 ± 0.01 0.99 ± 0.03 0.35 ± 0.02 1.00 ± 0.11 
Testis 0.10 ± 0.01 0.29 ± 0.01 0.12 ± 0.01 0.33 ± 0.02 0.11 ± 0.004 0.31 ± 0.02 0.10 ± 0.01 0.26 ± 0.04 
Thymus 0.11 ± 0.01 0.62 ± 0.06 0.11 ± 0.01 0.58 ± 0.067 0.13 ± 0.01 0.67 ± 0.051 0.13 ± 0.01 0.74 ± 0.065 
Data is presented as mean ± SEM; PAM- methanol extract of Pluchea arguta; AOW- Absolute organ weight; ROW- Relative organ 
weight 
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Table 6.6 Absolute organ weight (g) and relative organ weight (g/100g body weight) of acute toxicity study of methanol 
extract of Pluchea arguta in female mice 
 
Organs 
Control 
 
PAM-1000 
 
PAM-3000 
 
PAM-6000 
AOW ROW AOW ROW AOW ROW AOW ROW 
            
Heart 0.15 ± 0.01 0.47 ± 0.03 
 
0.16 ± 0.01 0.50 ± 0.03 
 
0.16 ± 0.01 0.50 ± 0.02 
 
0.17 ± 0.01 0.55 ± 0.02 
Liver 1.59 ± 0.12 5.08 ± 0.32 1.76 ± 0.05 5.64 ± 0.21 1.70 ± 0.08 5.52 ± 0.34 1.74 ± 0.05 5.66 ± 0.15 
Brain 0.52 ± 0.02 1.65 ± 0.07 0.52 ± 0.01 1.64 ± 0.08 0.53 ± 0.01 1.73 ± 0.03 0.54 ± 0.01 1.75 ± 0.06 
Lung 0.27 ± 0.02 0.86 ± 0.06 0.34 ± 0.03 1.09 ± 0.13 0.35 ± 0.03 1.12 ± 0.08 0.4 ± 0.02 1.30 ± 0.08 
Spleen 0.11 ± 0.01 0.34 ± 0.03 0.14 ± 0.02 0.44 ± 0.06 0.15 ± 0.02 0.50 ± 0.06 0.13 ± 0.02 0.41 ± 0.04 
Kidney 0.23 ± 0.01 0.73 ± 0.05 0.23 ± 0.01  0.71 ± 0.03 0.24 ± 0.02 0.77 ± 0.06 0.24 ± 0.01 0.79 ± 0.05 
Uterus 0.20 ± 0.03 0.66 ± 0.11 0.23 ± 0.03 0.74 ± 0.08 0.24 ± 0.02 0.78 ± 0.06 0.26 ± 0.03 0.85 ± 0.1 
Thymus 0.08 ± 0.02 0.53 ± 0.05 0.10 ± 0.02 0.62 ± 0.06 0.11 ± 0.01 0.70 ± 0.05 0.11 ± 0.02 0.73 ± 0.06 
Data is presented as mean ± SEM, PAM- methanol extract of Pluchea arguta; AOW- Absolute organ weight; ROW- Relative organ weight 
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Table 6.7 Hematological parameters of acute toxicity study of Pluchea arguta extract in 
male mice 
Hematological parameters Control PAM-1000 PAM-3000 PAM-6000 
Hemoglobin (gms/100ml) 12.40 ± 1.49 14.45 ± 0.96 15.08 ± 0.21 14 ± 0.58 
Total RBC (ml/cu. mm.) 7.70 ± 0.92 9.22 ± 0.73 9.60 ± 0.18 8.73 ± 0.36 
PCV (%) 38.02 ± 4.92 44.98 ± 3.15 45.74 ± 0.64 43.08 ± 2.01 
MCV (cu. micron) 49.06 ± 0.70 48.97± 0.89 47.76 ± 0.59 49.29 ± 0.48 
MCH (Pico gram) 16.10 ± 0.13 15.87 ± 0.21 15.72 ± 0.16 16.03 ± 0.11 
MCHC (%) 32.83 ± 0.51 32.43 ± 0.43 32.91 ± 0.14 32.54 ± 0.22 
Neutrophils (%) 26.80 ± 4 40.40 ± 6.78 27.60 ± 3.33 36.40 ± 5.69 
Lymphocytes (%) 72.40 ± 4.08 58.40 ± 6.93 71.20 ± 3.68 62.20 ± 6.29 
Eosinophils (%) 0.80 ± 0.37 1.20 ± 0.73 1.20 ± 0.58 1.40 ± 0.68 
Data is presented as mean ± SEM; PAM- methanol extract of P. arguta 
 
Table 6.8 Hematological parameters of acute toxicity study of Pluchea arguta extract in 
female mice  
 
Hematological parameters Control PAM-1000 PAM-3000 PAM-6000 
Hemoglobin (gms/100ml) 15.50 ± 0.32 15.10 ± 0.24 14.68 ± 0.13 15.56 ± 0.25 
Total RBC (ml/cu. mm.) 9.68 ± 0.1 9.54 ± 0.15 9.19 ± 0.12 9.51 ± 0.19 
PCV (%) 47.08 ± 0.89 45.50 ± 1.02 44.34 ± 0.76 46.34 ± 0.73 
MCV (cu. micron) 48.63 ± 0.55 47.70 ± 0.70 48.26 ± 0.60 48.47 ± 0.47 
MCH (Pico gram) 16.01 ± 0.24 15.84 ± 0.30 15.99 ± 0.21 16.28 ± 0.16 
MCHC (%) 32.93 ± 0.40 33.21 ± 0.45 33.13 ± 0.39 33.59 ± 0.56 
Neutrophils (%) 27.60 ± 2.18 30.40 ± 2.77 24.40 ± 3.54 24.40 ± 3.36 
Lymphocytes (%) 72 ± 2.45 69 ± 2.97 75.20 ± 3.53 75.40 ± 3.47 
Eosinophils (%) 0.40 ± 0.40 0.60 ± 0.40 0.40 ± 0.40 0.20 ± 0.20 
Data is presented as mean ± SEM, PAM- methanol extract of Pluchea arguta  
 
6.4. CONCLUSION 
 
In conclusion, Pluchea arguta extract was found to be fairly nontoxic when 
oral acute toxicity study in mice was performed at single dose level.  Detailed 
experimental analysis on chronic toxicity is essential for further support of this 
drug. 
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CHAPTER 7: ANTI-INFLAMMATORY AND ANALGESIC EFFECTS OF 
PLUCHEA ARGUTA BOISS  
 
 
7.1. INTRODUCTION 
 
 
7.1.1. Inflammation 
 
Inflammation, which was recognized as a simple allergic reaction for decades, 
is currently being considered to underline pathophysiology of a much broader 
spectrum of diseases than previously expected. The complex interplay of 
cellular and humoral mediators during inflammation is unfolding but our 
understanding of the inflammatory reaction is still incomplete (Sadowski-
Debbing et al. 2002; Plytycz and Seljelid 2003). All inflammatory processes 
develop along a known sequence: locally increased blood supply, leakage of 
fluid, small molecules and proteins, and infiltration of cells (Roitt 1997). 
 
Based on visual observation, the ancients characterized inflammation by five 
cardinal signs, viz. redness, swelling, heat, pain and loss of function (Hurley 
1972). The swelling (oedema) is the result of increased passage of fluid from 
dilated and permeable blood vessels into the surrounding tissues, infiltration 
of cells into the damaged area, and in prolonged inflammatory responses 
deposition of connective tissue. Pain is due to the direct effects of mediators, 
either from initial damage or that resulting from the inflammatory response 
itself, and the stretching of sensory nerves due to oedema. The loss of 
function refers to either simple loss of mobility in a joint, due to the oedema 
and pain, or to the replacement of functional cells with scar tissue (Punchard 
et al. 2004). 
 
The inflammatory process initiated in response to a pathogen or an injury is 
maintained at a certain, adequate level till the offending stimulus is 
neutralized, after which the reaction resolves on its own. In an auto-immune 
disorder, a harmless antigen is mistaken by the immune system as being 
foreign, thus initiating the inflammatory reaction. The persistence of a stimulus 
that physiologically resides in the organism prevents the natural, resolving 
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mechanisms from prevailing (Levy and Serhan 2003). As a result one’s own 
defense mechanism can turn into a perpetuator of a persistent injury which 
although not fatal, can lead to loss of function of the organs involved. 
Additionally, many of the mediators can leak from the local region and initiate 
inflammatory reactions elsewhere (Cleeland et al. 2003). Animal experiments 
have been extremely useful in understanding the entire inflammatory reaction 
since they demonstrate a complete window of events, from the time when the 
stimulus is given till the reaction naturally resolves (Dawson et al. 1991; 
Finlay-Jones et al. 1999). 
 
Inflammation is an essential and beneficial process in the protection against 
pathogens. Occasionally the inflammatory process is directed against 
autologous antigens, or the process does not alleviate after its onset and 
escalates into long-term persistence of inflammation, i.e., chronic 
inflammation (Robbins et al. 1999). The excessive release of proteases and 
ROS by the activated leukocytes and endothelial cells in such conditions can 
ultimately result in severe tissue damage (Conner and Grisham 1996). In the 
pathogenesis of several diseases such as rheumatoid arthritis, inflammatory 
bowel disease, atherosclerosis, multiple sclerosis, Alzheimer’s disease, and 
transplant rejection, inflammation- mediated tissue injury plays an important 
role (Cotran and Mayadas-Norton 1998).  
  
Inflammation is a pathophysiological response of mammalian tissues to a 
variety of hostile agents including infectious organisms, toxic chemical 
substances, physical injury or tumor growth leading to local accumulation of 
plasmic fluid and blood cells (Sobota et al. 2000). Although inflammation is a 
defense mechanism, the complex events and mediators involved in the 
inflammatory reaction can induce, maintain and aggravate many disorders. 
Hence, the employment of anti-inflammatory agents would be helpful in the 
therapeutic treatment of those pathologies associated with inflammatory 
reactions (Sosa et al. 2002). 
 
There are several mediators involved in inflammation. Histamine, serotonine, 
bradykinin and prostaglandins (PG) are involved in the increased vascular 
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permeability (Posadas et al. 2004). Histamine, bradikinin and serotonin are 
released in the early phase (Di Rosa et al. 1971; Hori et al. 1988) while 
prostaglandins (PGs) are involved in both early and late phases of 
inflammation (Kikuchi et al. 1996). Prostaglandins (PGs) elicit a variety of 
important biological responses. Among the properties of PGs are their abilities 
to induce pain, fever and symptoms associated with inflammatory responses. 
Most of nonsteroidal anti-inflammatory drugs (NSAIDs), which are clinically 
used to date, inhibit the production of PGs by inhibition of COX enzymes and 
are the main drugs used to reduce the untoward consequences of 
inflammation (Albert et al. 2002). They are also involved in maintaining normal 
physiological processes (Moon et al. 1999). There are two isoforms of COX: 
COX-1 and COX-2. COX-1 is detectable, but COX-2 is not detectable in most 
normal tissues, however, COX-2 can be induced by many factors such as pro-
inflammatory cytokines, phlogistic factors, etc. Studies indicated that COX-2 
plays an important role in inflammation (Subbaramaiah et al. 1996). Thus, 
those agents that could suppress the activity or protein expression of COX-2 
are likely to be valuable medicine for anti-inflammation and easing of pain 
(Shu et al. 2006). Recent development of selective COX-2 inhibitors as anti-
inflammatory agents is considered a major therapeutic breakthrough in the 
treatment of inflammatory diseases since the inhibition of COX-2-derived PGs 
is thought to be the major pharmacodynamic action responsible for their anti-
inflammatory effects (Abad et al. 2006).  
 
Acute and chronic inflammatory diseases are still one of the most important 
health problems in the world. Various agents are adapted to treat 
inflammatory disorders; their prolonged use often leads to serious adverse 
reactions such as gastric intolerance, bone marrow depression, water and salt 
retention. Consequently, development of new anti-inflammatory drugs with 
low side-effects is still necessary (Xiao et al. 2005; Yonathan et al. 2006; 
Kupeli et al. 2007). 
  
Acute inflammation is characterized by rapid onset and is of short duration. It 
is characterized by the exudation of fluids and plasma proteins and the 
migration of leukocytes, most notably neutrophils into the injured area. This 
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acute inflammatory response is believed to be a defense mechanism aimed at 
killing of bacteria, viruses and parasites while still facilitating wound repair 
(Iwalewa et al. 2007). Inflammatory response is triggered by tissue mast cells 
and resident macrophages whose degranulation and activation sequentially 
release a battery of inflammatory mediators, including bioactive amines 
(Histamine and 5-HT), cytokines, chemokines as well as lipid mediators that 
collectively recruit and activate inflammatory cells as well as bring about 
oedema formation (Lawrence and Gilroy 2007). 
 
Chronic inflammation is the reaction arising when the acute response is 
insufficient to eliminate the pro-inflammatory agents. Chronic inflammation 
includes a proliferation of fibroblasts and infiltration of neutrophils with 
exudation of fluid. It occurs by means of development of proliferative cells 
which can either spread or form granuloma. Efficacy of anti-inflammatory 
agents in chronic inflammatory states is indicated by their ability to inhibit the 
increase in the number of fibroblasts during granular tissue formation (Recio 
et al. 1995; Gupta et al. 2003). The persistent chronic inflammation increases 
the development of the degenerative diseases such as rheumatoid arthritis, 
atherosclerosis, heart disease, Alzheimer’s, asthma, acquired 
immunodeficiency disorder (AIDS), cancer, congestive heart failure, multiple 
sclerosis, diabetes, infections (bacterial, fungal, parasitic), gout, inflammatory 
bowel disease, aging and neurodegenerative CNS depression, all of which 
are associated with immunopathology that appears to play a key role in the 
onset of the condition (Dalgleish and O’Byrne 2002; Barnes 2004).  
 
7.1.2. Analgesia 
 
Pain is the most common symptomatic reason for seeking a medical 
consultation. Everyone is affected by pain at some point in their lives, whether 
it is from headaches, cuts and bruises or more severe pain resulting from 
surgery, which would be pre-controlled in anticipation of the event. Although 
chronic types of pain may generally appear to have no purpose, acute pain 
acts as an important warning mechanism to the person by instructing the 
brain to isolate the individual from that particular pain stimulus. The treatment 
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of pain, a major problem in medicine, is complicated by many factors. Pain is 
not a uniform sensation, as illustrated by its many common descriptions, e.g. 
sharp, dull, aching, burning, shooting, cramping, stabbing and throbbing. 
There are several ways to classify pain, but the first distinction usually made 
is that between acute and chronic pain. Pain is a subjective sensation which 
cannot be measured objectively (Buschmann et al. 2002). 
 
The management and treatment of pain is probably one of the most common 
and yet difficult aspects of medicinal practice. Analgesic therapy is domain by 
two major classes of analgesic drugs; viz. opioids and non steroidal anti-
inflammatory drugs (NSAIDs). Both classes of analgesic drugs produce 
serious side effects, such as gastrointestinal disturbance, renal damage (with 
NSAIDs drugs), etc. (Domaj et al. 1999; Dahl and Reader 2000). 
 
7.1.3. Standard drugs as anti-inflammatory agents and their side effects 
 
Inflammatory diseases are very common throughout the world and non-
steroidal anti-inflammatory drugs are the most prescribed drugs for the 
treatment of inflammatory diseases. However, prolonged use of both steroidal 
and non-steroidal anti-inflammatory drugs is well known to be associated with 
gastric injury and ulceration, renal damage and bronchospasm due to their 
non-selective inhibition of both isoforms of the COX enzymes (Tapiero et al. 
2002). The use of steroidal drugs as anti-inflammatory agents is also 
becoming highly controversial due to their multiple side effects (Van den 
Worm et al. 2001). 
 
Therapy of inflammatory diseases is usually directed at the inflammatory 
processes. Through years of ingenious syntheses and structural 
modifications, which usually accompany design and development of new drug 
substances, many non-steroidal anti-inflammatory drugs (NSAIDS) have been 
prepared and marketed (Osadebe and Okoye 2003).  NSAIDs are the most 
common medications taken worldwide for the treatment of pain, inflammation 
and fever. Although chemically disparate they produce therapeutic effects by 
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the common ability to inhibit the activity of cyclooxygenase (COX) enzymes 
(Ferreira et al. 1971; Smith and Willis 1971; Vane 1971).  
 
The nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, 
indomethacin and ibuprofen inhibit early steps in the biosynthesis pathway of 
prostaglandins by inhibition of COX enzymes and are the main drugs used to 
reduce the untoward consequences of inflammation (Albert et al. 2002). 
However, the side effects of the currently available anti-inflammatory drugs 
pose a major problem in their clinical use (Mattison et al. 1998). They provide 
sympathetic relief, but they do not modify the pathogenesis of inflammation 
and do not reduce the disabling bone and cartilage damage (Ford-Hutchinson 
et al. 1981). Therefore, people suffering from chronic inflammatory conditions 
have turned to the use of complementary and alternative medicines including 
herbal products to restore their health (Kaboli et al. 2001). As a result the 
search for other alternatives seems necessary and beneficial (Vasudevan et 
al. 2007).  
 
7.1.4. Use of medicinal plants 
 
Herbal drugs are being proved as effective as synthetic drugs with lesser side 
effects. So, there is a continuous search for indigenous drugs, which can 
provide relief from inflammation (Balasubramanian et al. 2005). Medicinal 
herbs have been used as a form of therapy for the relief of pain throughout 
history (Almeida et al. 2001). Medicinal plants are believed to be an important 
source of new chemical substances with potential therapeutics (Farnsworth 
1989; Eisner 1990). The search for plants with reported folkloric use as pain 
relievers, anti-inflammatory agents, should therefore be viewed as a fruitful 
and logical research strategy in the search for new anti-inflammatory drugs.   
 
Plants have been used by human beings since ages in traditional medicine 
due to their therapeutic potential and search for medicinal plants has led the 
discovery of novel drugs (Orhan et al. 2006). Plant extracts have been used 
for centuries as a popular method for treating several health disorders. Over 
the last ten years the study of plant extracts has attracted attention in different 
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fields of the biological sciences (Penna et al. 2003; Ratheesh and Helen 
2007). The use of botanical and herbal medicines as a complementary 
approach for the treatment of inflammatory diseases has been steadily 
increasing, possibly because of the adverse effects associated with the use of 
non steroidal anti-inflammatory drugs. One approach to discover newer anti-
inflammatory agents is to search from natural sources (Mazura et al. 2007).  
 
Natural products from some plants, fungi, bacteria and other organisms 
continue to be used in pharmaceutical preparations either as pure compounds 
or as extracts. There is a great variety of compounds that can be extracted 
and characterized from plants, which can provide a wide spectrum of 
medicinal properties. The herbal products seems to be a potential source, 
having different substances to be investigated, including alkaloids, 
curcuminoids, terpenoids, flavonoids, etc, which have been commonly used in 
folk medicine and have efficacy against many diseases.  
 
A number of natural products are used in the traditional medical systems in 
many countries. Alternative medicine for treatment of various diseases is 
getting more and more popular. Many medicinal plants provide relief from 
symptoms comparable to that obtained from allopathic medicines. The 
majority of clinically important medicines belong to steroidal or non-steroidal 
anti-inflammatory chemical therapeutics for treatment of various inflammatory 
diseases. Though these drugs have potent properties, they have various and 
severe adverse effects. Therefore, agents of natural origin with very little side 
effects are required as substitute chemical therapeutics (Ahmadiani et al. 
1998; Verpoorte 1999).  
 
Hence, search for new anti-inflammatory agents that retain therapeutic 
efficacy and yet are devoid of side effects is the need of the hour. Thus, study 
of plant species that traditionally have been used as pain killers should still be 
seen as a logical research strategy, in search for new anti-inflammatory and 
analgesic drugs (Mantri and Witiak 1994; Elisabetsky et al. 1995). There are 
many reports of natural products which show anti-inflammatory and analgesic 
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activity (Vaghasiya et al. 2007; Rao et al. 2008; Owoyele et al. 2009; Tanna et 
al. 2009). 
 
7.1.5. Pluchea arguta 
 
Pluchea arguta Boiss is a member of family Asteraceae and about 1000 
genera of this family are well known in the world (Jaffri 1966). Different 
species of Pluchea are used in Ayurvedic system of medicine in various 
diseases. Pharmacological studies demonstrated anti-inflammatory and 
antioxidant activities of different Pluchea species (Barros et al. 2006; 
Fernandez and Torres 2006). In view of the therapeutic properties attributed 
by people to different species of this plant, anti-inflammatory and analgesic 
effects of methanol extract of Pluchea arguta Boiss in rats and mice was 
studied using various inflammatory and analgesic models. 
 
7.1.6. Models for anti-inflammatory study 
 
Rat paw edema is the most commonly used model for acute inflammation 
while subcutaneous implantation of biomaterial is usually used for the chronic 
inflammatory model. There are various models of acute inflammation which is 
induced by formalin, dextran, histamine, serotonin, bradykinin, prostaglandin 
and carrageenan and they are commonly used to investigate anti-
inflammatory effects of drugs (Maling et al. 1974; Suleyman and 
Buyukokuroolu 2001). The cotton pellet method is widely used to evaluate the 
transudative and proliferative components of the chronic inflammation. The 
dry weight of the pellets correlates with the amount of the granulomatous 
tissue (Suleyman et al. 2002). 
 
Considering the above, the aim of the present study was to evaluate the anti-
inflammatory and analgesic potency of methanol extract of Pluchea arguta 
Boiss. (leaf + stem)  
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7.2. MATERIAL AND METHODS 
 
7.2.1 Plant material and extraction 
 
The collection of the plant material and the extraction of Pluchea arguta was 
done by soxhlet extraction method as described in Chapter 6.2.1. and 
Chapter 6.2.2. 
 
7.2.2. Drug dose 
 
The doses considered for the experiment on rat and mice were obtained from 
conversion of human dose of Pluchea arguta (3 g kg-1). The conversion factor 
of human dose to rat (Per 200 g body weight) dose is 0.018 (Paget and 
Barnes 1964) and the conversion factor of human dose to mice (Per 20g body 
weight) dose is 0.0026. Hence the calculated dose for the rat is 270 mg/kg 
and for the mouse is 390 mg/kg. From this calculation, all the anti-
inflammatory and analgesic experiments were carried out in two different 
doses of 200 and 400 mg/kg body weight. 
 
7.2.3. Preparation of test drug and standard drug 
 
Test drug (Methanol extract of Pluchea arguta) and standard drug 
(Indomethacin) were prepared as a suspension in distilled water using mortal 
and pestle.  
 
7.2.4. Animal grouping 
 
The animals were divided into four groups for anti-inflammatory and analgesic 
studies. Each group consisted of six animals of either sex. The groups were:  
 
Group I:  Negative control - Distilled water 
Group II: Test drug- Methanol extract of Pluchea arguta- 200 mg/kg body 
weight (PAM-200) 
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Group III: Test drug- Methanol extract of Pluchea arguta- 400 mg/kg body 
weight (PAM-400) 
Group IV: Positive control- Standard drug indomethacin- 2.5 mg/kg body 
weight (Indo-2.5) 
 
7.2.5. Carrageenan induced rat paw edema (Winter et al. 1962) 
 
Acute inflammation was produced by subplantar injection of 0.1 ml of 1% 0.1 
ml of 1% carrageenan in normal saline in the hind paw of rats 1 h after the 
administration of the test drug as well as positive and negative controls. The 
paw volume was measured at 1 h, 2 h and 3 h after carrageenan injection, 
using plethysmograph as described in Chapter 4.2.5. 
 
7.2.6. Dextran induced rat paw edema (Winter and Porter 1957) 
 
The animals were treated in a manner similar to that of carrageenan induced 
paw edema model. 0.1 ml 1% dextran (60,000-90,000 m.w., HiMedia, India) 
was used for the study. Paw volume was measured as mentioned in 
carrageenan induced paw edema model at 1 h, 2 h and 3 h. 
 
7.2.7. Histamine induced rat paw edema (Suleyman et al. 1991) 
 
In this model paw edema of a rat was induced by subplantar injection of 0.1 
ml of 1% freshly prepared histamine in normal saline and the paw oedema 
was measured as mentioned in carrageenan induced paw edema model. The 
paw volume was measured at 0.5 h, 1 h, 2 h and 3 h. 
 
7.2.8. Formalin induced paw edema (Brownlee 1950) 
 
The test drug was administered once daily for seven consecutive days to all 
the groups. On seventh day, initial paw volume was measured before drug 
administration. After 1 h of drug administration, paw edema of the rat was 
induced by subplantar injection of 0.1 ml of 3% formalin solution in normal 
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saline. Paw volumes were measured at 3 h, 24 h and 48 h after formalin 
injection as described earlier in carrageenan model. 
 
7.2.9. Cotton pellet induced granuloma in rats (Swingle and Shideman 
1972) 
 
Cotton pellet induced granuloma formation in rats was performed for chronic 
anti-inflammatory study. This model represents the exudative and proliferative 
phases of inflammation. The cotton pellets weighing 100 mg were made by 
rolling of cotton piece and sterilizing by autoclaving. The rats were 
anaesthetized with ether; dorsum was shaved clear and swabbed with 70% 
(v/v) alcohol. Midline incision of 1 cm was made in the intrascapular region. A 
small tunnel was made on either side of the incision with the help of a small 
blunt forceps. Sterile cotton pellet (100 mg) was implanted in each tunnel. Air 
was removed from the tunnel and then incision was closed with sutures. The 
test drugs were administered for 7 consecutive days starting from the day of 
implantation. The rats were sacrificed on the 8th day, cotton pellets were 
removed and cleaned of extraneous tissue and dried by placing them in a hot 
air oven overnight at 80OC and then weighed. The difference between the 
initial weight and the final weight of the pellet after drying was taken as the 
granuloma tissue weight. The results were expressed as mg granulation 
tissue formed per 100 g body weight. The adrenal gland, spleen, thymus and 
lymph nodes were dissected carefully and weight of these organs was noted. 
Further, these organs were placed in 4% formalin solution and sent to the 
pathological laboratory for histopathological investigations.  Blood samples 
were collected of all the animals and serum was separated. From the serum 
sample, following biochemical parameters were estimated: 
 
7.2.9.1. Serum total protein: 
 
The total serum protein was estimated by modified Biuret method (Vatzidis 
1977) using the total protein test kit (Span Diagnostics Ltd.). 
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7.2.9.1.1. Principle 
 
Peptide bonds of proteins react with cupric ions in alkaline solution to form a 
colored chelate, the absorbance of which is measured at 578 nm. The biuret 
reagent contains sodium-potassium tartrate, which helps in maintaining 
solubility of this complex at alkaline pH. The absorbance of final colour is 
proportional to the concentration of total protein in the samples.  
Protein + Cu++   Alkaline pH Cu-protein complex 
 
7.2.9.1.2. Reagents 
 
Reagent I: Biuret Reagent (Copper sulphate, 7 mM; sodium hydroxide 200 
mM; sodium potassium tartrate 20 mM; surfactant) 
Reagent II: Protein Standard (BSA, 6.5 g/dl; preservative) 
 
7.2.9.1.3. Procedure 
 
3 ml of Reagent I was added to all the test tubes. Thereafter, 30 µl serum was 
added for the test and 30µl Reagent II was added for the standard, while in 
blank 30µl of D/W was added. They were then mixed well and incubated at 37 
ºC for 5 minutes. The absorbance was read at 578 nm.  
 
7.2.9.1.4. Calculation:  
 
Total protein concentration  
(g/dL) 
= 
Absorbance of test 
X 6.5 
Absorbance of standard 
 
7.2.9.2. Serum albumin: 
 
The serum albumin was estimated by the method given by Corcoran and 
Durnan (1977) using albumin test kit (Span Diagnostics Ltd.). 
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7.2.9.2.1. Principle 
 
Determination of albumin in serum or plasma is based on the binding 
behaviour of the protein with the dye bromocresol green. At pH 3.68, albumin 
acts as a cation and binds to the anionic dye, forming a green complex, the 
absorbance of which is measured at 630 nm. 
 
7.2.9.2.2. Reagents 
 
Reagent I: Albumin reagent (Bromocresol green; Buffer pH 3.68; preservative; 
surfactant). 
Reagent II: Albumin standard (BSA, 4 g/dl; Buffer, preservatives). 
 
7.2.9.2.3. Procedure 
 
3 ml of albumin reagent (Reagent I) was added to all the test tubes. 
Thereafter, 30 µl serum was added for the test and 30µl Reagent II was 
added for the standard, while in blank 30µl of D/W was added. They were 
then mixed well and incubated at room temperature for 1 min.  
 
7.2.9.2.4. Calculation:  
 
Albumin 
(g/dL) 
= 
Absorbance of test 
X 4 
Absorbance of standard 
 
7.2.9.3. Serum aspartate transaminase (AST):  
 
Serum aspartate transaminase was estimated by the method of Reitman and 
Frankel (1957) using AST test kit (Span Diagnostics Ltd.).  
 
7.2.9.3.1. Principle 
 
α ketoglutarate and L- aspartate react to form L-glutmate and oxaloacetate. 
This reaction is catalysed by aspartate transaminase. Oxaloacetate so formed 
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is coupled with 2,4-dinitrophenyl hydrazine (2,4-DNPH) to give the 
corresponding hydrazone, which gives brown color  in alkaline medium and 
this can be measured colorimetrically.  
 
7.2.9.3.2. Reagents 
 
Reagent I: Buffered Aspartate α-KG substrate, pH 7.4 
Reagent II: DNPH colour reagent 
Reagent III: Sodium Hydroxide, 4 N 
Reagent IV: Working Pyruvate Standard, 2 mM 
Solution I: Dilute 1 ml of Reagent III up to 10 ml with D/W. 
 
7.2.9.3.3 Procedure 
 
0.25 ml of Reagent I was added in clean test tubes and incubated at 37 ºC for 
5 minutes. 0.05 ml of serum was added in the test, 0.05 ml Reagent IV was 
added in standard and 0.05 ml distilled water was added in the blank. They 
were mixed well and incubated at 37ºC for 60 minutes. Thereafter, 0.25 ml of 
Reagent II was added to all the tubes, mixed well and allowed to stand at 
room temperature (15º-30ºC) for 20 minutes. Then 2.5 ml of Solution I was 
added to all the tubes, mixed well and allowed to stand at room temperature 
(15º-30ºC) for 10 min. The absorbance of blank, standard and test were read 
at 505 nm.  
 
7.2.9.3.4. Calculation 
 
Standard curve of O.D. of test on Y-axis against enzyme activity on X-axis 
was drawn. O.D. of test was marked on the Y-axis of the standard curve and 
extrapolated into the corresponding enzyme activity curve. Serum aspartate 
transaminase activity is expressed as IU/L. 
 
 
 
 
Chapter 7: Anti-inflammatory and analgesic study 
140 
 
7.2.9.4. Serum alanine transaminase (ALT):  
 
Serum alanine transaminase was estimated by the method of Reitman and 
Frankel (1957) using ALT test kit (Span Diagnostics Ltd.).  
 
7.2.9.4.1. Principle 
 
α ketoglutarate and L- alanine react to form L-glutmate and pyruvate. This 
reaction is catalysed by alanine transaminase. Pyruvate so formed is coupled 
with 2,4-dinitrophenyl hydrazine (2,4-DNPH) to give the corresponding 
hydrazone, which gives brown color  in alkaline medium and this can be 
measured colorimetrically.  
 
7.2.9.4.2. Reagents 
 
Reagent I: Buffered Alanine α-KG substrate, pH 7.4 
Reagent II: DNPH colour reagent 
Reagent III: Sodium Hydroxide, 4 N 
Reagent IV: Working Pyruvate Std., 2 mM 
Solution I: Dilute 1 ml of Reagent III up to 10 ml with D/W. 
 
7.2.9.4.3. Procedure 
 
0.25 ml of Reagent I was added in clean test tubes and incubated at 37 ºC for 
5 minutes. 0.05 ml of serum was added in the test, 0.05 ml Reagent IV was 
added in the standard and 0.05 ml distilled water was added in the blank. 
They were mixed well and incubated at 37ºC for 30 minutes. Thereafter, 0.25 
ml of Reagent II was added to all the tubes, mixed well and allowed to stand 
at room temperature (15º-30ºC) for 20 minutes. Then 2.5 ml of Solution I was 
added to all the tubes, mixed well and allowed it to stand at room temperature 
(15º-30ºC) for 10 min. The absorbance of blank, standard and test were read 
at 505 nm. Serum alanine transaminase activity is expressed as IU/L. 
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7.2.9.4.4. Calculation 
 
Standard curve of O.D. of test on Y-axis against enzyme activity on X-axis 
was drawn. O.D. of test was marked on the Y-axis of the standard curve and 
extrapolated in to the corresponding enzyme activity curve. Serum alanine 
transaminase activity is expressed as IU/L. 
 
7.2.9.5. Alkaline Phosphatase (ALP) 
 
Alkaline phosphatase activity was estimated by the method of Kind and King 
(1954) using ALP test kit (Span Diagnostics Ltd.). 
 
7.2.9.5.1. Principle 
 
Alkaline phosphatase from serum converts phenyl phosphate to inorganic 
phosphate and phenol at pH 10.0. Phenol so formed reacts in alkaline 
medium with 4-aminoantipyrine in the presence of oxidizing agent potassium 
ferricyanide and forms an orange-red coloured complex, which is measured 
colorimetrically at 510 nm. The color intensity is proportional to the enzyme 
activity.  
 
7.2.9.5.2. Reagents  
 
Reagent I: Buffered Substrate, pH 10.0 
Reagent II: Chromogen Reagent 
Reagent III: Phenol Standard, 10 mg% 
Working solution: Reconstitute one vial of reagent I, buffered substrate with 
2.2 ml of purified water.  
 
7.2.9.5.3. Procedure 
 
All the test tubes were marked properly as blank (B), standard (S), control (C), 
and test (T). 0.5 ml of working buffered substrate was added in clean tubes. 
1.5 ml of purified water was added in all the tubes. They were mixed well and 
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incubated at 37oC for 3 min. 0.05 ml of serum was added in test (T), 0.05 ml 
of reagent III (Phenol standard) was added in standard (S) and 0.05 ml of 
purified water was added in blank (B) tubes. All the tubes were mixed well and 
incubated at 37o for 15 min. 1 ml of reagent II was added in all the tubes. 0.05 
ml of serum was added in control (C). All the tubes were mixed well and O.D. 
was measured at 510 nm. Serum alkaline phosphatase activity is expressed 
as KA units.  
 
7.2.9.5.4. Calculation 
 
Alkaline phosphatase 
activity (KA units) 
= 
O.D. of test - O.D. of control 
X 10 
O.D. of standard - O.D. of blank 
 
7.2.9.6. Acid phosphatase (ACP): 
 
Acid phosphatase activity was estimated by the method of King and 
Jagatheesan (1959) using ACP test kit (Span Diagnostics Ltd.). 
 
7.2.9.6.1. Principle 
 
Acid phosphatase from serum converts phenyl phosphate to inorganic 
phosphate and phenol at pH 4.9. Phenol so formed reacts in alkaline medium 
with aminoantipyrine in the presence of oxidizing agent potassium ferricyanide 
and forms an orange red colored complex, which is measured colorimetrically. 
The color intensity is proportional to the enzyme activity.  
 
7.2.9.6.2. Reagents  
 
Reagent I: Buffered Substrate, pH 4.9 
Reagent II: Sodium Hydroxide, 0.5 N 
Reagent III: Sodium Bicarbonate, 0.5 N 
Reagent IV: 4-aminoantipyrine, 0.6% 
Reagent V: Potassium Ferricyanide, 2.4% 
Reagent VI: Tartrate, 1 M 
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Reagent VII: Stock phenol Standard, 10 mg%   
 
7.2.9.6.3. Working solutions 
 
Solution I: Reconstitute one vial of reagent I, buffered substrate with 2 ml of 
purified water.  
Solution II: Dissolve reagent 4 in 25 ml of purified water 
Solution III: Dissolve reagent 5 in 25 ml of purified water 
Working standard: Dilute stock phenol standard 0.5 to 5 with purified water 
 
7.2.9.6.4. Procedure 
 
All the test tubes were marked properly as blank (B), standard (S), control (C) 
and test (T). 0.5 ml of solution I was added in control (C) and test (T). 0.5 ml 
of purified water was added in control (C) and test (T). 0.6 ml of purified water 
was added in standard (S) and 1.1 ml of purified water was added in blank 
(B). All the tubes were mixed well and incubated at 37o C for 3 min. 0.1 ml of 
serum was added in test (T), 0.5 ml of working standard was added in 
standard (S). All the tubes were mixed well and incubated at 37o for 60 min. 
0.5 ml of reagent II was added in all the tubes. 0.1 ml of serum was added in 
control (C). 0.5 ml of reagent III, 0.5 ml of solution II and 0.5 ml of solution III 
was added in all the tubes. All the tubes were mixed well and O.D. was 
measured at 510 nm.  
 
7.2.9.6.5. Calculation 
 
Acid phosphatase activity 
(KA units) 
= 
O.D. of test - O.D. of control 
X 5 
O.D. of standard - O.D. of blank 
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7.2.9.7. Ascorbic acid content in adrenal gland: 
 
The adrenal glands collected at the end of cotton pellet granuloma test were 
processed to estimate the adrenal ascorbic acid content as per Roe and 
Kuether (1943). 
 
7.2.9.7.1. Reagents 
 
1. Trichloroacetic Acid (TCA) 6% w/v 
2. 2,4-dinitrophenylhydrazine (DNPH) (2%) in 9 N H2SO4 
3. Thiourea (10%) 
4. H2SO4 (85%) 
5. Activated Charcoal  
6. Ascorbic Acid Standard (100 mg/dL) in D/W 
 
7.2.9.7.2. Procedure 
 
Adrenal glands were homogenized with 4 ml of 6% TCA by grinding in a 
mortar kept on ice blocks. The solutions were transferred to centrifuging tubes 
and approximately 10 mg (from a calibrated scoop) of acid washed norit was 
added and mixed thoroughly and centrifuged at 3000 rpm for 10 min.  
 
Two ml of the supernatant was taken in labeled test tubes and 2ml of 6% TCA 
in blank test tube. 1 drop of thiourea was added to all the tubes followed by 
0.5ml of DNPH except to blank. The tubes were transferred to a water bath 
maintained at 37OC and incubated for 3 hours. The tubes were removed and 
placed in an ice water bath and 2.5ml of 85 % H2SO4 was added drop by drop 
while stirring in the ice-cold condition. Next 0.5 ml of DNPH was added to the 
blank tube. The tubes were maintained at room temperature for 30 min. After 
removing them from the ice bath, optical density of the colour developed was 
measured spectrophotometrically (Systronic) at 540 nm. Ascorbic acid content 
is expressed as µg/mg adrenal gland.  
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7.2.9.8. Histology of studied organs 
 
7.2.9.8.1. Adrenal gland  
 
The adrenal gland is reported to be the most common endocrine organ 
associated with chemically induced lesions (Ribelin 1984). It is especially 
important to understand the structure and function of the adrenal gland to 
correctly interpret the significance and mechanisms of drug induced lesions. 
The adrenal medulla is the central core of the adrenal gland, surrounded by 
the adrenal cortex. The adrenal cortex is composed of 3 distinct zones. The 
outer zone is the zona glomerulosa and is composed of a thin region of 
columnar cells arranged in an arched or arcuate pattern. This zone is also 
called the zona multiformis in animals because of its different patterns of 
arrangement of secretory cells. The zona glomerulosa produces the steroid 
hormone aldosterone, which is responsible for increasing sodium reabsorption 
and stimulating potassium excretion by the kidneys and thereby indirectly 
regulating extracellular fluid volume. Loss of this zone or the inability to 
secrete aldosterone may result in death due to retention of high levels of 
potassium with excess loss of sodium, chloride, and water. The zona 
fasciculate is the thickest zone (70% of the cortex) and is composed of 
columns of secretary cells separated by prominent capillaries. The cells are 
polyhedral and have many intracellular lipid droplets. This zone produces 
glucocorticoids. The zona reticularis is also composed of polyhedral cells, 
whose arrangement is less linear and more as round nests or clumps of cells. 
The zona reticularis produces glucocorticoids and in some species small 
amounts of sex steroids, namely, androgens, estrogens, and progestins 
(Rosol et al. 2001).  
 
7.2.9.8.2. Lymph node 
 
Pathogens can set up infections anywhere in the body. However, lymphocytes 
will meet the antigens in the peripheral lymphoid organs, which include lymph 
nodes. Lymph is derived from interstitial fluid and originates in the interstitial 
spaces of most of the body’s tissues. A vast system of converging lymphatic 
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vessels funnels lymph to the thorax where it is returned to the circulation via 
the thoracic duct. When foreign antigens invade the body, antigenic material, 
antigen presenting cells known as dendritic cells and inflammatory mediators 
generated by local immunological activity at the site of infection are all picked 
up by the lymphatic vessels and swept along in the flow of lymph. The system 
of lymphatic vessels has been called an “information superhighway” because 
lymph contains a wealth of information about local inflammatory conditions in 
upstream drainage fields (von Andrian and Mempel 2003). 
 
The lymph node is surrounded by a fibrous capsule, and inside the lymph 
node the fibrous capsule extends to form trabeculae. The substance of the 
lymph node is divided into the outer cortex and the inner medulla surrounded 
by the former all around except for at the hilum, where the medulla comes in 
direct contact with the surface. 
 
Thin reticular fibers, elastin and reticular fibers form a supporting meshwork 
called reticular network inside the node, within which the white blood cells 
(WBCs), most prominently, lymphocytes are tightly packed as follicles in the 
cortex. Elsewhere, there are only occasional WBCs (Kaldjian et al. 2001).  
 
7.2.9.8.3. Spleen  
 
The spleen is a dark red to blue-black organ located in the left cranial 
abdomen. It is adjacent to the greater curvature of the stomach and within the 
omentum. It is an elongated organ, roughly triangular in cross section. The 
gross appearance and size of the spleen are variable, depending on the 
species and the degree of distension; nonetheless, spleen weights can be 
important in its evaluation. The ratio of spleen weight to body weight remains 
fairly constant regardless of age and, in rats, is typically around 0.2% (Losco 
1992). The spleen is the site of direct and indirect toxicity and a target for 
some carcinogens and also a site for metastasis of malignant neoplasms 
arising in other sites.  
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The functions of the spleen are centered on the systemic circulation. It is 
comprised of 2 functionally and morphologically distinct compartments, the 
red pulp and the white pulp. The red pulp is a blood filter that removes foreign 
material and damaged and effete erythrocytes. It is also a storage site for iron, 
erythrocytes, and platelets. In rodents, it is a site of hematopoiesis, 
particularly in fetal and neonatal animals. The spleen is also the largest 
secondary lymphoid organ containing about one-fourth of the body’s 
lymphocytes and initiates immune responses to blood-borne antigens (Nolte 
et al. 2002; Balogh et al. 2004). This function is charged to the white pulp 
which surrounds the central arterioles. The white pulp is composed of three 
subcompartments: the periarteriolar lymphoid sheath, the follicles and the 
marginal zone. The spleen is surrounded by a capsule composed of dense 
fibrous tissue, elastic fibers, and smooth muscle.  
 
The red pulp is a soft mass of a dark reddish-brown color, resembling 
grumous blood. It consists of a fine reticulum of fibers, continuous with those 
of the splenic trabeculae, to which are applied flat, branching cells.  
 
7.2.9.8.4. Thymus 
 
The thymus is the first of the lymphoid organs to be formed and grows 
considerably immediately after birth in response to postnatal antigen 
stimulation and the demand for large numbers of mature T cells. Genetic 
factors also influence the age of onset, rate and magnitude of thymus 
dependant immunological function. In rats and mice, the thymus reaches 
maximal size by sexual maturity and then gradually involutes (Pearse 2006). 
 
A thin connective tissue capsule surrounds each lobe and, in most species, 
gives rise to septae, that partially subdivide the thymus into interconnecting 
lobules of variable size and orientation. The capsule is composed of an outer 
and inner layer of collagen and reticular fibers between which are occasional 
clusters of lymphocytes. This inner layer invaginates to form the septae. The 
bulk of the supporting framework in the thymus is composed of the network of 
epithelial reticular cells. 
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7.2.9.9. Methods for histopathological studies: 
 
The organs were transferred to 4% formalin solution for fixation and later on 
processed for histopathological studies following the standard procedure 
described by Raghuramulu et al. (1983). The microtome sections were cut 
processed and stained with haematoxylin and eosin. The section thus 
obtained was scanned in Trinocular Carl-Zeiss microscope (Germany) under 
different magnifications. Changes if any in the cytoarchitecture were noticed. 
 
7.2.9.9.1. Fixation 
 
Fixation is the process of preserving, hardening and preventing postmortem 
changes of the tissues. The tissues were excised out immediately after 
sacrificing, cleaned of extraneous matter, cut in to pieces of such thickness 
that the fixative readily penetrated throughout the tissue to be fixed. Tissue 
was transferred to the 4% formalin solution and allowed to remain in it till they 
were taken up for processing. 
 
7.2.9.9.2. Tissue processing 
 
Tissue processing involves dehydration, clearing and infiltration of the tissue 
with paraffin. The usual dehydrating agent is ethyl alcohol; acetone and 
isopropyl alcohol can also be used. Following dehydration, the tissue was 
transferred to a paraffin solvent, which is miscible with the dehydrating agent 
as well. These are known as clearing agents such as chloroform and xylene. 
Tissue were thoroughly washed by placing them under running tap water and 
then conveyed through a series of the following solvents as per schedule for 
dehydration, clearing and paraffin infiltration. 
 
Alcohol 70%   -  20 minutes 
Alcohol 80%   -  20 minutes 
Alcohol 90%   -  20 minutes 
Alcohol 95% (2 changes) -  20 minutes each 
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Isopropyl alcohol  -  20 minutes 
Acetone (2 changes) -  20 minutes each 
Chloroform (3 changes) -  20 minutes each 
Melted paraffin wax (60OC) (3 changes) - 30 minutes each 
 
Next the tissues were embedded in paraffin wax to prepare tissue blocks, 
which were oriented so that sections could be cut in desired plane of the 
tissue. Tissues were then fixed to metal object holder after trimming them to 
suitable size. 
 
7.2.9.9.3. Section cutting 
 
A smear of 5% Mayer’s egg albumin was prepared and smeared onto the 
slide and dried. The tissue sections of 6 µm thickness were cut with the help 
of Spencer type rotating microtome. The tissue sections were put on slide and 
then section were floated in water on slide at 55-60OC, water drained off and 
slide dried on hot plate at about 50OC for 30 minutes. This section was ready 
for staining. 
 
7.2.9.9.4. Staining procedure 
 
Reagents: 
1). Mayer’s heamotoxyline stain 
2). Eosin stain, 2% w/v in alcohol 
 
After fixing the sections on slides, they were stained by serially placing them 
in the following reagents: 
 
Xylol (2 changes)   -  3 minutes 
Acetone    -  3 minutes 
Alcohol 95%    -  3 minutes 
Haematoxyline stain  -  20 minutes 
Running water   -  20 minutes 
Eosin stain    -  5 minutes 
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Alcohol 95% (3 changes)  -  3 minutes each 
Acetone (2 changes)  -  3 minutes each 
Xylol (2 changes)   -  3 minutes each 
 
After passing through all the above reagents and stains, the slides were 
mounted with D.P.X. (Diphenyl Phthalate Xylene) and cover slip was placed. 
Care was taken to avoid air bubbles while mounting the slide. The slides were 
viewed under Trinocular research Carl Zeiss microscope (Germany) at 
various magnifications to note down the changes in the microscopic features 
of the tissues studied. 
 
7.2.10. Analgesic studies 
 
Analgesic study was determined in two different models: 
 
7.2.10.1. Acetic acid induced writhing in mice (Hernandez-Perez and 
Rabanal 2002) 
 
Intraperitoneal injection of diluted solution of acetic acid is a well established 
animal model for tonic visceral pain in rodents (Martinez et al. 1999). Swiss 
albino mice were used for acetic acid induced writhing test. Mice were divided 
in to four groups as described earlier in Chapter 7.2.4. Test drug or standard 
drug or distilled water was administered orally, 1 h prior to the injection of 
acetic acid. Writhing was induced by administrating of 3% aqueous solution of 
acetic acid (10ml/kg body weight) intraperitoneally. Immediately after the 
acetic acid injection, each animal was placed in a transparent observation 
cage and the number of writhes per mouse was counted for 30 min. Writhing 
movement is accepted as contraction of the abdominal muscles accompanied 
by stretching of hind limbs. The percentage inhibition was calculated using the 
following ratio:  
 
[(Control mean - treated mean)/control mean] X 100 
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7.2.10.2. Formalin induced paw licking response in rats 
 
The effect of methanol extract of Pluchea arguta Boiss upon formalin induced 
paw licking response was evaluated by adopting the procedure of Magali et 
al. (2000). 
 
The procedure is same as that followed for formalin induced hind paw edema, 
which is mentioned above (7.2.8.). After the injection of formalin, the animals 
were kept under observation for half an hour. The amount of time spent licking 
the injected paw was noted, and was considered to be indicative of pain. The 
time taken for the onset of paw licking was initially measured. The first of the 
nociceptive responses normally peaked 5 min after formalin injection and the 
second phase 15-30 min after formalin injection, representing the neurogenic 
and inflammatory pain (Hunskaar and Hole 1987). Therefore the frequency of 
paw licking was measured in five intervals at 0-5 min., 6-10 min., 11-15 min., 
16-20 min. and 21-30 min. 
 
7.3. RESULTS AND DISCUSSION 
 
7.3.1. Anti-inflammatory activities 
 
From the results of screening of anti-inflammatory activity of 6 plants in 
carrageenan induced rat paw edema (Chapter 4), Pluchea arguta was 
selected for further pharmacological studies. Carrageenan-induced edema 
has been commonly used as an experimental animal model for acute 
inflammation and is believed to be biphasic. The early phase (1-2 h) of the 
carrageenan model is mainly mediated by histamine, serotonin and increased 
synthesis of prostaglandins in the damaged tissue surroundings. The late 
phase (3 h) is associated with neutrophil originated free radicals, such as 
hydrogen peroxide, superoxide and hydroxyl radicals, as well as 
prostaglandin release (Mazzon et al. 2001; Ogonowski et al. 1997; Vineger et 
al. 1969; Brito and Antonio1998)  
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7.3.1.1. Carrageenan induced paw edema 
 
 The results of anti-inflammatory activity of methanol extract of Pluchea arguta 
in carrageenan induced paw edema is shown in Table 7.1. PAM-200 group 
showed potent anti-inflammatory activity at 1 h (71.47%, P≤0.001), 2 h 
(45.25%, P≤0.001) and 3 h (39.06%, P≤0.05). PAM-400 group showed 
significant decrease in paw volume at 1 h (72.97%, P≤0.001), 2 h (68.45%, 
P≤0.001) and 3 h (49.08%, P≤0.05).  Indomethacin group showed significant 
decrease in paw volume at 1 h (67.45%, P≤0.001), 2 h (66.53%, P≤0.001) 
and 3 h (72.61%, P≤0.01). PAM-200 showed more anti-inflammatory activity 
than reference drug indomethacin at 1 h, while PAM-400 group showed more 
anti-inflammatory activity than reference drug indomethacin at 1 h and 2 h. 
Thus it can be concluded that methanol extract of Pluchea arguta has potent 
anti-inflammatory activity in carrageenan induced rat paw edema in early 
phase (1 h) and also in later phase (3 h).  
 
Hence, further anti-inflammatory studies were carried out on methanol extract 
of Pluchea arguta in different anti-inflammatory models. 
 
Table 7.1 Anti-inflammatory activity of methanol extract of Pluchea arguta in 
carrageenan induced paw edema 
 
Groups 
 
After 1 h After 2 h After 3 h 
Increase 
in paw 
volume (%) 
%  
Change 
Increase 
in paw 
volume (%) 
%  
Change 
Increase 
in paw 
volume (%) 
%  
Change 
Control 28.45 ± 2.88 - 38.98 ± 2.45 - 38.94 ± 5.33 - 
PAM-200 8.12 ± 2.65** 71.47↓ 19.90 ± 2.20** 45.25↓ 23.73 ± 2.05* 39.06↓ 
PAM-400 7.69 ± 1.64*** 72.97↓ 12.30 ± 1.87*** 68.45↓ 19.83 ± 1.55* 49.08↓ 
Indo-2.5 9.26 ± 1.25*** 67.45↓ 13.05 ± 3.17*** 66.53↓ 10.67 ± 3.39** 72.61↓ 
Data is expressed as mean ± SEM; P≤ (0.05*, 0.01**, 0.001***); F ≤ 0.05; PAM- methanol extract of 
Pluchea arguta, ↓ decrease 
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7.3.1.2. Dextran induced paw edema 
 
It is well established that carrageenan and dextran induce rat paw oedema by 
different mechanisms. Dextran is a polysaccharide of high molecular weight 
that induces anaphylactic reaction after injection in rat’s extremities, which is 
characterized by extravasation and oedema formation, as a consequence of 
liberation of histamine and serotonin from mast cells (Rowley and Benditt 
1956; Van Wauve and Goosens 1989). 
 
The results of anti-inflammatory activity of methanol extract of Pluchea arguta 
in dextran induced paw edema is shown in Table 7.2. PAM-200 group and 
PAM-400 group showed significant anti-inflammatory activity in dextran 
induced paw edema model when compared with the control group. PAM-200 
group showed significant decrease in paw volume at 1 h (31.97%, P≤0.05), 2 
h (53.70%, P≤0.01) and 3 h (72.04%, P≤0.01). PAM-400 group showed 
significant decrease in paw volume at 1 h (32.26%, P≤0.01), 2 h (55.64%, 
P≤0.001) and 3 h (79.31%, P≤0.01). Indomethacin group showed significant 
decrease in paw volume at 1 h (49.39%, P≤0.001), 2 h (38.85%, P≤0.05) and 
3 h (65.61%, P≤0.01). Methanol extract of Pluchea arguta showed anti-
inflammatory activity in dose dependant manner. PAM-200 and PAM-400 
groups showed almost similar anti-inflammatory activity at 1 h and 2 h, while 
at PAM-400 group showed higher anti-inflammatory activity than PAM-200 
group at 3 h. PAM-200 and PAM-400 groups showed higher anti-inflammatory 
activity than reference drug indomethacin group at 2 h and 3 h, while it was 
lower at 1 h. The results tend to suggest that the anti-inflammatory activity of 
the methanol extract of Pluchea arguta is possibly backed by its anti-
histamine or anti-serotonin activity. 
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Table 7.2 Anti-inflammatory activity of methanol extract of Pluchea arguta in dextran 
induced paw edema 
Groups 
After 1 h After 2 h After 3 h 
Increase 
in paw 
volume (%) 
%  
Change 
Increase 
in paw 
volume (%) 
%  
Change 
Increase 
in paw  
volume (%) 
%  
Change 
Control 67.73 ± 2.87 - 51.19 ± 4.28 - 42.59 ± 5.69 - 
PAM-200 46.08 ± 5.85* 31.97↓ 23.70 ± 3.30** 53.70↓ 11.91 ± 2.79** 72.04↓ 
PAM-400 45.88 ± 4.96** 32.26↓ 22.71 ± 1.50*** 55.64↓ 8.81 ± 2.61** 79.31↓ 
Indo-2.5 34.28 ± 3.53*** 49.39↓ 31.30 ± 3.41* 38.85↓ 14.65 ± 2.11** 65.61↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**, 0.001***), F ≤ 0.05, PAM- methanol extract 
of Pluchea arguta, ↓ decrease 
 
7.3.1.3. Histamine induced paw edema 
 
The histamine is a basic amine related with inflammatory and allergic process 
causing, among several effects, both vasodilatation and increase of vascular 
permeability (Cuman et al. 2001; Linardi et al. 2002). The results of anti-
inflammatory activity of methanol extract of Pluchea arguta in histamine 
induced paw edema is shown in Table 7.3.  Anti-inflammatory activity of PAM-
200 and PAM-400 groups was statistically significant at 0.5 h, 1 h, 2 h and 3 h 
as compared with the control group.  PAM-200 group showed significant 
decrease in paw volume at 0.5 h (24.39%, P≤ 0.05), 1 h (25.99%, P≤ 0.01), 2 
h (36.40%, P≤ 0.05) and 3 h (39.27%, P≤ 0.05). PAM-400 group showed 
significant decrease in paw volume at 0.5 h (26.10%, P≤ 0.05), 1 h (26.16%, 
P≤ 0.01) and highly significant at 2 h (42.72%, P≤ 0.001) and 3 h (46.42%, P≤ 
0.001). Reference drug indomethacin group showed highly significant 
decrease in paw volume at 0.5 h (51.15%, P≤ 0.001), 1 h (57.08%, P≤ 0.001), 
2 h (66.45%, P≤ 0.001) and 3 h (66.34%, P≤ 0.001) as compared with the 
control group. Thus PAM-200 and PAM-400 groups did not show higher anti-
inflammatory activity than reference drug indomethacin group. 
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Table 7.3 Anti-inflammatory activity of methanol extract of Pluchea arguta in histamine 
induced paw edema 
 
Groups 
 
After 0.5 h After 1 h After 2 h After 3 h 
Increase 
in paw 
volume 
%  
Change 
Increase 
in paw 
volume 
%  
Change 
Increase 
in paw 
volume 
%  
Change 
Increase 
in paw 
volume 
%  
Change 
Control  60.65 ±  
3.33 
- 58.42 ±  
3.15 
- 45.23 ±  
2.76 
- 35.98 ±  
2.52 
- 
PAM-200 45.85 ±  
4.15* 
24.39↓ 43.24 ±  
2.48** 
25.99↓ 28.77 ± 
 3.53* 
36.40↓ 21.85 ±  
3.30* 
39.27↓ 
PAM-400 44.82 ±  
3.36* 
26.10↓ 43.14 ±  
2.46** 
26.16↓ 25.91 ±  
1.64*** 
42.72↓ 19.28 ±  
1.11*** 
46.42↓ 
Indo-2.5 29.63 ±  
3.42*** 
51.15↓ 25.07 ±  
2.72*** 
57.08↓ 15.18 ±  
2.80*** 
66.45↓ 12.11 ±  
2.20*** 
66.34↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**, 0.001***), F ≤ 0.05, PAM- methanol extract of Pluchea 
arguta, ↓ decrease 
 
7.3.1.4. Formalin induced paw edema 
 
The results of anti-inflammatory activity of methanol extract of Pluchea arguta 
in formalin induced paw edema is shown in Table 7.4. It is well known that 
inhibition of formalin induced paw edema in rats is one of the most suitable 
test procedures to screen anti-arthritic and anti-inflammatory agents as it 
closely resembles human arthritis (Greenwald 1991). Thus formalin-induced 
paw edema is a model used for the evaluation of an agent with anti-
proliferative activity (Banerjee et al. 2000). Injection of formalin 
subcutaneously into hind paw of rats produces localized inflammation. The 
administration of PAM-200, PAM-400 and indomethacin daily for 7 days 
successfully inhibited edema induced by formalin (Table 7.4). PAM-200 group 
showed decrease in paw volume at 3 h (40.79%, P≤0.05), 24 h (34.98%, 
P≤0.05) and 48 h (35.96%). PAM-400 group showed decrease in paw volume 
at 3 h (42.96%, P≤0.05), 24 h (36.50%, P≤0.05) and at 48 h (39.67%). 
Indomethacin group showed decrease in paw volume at 3 h (30.98%, 
P≤0.05), 24 h (42.64%, P≤0.01) and 48 h (21.67%). PAM-200 and PAM-400 
groups showed almost similar anti-inflammatory activity at 3 h, 24 h and 48 h. 
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PAM-200 and PAM-400 groups showed higher anti-inflammatory activity than 
reference drug indomethacin at 3 h and 48 h. Thus, from the results, it can be 
concluded, that methanol extract of P. arguta has higher anti-inflammatory 
activity in formalin induced paw edema test.  PAM showed significant 
decrease in paw volume till 48 h with both doses, which suggests its long 
duration of action. 
 
Table 7.4 Anti-inflammatory activity of methanol extract of Pluchea arguta in 
formalin induced paw edema 
 
Groups 
 
 
% Increase in Paw volume 
After 3 h After 24 h After 48 h 
Increase 
In paw 
volume 
% 
Change 
Increase 
In paw 
volume 
% 
Change 
Increase 
In paw 
volume 
% 
Change 
Control 53.03 ± 4.98 - 54.03 ± 4.97 - 38.57 ± 4.23 - 
PAM-200 31.40 ± 3.76* 40.79↓ 35.13 ± 2.12* 34.98↓ 24.70 ± 4.31 35.96↓ 
PAM-400 30.25 ± 4.76* 42.96↓ 34.31 ± 3.45* 36.50↓ 23.27 ± 4.71 39.67↓ 
Indo-2.5 36.60 ± 3.73* 30.98↓ 30.99 ± 2.52** 42.64↓ 30.21 ± 3.89 21.67↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**), F ≤ 0.05, PAM- methanol extract of Pluchea 
arguta, ↓ decrease 
 
7.3.1.5. Cotton pellet induced granuloma 
 
Cotton pellet granuloma test is a chronic inflammation model commonly used 
to evaluate the anti-proliferative activities of drugs (Panthong et al. 2004; 
Gupta et al. 2005). Tissue granulation, one of the distinctive features of 
chronic inflammation, which is composed of marked infiltration macrophages 
and neovascularization, was induced by subcutaneous implantation of 
biomaterials. The implanted material induces a host’s inflammatory response 
and modulates the release of inflammatory mediators which finally leads to 
tissue proliferation and granular formation (Tang and Eaton 1995; Hu et al. 
2001). 
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The results of anti-inflammatory activity of methanol extract of Pluchea arguta 
in cotton pellet induced granuloma is shown in Table 7.5. In the present study, 
PAM-200 and PAM-400 groups showed dose dependent activity and 
markedly inhibited granuloma formation surrounding the pellets compared 
with the control group. PAM-200 group showed significant decrease in 
granuloma formation with 24.01% (P≤ 0.05), while PAM-400 group showed 
significant decrease in granuloma formation with 28.68% (P≤ 0.05) which was 
almost near to the reference drug indomethacin (33.97%, P≤ 0.01) group. 
Thus, the results showed that methanol extract of Pluchea arguta has potent 
anti-inflammatory activity in chronic inflammatory model.  
 
Table 7.5 Anti-inflammatory activity of methanol extract of Pluchea 
arguta in cotton pellet induced granuloma formation 
Groups 
Pellet weight 
(g / 100g body weight) 
% Change 
Control 0.157 ± 0.011                       -                 
PAM-200 0.119 ± 0.006* 24.2↓ 
PAM-400 0.112 ± 0.009* 28.66↓ 
Indo-2.5 0.104 ± 0.007** 33.76↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**), F ≤ 0.05, PAM- methanol 
extract of Pluchea arguta, ↓ decrease 
 
 
7.3.1.5.1. Organ weight 
 
7.3.1.5.1.1. Adrenal 
 
The results of organ weight for the adrenal gland in cotton pellet induced 
granuloma rats are shown in Table 7.8. Increase in the absolute weight of the 
adrenal for PAM-200, PAM-400 and indomethacin groups was 3.7%, 7.41% 
and 29.63% respectively as compared with the control group. Increase in the 
relative weight of the adrenal for PAM-200, PAM-400 and indomethacin 
groups was 3.15%, 14.94% and 40.42% respectively as compared with the 
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control group. Indomethacin group showed higher increase in absolute and 
relative weight of the adrenal than PAM-200 and PAM-400 groups. 
 
Table 7.6 Effect of methanol extract of Pluchea arguta on weight of adrenal in 
cotton pellet induced granuloma rats 
Groups 
 
Absolute 
weight 
%  
Change 
Relative 
organ weight 
%  
Change 
Control (D/W) 0.027 ± 0.002 - 0.01 ± 0.001 - 
PAM-200 0.028 ± 0.002 3.7↑ 0.011 ± 0.001 3.15↑ 
PAM-400 0.029 ± 0.002 7.41↑ 0.012 ± 0.001 14.94↑ 
Indo-2.5 0.035 ± 0.003 29.63↑ 0.015 ± 0.002 40.42↑ 
Data is expressed as mean ± SEM, PAM- methanol extract of Pluchea arguta, ↑ Increase 
 
7.3.1.5.1.2. Lymph node 
 
The results of organ weight for the lymph node in cotton pellet induced 
granuloma rats are shown in Table 7.7. The absolute weight of the lymph 
node for PAM-200 group was 33.33% less as compared with the control 
group, while it was similar for PAM-400 group and reference drug 
indomethacin group. The relative weight of the lymph node for PAM-200 
group was 14.57% less and for PAM-400 it was 28.16% more as compared 
with the control group. 
 
Table 7.7 Effect of methanol extract of Pluchea arguta on weight of lymph node 
in cotton pellet induced granuloma rats 
Groups 
 
Absolute 
weight 
%  
Change 
Relative 
organ weight 
% Change 
Control 0.03 ± 0.005 - 0.011 ± 0.002 - 
PAM-200 0.02 ± 0.004 33.33↓ 0.009 ± 0.002 14.57↓ 
PAM-400 0.03 ± 0.004 - 0.014 ± 0.002 28.16↑ 
Indo-2.5 0.03 ± 0.003 - 0.011 ± 0.002 - 
Data is expressed as mean ± SEM, PAM- methanol extract of Pluchea arguta, ↑ Increase, ↓ 
decrease 
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7.3.1.5.1.3. Spleen 
 
The results of organ weight for the spleen in cotton pellet induced granuloma 
rats are shown in Table 7.6. The absolute weight of the spleen for PAM-200 
group was 1.61% more as compared with the control group, while it was 
similar for PAM-400 group. The absolute weight of the spleen for standard 
drug indomethacin group was 29.03% more as compared with the control 
group. The relative weight of the spleen for PAM-200 group was similar to the 
control group, while it was 5.16% more in PAM-400 group and much more 
with 36.8% (P≤ 0.05) in indomethacin group as compared with the control 
group. 
 
Table 7.8 Effect of methanol extract of Pluchea arguta on weight of 
spleen in cotton pellet induced granuloma rats 
Groups 
 
Absolute 
weight 
% 
Change 
Relative 
weight 
 
%  
Change 
Control 0.62 ± 0.02 - 0.24 ± 0.01 - 
PAM-200 0.63 ± 0.04 1.61↑ 0.24 ± 0.01 - 
PAM-400 0.62 ± 0.03 - 0.25 ± 0.01 5.16↑ 
Indo-2.5 0.80 ± 0.08 29.03↑ 0.32 ± 0.03* 36.80↑ 
Data is expressed as mean ± SEM, P≤ (0.05*), PAM- methanol extract of Pluchea 
arguta, ↑ Increase 
 
 
7.3.1.5.1.4. Thymus 
 
The results of organ weight for the thymus in cotton pellet induced granuloma 
rats are shown in Table 7.9. The absolute weight of the thymus for PAM-200 
group showed 8.51% increase, PAM-400 group showed 11.35% decrease and 
indomethacin group showed 4.61% decrease as compared with the control 
group. The relative weight of the thymus in PAM-200 group showed 8.85% 
increase, PAM-400 group showed 7.78% decrease and indomethacin group 
showed 2.59% increase as compared with the control group. PAM-400 group 
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showed more decrease in absolute and relative weight of the thymus than in 
other two groups, while PAM-200 showed more increase in absolute and 
relative weight of the thymus than in other two groups. 
 
Table 7.9 Effect of methanol extract of Pluchea arguta on weight of thymus in 
cotton pellet induced granuloma rats 
Groups 
 
Absolute 
weight 
%  
Change 
Relative  
organ weight 
%  
Change 
Control (D/W) 0.564 ± 0.044 - 0.21 ± 0.01 - 
PAM-200 0.612 ± 0.026 8.51↑ 0.23 ± 0.01 8.85↑ 
PAM-400 0.500 ± 0.052 11.35↓ 0.20 ± 0.01 7.78↓ 
Indo-2.5 0.538 ± 0.029 4.61↓ 0.22 ± 0.01 2.59↑ 
Data is expressed as mean ± SEM, PAM- methanol extract of Pluchea arguta, ↑ Increase, ↓ 
decrease 
 
7.3.1.5.2. Biochemical parameters  
 
7.3.1.5.2.1. Total protein and albumin levels 
 
The results of the total protein level in serum in cotton pellet induced 
granuloma rats are shown in Table 7.10. PAM-200 and PAM-400 groups 
showed increase in protein levels by 4.32% and 5.76% respectively, while 
indomethacin group showed decrease in protein level by 3.68% as compared 
with the control group. In present study, increase in protein level was dose 
dependent.  
 
The results of the albumin level in serum in cotton pellet induced granuloma 
rats are shown in Table 7.10. PAM-200 and PAM-400 groups showed 
increase in albumin level by 4.03% and 18.65% respectively, while 
indomethacin group showed an increase of 2.87% as compared with the 
control group. In present study, increase in albumin level was statistically 
significant in PAM-400 group (P≤ 0.01). 
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Table 7.10 Effect of methanol extract of Pluchea arguta on protein and 
albumin level in cotton pellet induced granuloma rats 
 
Groups Total 
protein 
%  
Change 
Albumin 
%  
Change 
Control 6.25 ± 0.09 - 3.11 ± 0.09 - 
PAM-200 6.52 ± 0.07* 4.32↑ 3.23 ± 0.05 4.03↑ 
PAM-400 6.61 ± 0.06* 5.76↑ 3.69 ± 0.04*** 18.65↑ 
Indo-2.5 6.02 ± 0.19 3.68↓ 3.2 ± 0.16 2.87↑ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.001***), PAM- methanol extract of Pluchea 
arguta, ↑ Increase, ↓ decrease 
 
 7.3.1.5.2.2. Serum aspartate transaminase (AST) and serum alanine 
transaminase (ALT) activities 
 
AST and ALT are considered as markers for liver function (Hilaly et al. 2004). 
The results of the serum AST and ALT activity in cotton pellet induced 
granuloma rats are shown in Table 7.11. PAM-200 group showed a decrease 
in AST level by 11.44%, PAM-400 group showed significant increase in AST 
level by 54.71% (P≤ 0.05) and indomethacin group showed an increase of 
90.41% which was highly significant (P≤ 0.01) as compared with the control 
group. All the three groups showed significant increase in ALT level as 
compared with the control group. PAM-200 group showed 10.56% (P≤ 0.05) 
increase in ALT level, PAM-400 group showed 15.85% (P≤ 0.05)  increase in 
ALT level and indomethacin group showed 15.53% (P≤ 0.01) increase in ALT 
level.  Thus, in the present study, there was significant increase in AST and 
ALT levels in PAM-400 and indomethacin group. However, the ALT values 
were still within the normal range in all the groups. ALT is located primarily in 
cytosol and hepatocytes, and this enzyme is considered a more sensitive 
marker of hepatocellular damage than AST. AST is an enzyme found in the 
cytoplasm and mitochondria in different tissues, chiefly in the heart and 
skeletal muscles, liver, kidneys, pancreas and erythrocytes (Chaves and Silva 
1998; Aniagu et al. 2004). The increase in AST level in the treated groups 
may be due to the release of enzymes from the cells of the damaged organ, 
or to a change in the membrane permeability of the cells (Obici et al. 2008).  
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Table 7.11 Effect of methanol extract of Pluchea arguta on serum 
aspartate transaminase (AST) and serum alanine 
transaminase (ALT) activity in cotton pellet induced granuloma 
rats 
 
Groups AST 
%  
Change 
ALT 
% 
Change 
Control 80.88 ± 2.91 - 40.25 ± 073 - 
PAM-200 71.63 ± 3.18 11.44↓ 44.5 ± 1.32* 10.56↑ 
PAM-400 125.13 ± 9.82* 54.71↑ 46.63 ± 2.4* 15.85↑ 
Indo-2.5 154 ± 12.32** 90.41↑ 46.5 ± 2.54* 15.53↑ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**), PAM- methanol extract of 
Pluchea arguta, ↑ Increase, ↓ decrease 
 
 
7.3.1.5.2.3. Alkaline phosphatase (ALP) and acid phosphatase (ACP) 
activities 
 
The results of alkaline phosphatase and acid phosphatase activity in cotton 
pellet induced granuloma rats are shown in Table 7.12. PAM-200 and PAM-
400 groups showed 15.92% and 11.9% decrease in alkaline phosphatase 
level respectively as compared with the control group. Indomethacin group 
showed 30.71% increase in alkaline phosphatase level as compared with the 
control group. PAM-200 and PAM-400 groups showed 13.15% and 7.78% 
decrease in acid phosphatase level respectively as compared with the control 
group. Indomethacin group showed 1.49% increase in acid phosphatase level 
as compared with the control group. Significant difference was not seen by 
any group. 
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Table 7.12 Effect of methanol extract of Pluchea arguta on alkaline 
phosphatase and acid phosphatase activity in cotton pellet 
induced granuloma rats 
Groups ALP % Change ACP % Change 
Control 23.87 ± 4.44 - 14.14 ± 1.57 - 
PAM-200 20.07 ± 2.99 15.92↓ 12.28 ± 1.55 13.15↓ 
PAM-400 21.03 ± 2.98 11.90↓ 13.04 ± 1.05 7.78↓ 
Indo-2.5 31.20 ± 5.45 30.71↑ 14.35 ± 1.12 1.49↑ 
Data is expressed as mean ± SEM, PAM- methanol extract of Pluchea arguta, ↑ Increase, ↓ 
decrease 
 
7.3.1.5.2.4. Ascorbic acid content in adrenal gland 
 
The results of ascorbic acid content in adrenal gland in cotton pellet induced 
granuloma rats are shown in Table 7.13. The ascorbic acid content increased 
in PAM-400 group (13.38%), while it decreased in PAM-200 group (5.72%) 
and indomethacin group (1.34%).   
 
Table 7.13 Effect of methanol extract of Pluchea arguta on ascorbic acid 
content in adrenal gland in cotton pellet induced granuloma rats 
Groups 
Ascorbic acid 
(µg/mg adrenal) 
% Change 
Control                     8.22 ± 1.08                                               -
PAM-200 7.75 ± 1.27 5.72↓ 
PAM-400 9.32 ± 0.78 13.38↑ 
indo-2.5 8.11 ± 0.33 1.34↓ 
Data is expressed as mean ± SEM, PAM- methanol extract of Pluchea arguta, ↑ Increase, ↓ 
decrease 
 
7.3.1.5.3. Histopathological studies 
 
The histopathological studies of four tissues (Adrenal, lymph node, spleen 
and thymus) in cotton pellet induced granuloma rats are shown in Plate 1 and 
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Plate 2. All the four groups did not produce any changes on cytoarchitecture 
of adrenal, lymph node, spleen and thymus.  
 
7.3.2. Analgesic activities 
 
7.3.2.1. Acetic acid writhing test 
 
Methanol extract of Pluchea arguta was used to distinguish between the 
central and peripheral analgesic action by acetic acid induced writhing 
response in mice. This method is not only simple and reliable but also affords 
rapid evaluation of peripheral type of analgesic action (Gene et al. 1998). In 
this test the animals react with characteristic stretching behavior, which is 
called writhing (Ganesh et al. 2008). The writhing response of the mouse to 
an intraperitoneal injection of noxious chemical is used to screen for both 
peripherally and centrally acting analgesic activities (Trongsakul et al. 2003). 
 
Intraperitoneal injection of diluted solutions of acetic acid is a well established 
animal model for tonic visceral pain in rodents. Intraperitoneal injection of 
acetic acid induces a stereotypic response pattern in the form of abdominal 
contractions (lengthwise stretches of the torso with a concomitant concave 
arching of the back) that may persist beyond 6 h after the administration, 
although most contractions occur within 30 min of the application of the irritant 
(Koster et al. 1959; Mogil et al. 1996).  
 
The results of analgesic activity of methanol extract of Pluchea arguta in 
acetic acid induced writhing test is shown in Table 7.14. PAM-200 and PAM-
400 groups showed 31% and 35% inhibition significantly in abdominal writhes 
produced by acetic acid respectively as compared with the control group. 
Thus, PAM-200 and PAM-400 groups produced a significant (P≤ 0.05) and 
dose dependant inhibition of analgesic effect produced by acetic acid. 
Indomethacin group showed significant inhibition with 46% (P≤ 0.01) as 
compared with the control group. This probably means that the extract is able 
to reduce the receptor sensitivity to the acetic acid induced pain in a dose 
dependent manner. The abdominal constriction is related to the sensitization 
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of nociceptive receptors to prostaglandins. This therefore shows anti-
nociceptive activity (Nwinyi et al. 2006). 
 
Table 7.14 Analgesic activity of methanol extract of Pluchea arguta in acetic 
acid writhing test in Swiss albino mice 
Groups 
Onset time  
(Sec.) 
% Change Frequency % Change 
Control (D/W) 29 ± 5 - 84 ± 7 - 
PAM-200 226 ± 49** 675↑ 58 ± 5* 31↓ 
PAM-400 246 ± 52** 743↑ 54 ± 5* 35↓ 
Indo-2.5 495 ± 51*** 1594↑ 45 ± 8** 46↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**, 0.001***), PAM- methanol extract of 
Pluchea arguta, ↑ Increase, ↓ decrease 
 
 
7.3.2.2. Formalin induced paw licking test 
 
The formalin test is a valid and reliable model of nociception, and it is 
sensitive to various classes of analgesic drugs (Karabay-Yavasoglu et al. 
2007). The formalin test may be more useful as model of pain in which the 
first phase seems to be due to direct chemical activation on nociceptive 
afferent fibers, whereas the second phase is dependent of peripheral 
inflammation and changes in central processing (Tjolsen et al. 1992; Sayyah 
et al. 2004).  
 
The results of analgesic activity of methanol extract of Pluchea arguta in 
formalin induced paw licking are shown in Table 7.15. The onset time of paw 
licking was measured after formalin injection. PAM-200 and PAM-400 showed 
7.29% and 21.53% increase in onset time respectively, while indomethacin 
group showed 25% increase in onset time as compared with the control 
group. Onset time of paw licking response of PAM-400 group was almost the 
same as that of the indomethacin group. PAM-400 and indomethacin groups 
showed statistically significant increase in paw licking response (P≤ 0.05).  
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After formalin injection, the frequency of paw licking was measured between 
0-5 min, 6-10 min, 11-15 min, 16-20 min and 21-30 min. As compared with 
the control group, PAM- 200 group showed 14.04% decrease in frequency 
between 0-5 min, 38.34% between 6-10 min, 62.24% between 11-15 min, 
2.74% between 16-20 min and 13.04% between 21-30 min. PAM-400 group 
showed 38% decrease in frequency between 0-5 min, 80.83% between 6-10 
min, 54.13% between 11-15 min, 14.24% between 16-20 min and 13.93% 
between 21-30 min. Indomethacin group showed  28.01% decrease in 
frequency between 0-5 min, 72.98% between 6-10 min, 48.62% between 11-
15 min, 5.66% between 16-20 min and 11.32% between 21-30 min. 
Statistically significant decrease in frequency between 0-5 min was seen in 
PAM-400 group (P≤0.05) and indomethacin group (P≤0.05). Statistically 
significant decrease in frequency between 6-10 min was seen in PAM-400 
group (P≤0.01) and indomethacin group (P≤0.05). Higher level of frequency in 
paw licking was observed between 0-5 min and 21-30 min. 
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Table 7.15 Analgesic activity of methanol extract of Pluchea arguta in formalin induced paw licking test in rats 
 
Groups 
 
Onset  
time 
(Sec) 
% 
Change 
0-5min 6-10min 11-15min 16-20min 21-30min 
Frequency 
%  
Change 
Frequency 
%  
Change 
Frequency 
% 
Change 
Frequency 
%  
Change 
Frequency 
% 
Change 
Control 
48 ±  
3.13 
- 
16.67 ± 
1.05 
- 
4.33 ±  
0.56 
- 
6.17 ±  
1.58 
- 
5.83 ±  
0.91 
- 
19.17 ±  
2.52 
- 
PAM-200 
51.50 ±  
4.19 
7.29↑ 
14.33 ±  
1.96 
14.04↓ 
2.67 ±  
0.61 
38.34↓ 
2.33 ±  
0.95 
62.24↓ 
5.67 ±  
1.43 
2.74↓ 
16.67 ±  
2.03 
13.04↓ 
PAM-400 
58.33 ±  
1.56* 
21.53↑ 
10.33 ±  
2.23* 
38↓ 
0.83 ±  
0.40** 
80.83↓ 
2.83 ±  
1.14 
54.13↓ 
5 ± 
 0.68 
14.24↓ 
16.50 ±  
1.09 
13.93↓ 
Indo-2.5 
60 ±  
2.14* 
25↑ 
12 ±  
1.34* 
28.01↓ 
1.17 ±  
0.98* 
72.98↓ 
3.17 ±  
0.91 
48.62↓ 
5.50 ±  
1.45 
5.66↓ 
17 ±  
1.86 
11.32↓ 
Data is expressed as mean ± SEM, P≤ (0.05*, 0.01**), PAM- methanol extract of Pluchea arguta, ↑ Increase, ↓ decrease 
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7.4. CONCLUSION 
 
The action of methanol extract of Pluchea arguta observed in the first phase 
of carrageenan induced inflammation may be due to the inhibition of early 
mediators such as histamine and serotonin. The action in the second phase 
may be due to the inhibition of bradykinin and prostaglandins. The methanol 
extract of Pluchea arguta was active on dextran-induced rat paw edema; it 
seems that its activity is related to histamine and serotonine mediators from 
the mast cells (Nishida et al. 1979; Nishida and Tomizawa 1980). Histamine, 
one of the important inflammation mediators, is a potent vasodilator 
substance and increases the vascular permeability (Cuman et al. 2001; 
Linardi et al. 2002). This study showed that all doses of PAM significantly 
suppressed the edema produced by histamine at 3 h, so it may be suggested 
that its anti-inflammatory activity is possibly backed by its antihistaminic 
activity. From the results, it showed that antiedematogenic effects of the PAM 
on carrageenan, dextran and histamine induced oedema may be related to 
inhibition of inflammation mediator formation. 
 
It is well known that inhibition of formalin induced edema in rats is one of the 
most suitable test procedures to screen anti-arthritic and anti-inflammatory 
agents as it closely resembles human arthritis (Greenwald 1991). Thus 
formalin-induced arthritis is a model used for the evaluation of an agent with 
anti-inflammatory activity (Banerjee et al. 2000).  Injection of formalin 
subcutaneously into hind paw of rats produces localized inflammation 
(Vasudevan et al. 2006). PME and indomethacin administered continuously 
for 7 days successfully inhibited edema induced by formalin. 
 
As a model of chronic inflammation, cotton pellet induced granuloma in rats 
was utilized in the present study. During the repair process of inflammation, 
there is proliferation of macrophages, neutrophils, fibroblasts and 
multiplication of small blood vessels, which are the basic sources of forming a 
highly vascularised reddish mass, termed granulation tissue (Swingle 1974; 
Bhattacharya et al. 1992; Gepdiremen et al. 2004). The results of the present 
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study showed that PAM reduced the formation of granuloma tissue in a dose-
dependent manner, which represented an ability of PAM to inhibit the 
proliferation phase of inflammatory process. 
 
Acetic acid induced writhing test was non selective anti nociceptive model, 
since indirectly it induced the release of endogenous mediators stimulated the 
nociceptive neurons that were sensitive to non steroidal anti-inflammatory 
drugs (NSAIDs) (Sanchez-Mateo et al. 2006). The results of the present study 
indicated that methanol extract of Pluchea arguta at both the doses could 
reduce the number of writhing, thus showed powerful anti nociceptive effects.   
 
The most predictive of the models of acute pain is undoubtedly the formalin 
test (Dubuisson and Dennis 1977). In the formalin test, pretreatment of rats 
with the PAM at the doses of 200 and 400 mg/kg showed decrease in the paw 
licking at the first phase of the test (0–5 min) and the second phase (15– 30 
min). The ability of PAM to have an effect on both phases shows that the PAM 
contains active analgesic principle acting both centrally and peripherally. 
 
In conclusion, the results of the present study demonstrated that methanol 
extract of Pluchea arguta produced dose related acute anti-inflammatory 
activity (Carrageenan, dextran, histamine and formalin), chronic anti-
inflammatory activity (Cotton pellet) and analgesic activity (Acetic acid and 
formalin).  
 
These studies have shown that the methanol extract of Pluchea arguta 
contains some active ingredients with the potential of being good anti-
inflammatory and analgesic agents. There is a need for detailed investigation 
of the mechanism of action of methanol extract of Pluchea arguta based on 
which a possible therapy can be visualized. 
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SUMMARY 
 
An estimate of the World Health Organization (WHO) states that around 80% of 
the world’s population consumes traditional herbal medicines. Use of herbal 
remedies is on the rise in developing and developed countries. Many plant 
extracts have been used as a source of medicinal agents to cure urinary tract 
infections, vaginitis, gastrointestinal disorders, respiratory diseases, cutaneous 
affections, helmintic infections, parasitic protozoan diseases, inflammatory 
processes, liver diseases etc.  Herbal products have served as a major source of 
drugs for centuries, and about half of the pharmaceuticals in use today are 
derived from herbal products. The efficacy and safety of herbal medicines have 
turned the major pharmaceutical population towards medicinal plants research. 
 
With the availability of primary information, further studies can be carried out like 
phytopharmacology of different extracts, standardization of the extracts, 
identification and isolation of active principles and pharmacological studies of 
isolated compounds. This may be followed by development of lead molecules as 
well as it may serve for the purpose of use of specific extracts in specific herbal 
formulation. 
 
In recent years, pathogenic microorganisms have developed resistance to 
antibiotics in response to the indiscriminate use of commercial antimicrobial 
drugs commonly employed in the treatment of infectious diseases. This situation 
and the undesirable side effects of certain antibiotics, and the emergence of 
previously uncommon infections, has forced scientists to look for new 
antimicrobial substances from various sources, such as medicinal plants.   
 
In the present work, 53 plants were screened for their antimicrobial activity 
against 15 standard microbial strains (5 Gram positive bacteria, 7 Gram negative 
bacteria and 3 fungal strains). 53 plants were defatted with petroleum ether and 
then extracted in methanol and acetone by cold percolation method. 
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Antimicrobial screening of acetone and methanol extracts of 53 plants was 
performed by agar disc diffusion method at a concentration of 600 μg/disc. Out of 
53 plant extracts, methanol extracts showed 34.72% antibacterial activity against 
Gram positive bacteria, 19.95% antibacterial activity against Gram negative 
bacteria and 25.79% against fungal strains studied. Acetone extracts showed 
24.53% antibacterial activity against Gram positive bacteria, 19.41% against 
Gram negative bacteria and 10.69% against fungal strains. Methanol extracts 
showed more antibacterial activity than acetone extracts. Methanol extracts of 
Aristolochia indica (AIM), Argemone mexicana (AMM), Mangifera indica (MIM) 
and Woodfordia fruticosa (WFM) showed higher antimicrobial activity than other 
extracts. Therefore, these four plant extracts were selected for further 
antimicrobial activity against 74 clinically isolated microorganisms and 24 
standard microorganisms at two different concentrations (600 and 1200 μg/disc). 
Methanol extract of Mangifera indica showed 100% antibacterial activity against 
41 clinically isolated bacterial strains at both the concentrations followed by 
methanol extract of Aristolochia indica. Methanol extracts of Mangifera indica, 
Woodfordia fruticosa and Aristolochia indica showed more antibacterial activity 
against 20 standard bacterial strains. The four extracts did not show any 
antifungal activity. Eleven antibiotics were studied for antibiotic susceptibility test 
against 41 clinically isolated bacterial strains and 20 standard bacterial strains.  
Four antibiotics were studied against 33 clinically isolated Candida species and 4 
standard fungal strains. Imipenem was the most effective antibiotic against 
bacterial strains and Nystatin was the most effective antibiotic against fungal 
strains.  From the results it can be concluded that Gram-positive microorganisms 
were more sensitive to the plant extracts than the Gram-negative 
microorganisms. This in vitro study demonstrated that folk medicine can be as 
effective as modern medicine to combat pathogenic microorganisms. 
 
A growing body of evidence indicates that secondary plant metabolites play 
critical roles in human health and may be nutritionally important. Phytochemical 
screening of plants has revealed the presence of numerous chemicals including 
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alkaloids, tannins, flavonoids, steroids, glycosides, saponins etc. The results of 
preliminary qualitative phytochemical study of the crude powder of 53 plants 
showed presence of alkaloids, tannins, cardiac glycosides, steroids, flavonoids 
and saponins. Tannins were present in more number of plants followed by 
cardiac glycosides and steroids. The results of total phenolic and flavonoid 
content showed that the methanol extract of Mangifera indica showed highest 
total phenolic content, while acetone extract of Aristolochia bracteolate showed 
highest flavonoid content than other plant extracts. 
 
Inflammatory diseases are very common throughout the world and non-steroidal 
anti-inflammatory drugs are the most prescribed drugs for the treatment of 
inflammatory diseases. The greatest disadvantage in presently available potent 
synthetic drugs is their toxicity and reappearance of symptoms after 
discontinuation. Therefore, screening and development of drugs for anti-
inflammatory activity is still in progress and there is much hope for finding anti-
inflammatory drugs from indigenous medicinal plants. Carrageenan induced rat 
paw edema is a suitable in vivo model to predict the value of anti-inflammatory 
agents, which act by inhibiting the mediators of acute inflammation. Methanol 
extracts of Aristolochia indica, Argemone mexicana, Alpinia speciosa, Causarina 
equissetifolia, Gymnema sylvestre and Pluchea arguta were screened for acute 
anti-inflammatory study by carrageenan induced rat paw edema model. Out of 
six plant extracts, the methanol extract of Pluchea arguta showed a potent anti-
inflammatory activity followed by Causarina equissetifolia and Alpinia speciosa. 
Thus, on the bases of availability of plant material and literature search, Pluchea 
arguta (Leaf + stem) was selected for further pharmacognostic, toxicological and 
pharmacological studies. 
 
Pluchea arguta Boiss is a member of family Asteraceae and about 1000 genera 
of this family are well known in the world. Different species of Pluchea are used 
in Ayurvedic system of medicine in various diseases. Various pharmacognostic 
standards like botanical description, microscopy, ash values, extractive values, 
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microscopical characteristics of powder, heavy metals, pH, solubility, HPTLC and 
preliminary phytochemical analysis of Pluchea arguta (Leaf + stem) was studied 
for proper identification of the plant. Standardization procedures and 
pharmacognostical studies of medicinal plants would reduce drastically much of 
the accidents in wrong prescriptions of traditional herbal medicines.  
 
Toxicity testing in animals is carried out on new drugs to identify potential 
hazards before administrating them to humans. Acute toxicity study was 
undertaken to contribute data on the safety of the methanol extract of Pluchea 
arguta. Methanol extract Pluchea arguta extract was found to be nontoxic when 
oral acute toxicity study in mice was performed at single dose level.   
 
Inflammation is a pathophysiological response of mammalian tissues to a variety 
of hostile agents including infectious organisms, toxic chemical substances, 
physical injury or tumor growth leading to local accumulation of plasmic fluid and 
blood cells. Acute and chronic inflammatory diseases are still one of the most 
important health problems in the world. Methanol extract of Pluchea arguta was 
studied for anti-inflammatory and analgesic activity by using different models. 
Methanol extract of Pluchea arguta produced dose related acute anti-
inflammatory activity (Carrageenan, dextran, histamine and formalin), chronic 
anti-inflammatory activity (Cotton pellet) and analgesic activity (Acetic acid and 
formalin). Over all it can be concluded that Mangifera indica possessed good 
antibacterial property and Pluchea arguta possessed good anti-inflammatory and 
analgesic property. Both these plants warrant further investigation to elucidate 
their mechanism of action. 
  
 
 
 
 
 
Fig. 5.1 Macroscopic characteristics of 
Pluchea arguta Boiss. 
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Fig. 5.2 Microscopic characteristic s of 
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Fig. 5.7  HPTLC fingerprinting of methanol extract of P.     
arguta at (A) 254 nm (B) Visible and (C) 366 nm
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Fig. 5.6 HPTLC spectra of methanol extract of P. arguta at (A) 230 nm (B) 290 
nm and (C) 580 nm 
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Fig. 5.3 Microscopic characteristics of Pluchea arguta leaf 




Plate 1 
 
Fig. 1A: Photomicrograph of respective section of adrenal gland of albino rats 
from control group (1 X 400 magnification)  
Md- Medulla; Cr- Cortex; Cp- Capsule 
Note: Normal cytoarchitecture  
 
Fig. 1B: Photomicrograph of respective section of adrenal gland of albino rats 
from PAM-200 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 1C: Photomicrograph of respective section of adrenal gland of albino rats 
from PAM-400 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig.1D: Photomicrograph of respective section of adrenal gland of albino rats 
from standard group (Indomethacin-2.5) (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 1E: Photomicrograph of respective section of lymph node of albino rats 
from control group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 1F: Photomicrograph of respective section of lymph node of albino rats 
from PAM-200 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig.1G: Photomicrograph of respective section of lymph node of albino rats 
from PAM-400 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 1H: Photomicrograph of respective section of lymph node of albino rats 
from standard group (Indomethacin-2.5) (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
 
 
Plate 2 
 
Fig. 2A: Photomicrograph of respective section of spleen of albino rats from 
control group (1 X 100 magnification)  
Rp- Red pulp; Wp- White pulp; Cp- Capsule 
Note: Normal cytoarchitecture 
 
Fig. 2B): Photomicrograph of respective section of spleen of albino rats from 
PAM-200 group (1 X 100 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 2C: Photomicrograph of respective section of spleen of albino rats from 
PAM-400 group (1 X 100 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 2D: Photomicrograph of respective section of spleen of albino rats from 
standard group (Indomethacin-2.5) (1 X 100 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 2E: Photomicrograph of respective section of thymus of albino rats from 
control group (1 X 400 magnification)  
Md- Medulla; Lc- Lymphocytes; L- Lobule 
Note: Normal cytoarchitecture 
 
Fig. 2F: Photomicrograph of respective section of thymus of albino rats from 
PAM-200 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 2G: Photomicrograph of respective section of thymus of albino rats from 
PAM-400 group (1 X 400 magnification)  
Note: Normal cytoarchitecture 
 
Fig. 2H: Photomicrograph of respective section of thymus of albino rats from 
standard group (Indomethacin-2.5) (1 X 400 magnification) 
Note: Normal cytoarchitecture 
